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Abstract 
Multi drug resistant (MDR) strains of Acinetobacter baumannii have emerged as a major 
cause of nosocomial infections associated with significant morbidity and mortality. Over 
the last 20 years a worldwide expansion in Acinetobacter infections has been observed 
associated with intensive care units (ICUs), long term care facilities and wounded 
armed forces personnel. The developing resistance patterns seen in Acinetobacter sp 
suggest that the number of effective antibiotics may shortly be exhausted. The ability of 
Acinetobacter sp to form biofilms, resist desiccation and persist on hospital surfaces has 
played a critical role in the emergence of this bacterium as a human pathogen. The 
ability of clinical strains of A. baumannii to form strong adherent biofilms has also been 
recognised as a key virulence factor for this pathogen.  
This thesis has investigated the ability of a range of A. baumannii strains to form 
biofilms and resist the impact of common biocides. In order to facilitate this research a 
carbohydrate free minimal media employing glucose or alcohols as sole carbon sources 
was developed. Considerable variations in the sensitivity of strains to ethanol or IPA 
was observed with the Type strain being more sensitive and less able to use alcohols to 
support growth than many of the clinical strains investigated. Alcohols as sole carbon 
sources had an impact on bacterial adherence, with 71% of strains being highly 
adherent when fed on alcohol as the sole carbon source. Scanning electron microscopy 
and fluorescent microscopy indicated that highly adherent strains were able to establish 
biofilms on both hydrophobic (plastic) and hydrophilic (glass) surfaces, forming 
carbohydrate based extracellular polymeric substances (EPS) during biofilm formation. 
EPS generation occurred alongside the transient generation of lactate, the latter being 
degraded during the stationary phase. Biofilm forming strains generated high MW EPS 
when grown on mineral media with ethanol as a sole carbon source, extracted EPS was 
shown to contain repeating units of both galactose and rhamnose sugars.  
The Bioscreen system was used to determine the MICs of a range of quaternary 
ammonium compounds (QACs) and PHMB against the highly adherent strains. MIC 
values were below 35 mg/l for all biocides tested and MBC for planktonic cells were 
from 6 to 100 x greater than the MIC values. MBC values for biofilms were orders of 
magnitude greater than MBC values for planktonic cells with little variation between 
biocides or carbon source. Planktonic cells were able to form biofilms at concentration 
considerably greater than the 24 hour MBC for planktonic cells, demonstrating that 
biofilm formation provided additional protection against the biocides investigated.   
A range of antimicrobial wound dressings (NSCD, ISCD, Honey and PHMB) were 
evaluated for their impact on commonly occurring wound pathogens i.e. A. baumannii, 
P. aeruginosa and S. aureus (MRSA). Dressings were evaluated against both planktonic 
cells and cells immobilised in a collagen matrix. In all cases there were significant 
differences (p<0.05) between strains of the same species when treated with the same 
dressing, indicating that significant variations in the susceptibility of wound pathogens 
to antimicrobial dressings were present at the sub species level. The diffusion barrier 
provided by the collagen matrix generated lower reduction values than the planktonic 
approach with a few exceptions. Broadly speaking the NSDC dressing was the most 
effective, PHMB least effective and the Honey dressing was most affected by the 
diffusion barrier provided by the collagen matrix. 
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1 Introduction 
Historically the clinical isolation of Acinetobacter sp was frequently ignored, being considered 
a low grade pathogen (Bergogne-Berezin et al. 1996). However, in recent years, multi drug 
resistant (MDR) strains of  A. baumannii have emerged as a major cause of nosocomial 
infections associated with significant morbidity and mortality (McConnell et al. 2012). Over 
the last 20 years a worldwide expansion in Acinetobacter infections has been observed 
associated with intensive care units (ICUs), long term care facilities and wounded personnel 
(Sebeny et al., 2008, Sengstock et al. 2010). The developing resistance patterns seen in 
Acinetobacter sp suggest that the number of effective antibiotics may shortly be exhausted 
(Hanlon, 2005). The ability of Acinetobacter sp to resist desiccation and persist on hospital 
surfaces, materials and medical devices has played a critical role in the emergence of this 
bacterium as a human pathogen (Villegas and Hartstein, 2003).  
1.1. Aims and Objectives  
The overall aim of this research is to determine the impact of common biocides on the biofilm 
formation of clinical strains of A. baumannii.  
The related objective being: 
1. To determine the ability of A. baumannii strains to form biofilms when utilising a range 
of carbon sources including alcohols; 
2. To extract and characterize the EPS generated by biofilm forming strains of A. 
baumannii; 
3. To determine the Minimum Inhibitory Concentrations (MIC) of a range of biocides 
against clinical strains of A. baumannii; 
4. To determine the Minimum Biocidal Concentrations (MBC) of a range of biocides 
against planktonic cells and biofilms of clinical strains of A. baumannii; 
5. To determine whether or not A. baumannii strains are able to form biofilms in the 
presence of biocides; 
6. To evaluate the antimicrobial efficacy of range of wound dressings against a variety of 
Gram-positive and Gram-negative wound pathogens. 
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2 Literature Review 
 Acinetobacter 2.1
 The Genus Acinetobacter 2.1.1
In 1911 Beijerinck a Dutch Microbiologist, first isolated Acinetobacter sp from soil using a 
minimal media enriched with calcium acetate. Originally described as Micrococcus calco-
aceticus, the genus Acinetobacter ȋfrom Greek word ǲakinetosǳ, means non-motile) was 
proposed some 43 years later by Brisou and Prevot (Brisou and Prevot, 1954) to differentiate 
it from the motile organisms within the Genus Achromobacter. By 1968 the genus 
Acinetobacter was widely accepted after Baumann et al (Howard et al. 2012) published a 
comprehensive study of Mirococcuscalco-aceticus, Alcaligenes hemolysans, Mima polymorpha, 
Moraxella lwoffi, Herellea vaginicola and Bacterium anitratum, which concluded that they 
belonged to single genus and could not be further sub-classified (Howard et al., 2012, Lessel, 
1971). Later, in 1971 the sub-committee on the taxonomy of Moraxella and Allied Bacteria 
officially acknowledged the genus Acinetobacter based on the results of Baumann’s ͳͻ͸ͺ 
publication (Lessel, 1971). Acinetobacter may be easily identified presumptively to the genus 
level (Table 1) (Peleg et al. 2008) however; the organisms are often difficult to de-stain and, 
as such, are often incorrectly identified as Gram-positive (Howard et al. 2012). There is also a 
lack of a definitive metabolic test to distinguish Acinetobacter from other non-fermentating 
Gram-negative bacteria (Peleg et al., 2008). A widely used method to identify to the genus 
level relies on the ability of the mutant A. baylyi strain BD413 trpE27 to be transformed by the 
crude DNA of any Acinetobacter sp to a wild type phenotype (the transformation assay of 
Juni;) (Juni,1972).  
 Acinetobacter Species 2.1.2
For species level identification, the 28 available phenotype tests have proven to be 95.6% 
effective in identifying human skin-derived Acinetobacter (Seifert et al. 1997). However, 
phenotypic tests alone have proven to be ineffective in identifying more recently discovered 
genomic strains of Acinetobacter (Peleg et al. 2008). More advanced molecular diagnostic 
methods have been developed for the identification to the species level, these include: 
amplified 16S rRNA gene restriction analysis, high resolution fingerprints analysis by the 
amplified fragment length polymorphism, ribotyping, tRNA spacer fingerprinting, restriction 
analysis of the 16S-23S rRNA intergenic spacer sequences, sequence analysis of 16S-23S rRNA 
gene spacer region, and sequencing of the rpoB ȋRNA polymerase Ⱦ subunitȌ gene and its 
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flanking spacers (Howard et al. 2012). DNA/DNA hybridisation studies have revealed that the 
genus now consists of 27 species and nine generic sub species (Di Nocera et al. 2011). The 
four species of Acinetobacter (A. baumannii, A. calcoaceticus A. genomic species 3 and 
Acinetobacter genomic species 13TU) are difficult to distinguish phenotypically and therefore 
are often referred to as the A. calcoaceticus complex (Howard et al. 2012). This nomenclature 
can be misleading as the environmental species A. calcoaceticus has not been implicated in 
disease, while the other three species in the complex have being implicated in both 
communities acquired and nosocomial infections (Peleg et al. 2008). 
Characteristic  
Gram reaction -ve 
Metabolism Strictly aerobic 
Fermentation None 
Motile No 
Pigmented No 
Oxidase -ve 
Catalase +ve 
Fastidious No 
DNA G+C content 39-47% 
Morphology coccobacilli 
Growth pattern Diploid/chains 
Table 1. Characteristics of the Genus Acinetobacter (Peleg et al. 2008). 
 Distribution of Acinetobacter sp. 2.1.3
Acinetobacter baumannii has been recovered from soil, water, animals and humans (Paterson, 
2006). On the basis of ecology, epidemiology and antibiotic phenotype of different isolates, 
Towner proposed three major Acinetobacter populations (Towner, 2009, Howard et al. 2012). 
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The first one consisting of A. baumannii and closely related members of the A. baumannii 
complex is represented by the strains isolated from hospitalised patients, medical environments, associated equipment’s and medical personnel. Many of these isolates are 
resistant to multiple antibiotics; although strains such as the clinical isolate ATCC 19606T and 
ATCC 17978 remain sensitive. The second population include strains found on human and 
animal skin flora and those associated with food spoilage, members of this group include A. 
johnsonii, A. lwoffii, and A. radio-resistens. The last group consists of antibiotic-sensitive 
isolates obtained from environmental sources such as soil and wastewater and include A. 
calcoaceticus and A. johnsonii. Although most members of the last two groups are antibiotics 
sensitive, some isolates of A. radio-resistens, A. calcoaceticus and A. johnsonii have been found 
to be resistant to carbapenemase (Figueiredo et al. 2011).  
 Acinetobacter Infections 2.2
A. baumannii has become an increasingly important human pathogen, associated with 
infections acquired in hospitals, long term care facilities, in the community and in wounded 
military personnel (Sebeny et al. 2008, Anstey et al. 2002, Leung et al. 2006b, Scott et al. 2007, 
Sengstock et al., 2010, McConnell et al. 2012). In health care settings, it has become more 
difficult to treat Acinetobacter infections, because of their resistance to major groups of 
antimicrobial agents (Carling and Bartley, 2010, Kramer et al. 2006, Wagenvoort et al. 2011). 
A. baumannii infections are found across a wide range of anatomical regions and with varying 
severity and patient outcomes (Gordon and Wareham, 2010). There have been differences in 
opinion relating to the actual clinical impact of infection and associated impacts on patient 
mortality. Whilst most studies suggest that Acinetobacter infections results in detrimental 
effect on patient outcome, other studies have implied little or no impact (Grupper et al.2007, 
Wu et al., 2007, Sunenshine et al. 2007, Jang et al. 2009, Scott et al. 2007). One reason for this 
confusion is that the Acinetobacter isolates have only been identified to genus level, with 
many referring to infection with A.  calcoaceticus-baumannii complex which could conceivably 
indicate colonization with the environmental species A. calcoaceticus coupled with a 
polymicrobial infection, rather than a mono-microbial infection with a virulent Acinetobacter 
species such as MDR Acinetobacter (Scott et al. 2007). 
The most common types of infection caused by A. baumannii includes, but are not limited to 
pneumonia (both hospital and community-acquired), bacteraemia, skin and soft tissue 
infection, endocarditis, meningitis and urinary tract infections. Most of the cases are thought 
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to be acquired following exposure to A. baumannii that persists on contaminated hospital 
equipment or by contact with healthcare personnel that have been exposed through contact 
with colonized patients (Rodríguez-Baño et al. 2009, Maragakis et al. 2004, Crnich et al. 2005, 
Dijkshoorn et al. 2007, Asensio et al. 2008). 
Hospital acquired pneumonia represents the most common clinical A. baumannii infection, 
generally associated with mechanical ventilation in the intensive care settings. It is thought 
that ventilators-associated pneumonia caused by A. baumannii results from the colonization 
of the airway via environmental exposure, followed by development of pneumonia 
(Dijkshoorn et al. 2007). It has been reported that 40% to 70% mortality rate is related to the 
ventilators-associated Acinetobacter pneumonia (Garnacho et al.  2003), however the 
mortality directly attributable to A. baumannii has been the subject of controversy (Falagas 
and Rafailidis, 2007, Abbo et al. 2007, Falagas et al. 2006, Lee et al. 2007). Community-
acquired A. baumannii pneumonia is a less frequent infection with a 40% to 60% mortality 
rate (Leung et al. 2006a, Chen et al. 2001) often associated with underlying host factors such 
as alcohol abuse or chronic obstructive pulmonary disease (McConnell et al. 2012).  
A. baumannii is also a common cause of bloodstream infections in the intensive care settings 
(Wisplinghoff et al.  2004) associated with the lower respiratory tract infections and 
intravascular devices (Jang et al. 2009, Jung et al. 2010). Risk factors associated with A. 
baumannii bloodstream infections included; immunosuppression, previous antibiotic therapy, 
ventilator use associated with respiratory failure, colonization with A. baumannii and invasive 
procedures (Jang et al.  2009, Jung et al.  2010). Crude mortality rates for A. baumannii 
bloodstream infections have been reported to be between 28% and 43% (Seifert et al. 1995).  
The emergence of drug resistance has contributed significantly to the burden presented by A. 
baumannii blood stream infection. A UK retrospective study (1998-2006) identified an 
increase in carbapenem resistance from 0% in 1998 to 55% in 2006 in A. baumannii isolates 
causing bacteraemia (Wareham et al. 2008). A. baumannii bacteraemia also has an associated 
economic burden, for example bacteraemia caused by MDR A. baumannii strains generated 
$3758 additional medical cost and 13.4 additional days of hospitalization per patient 
compared with none MDR strains in a tertiary care hospital in Taiwan (Lee et al. 2007). A. 
baumannii is an important cause of burn infections, although it can be difficult to differentiate 
between colonization of burn sites and infection. Because of the poor penetration of some 
antibiotics into burns and the high rates of multi drug resistance, these infections can be 
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extremely challenging for clinicians (Chim et al. 2007, Keen Iii et al. 2010, Keen et al. 2010, 
Albrecht et al. 2006).  
A. baumannii is also responsible for meningitis, with the majority of cases occurring in 
patients recovering from neurosurgical procedures (Katragkou et al. 2006, Ng et al. 2006, Ho 
et al. 2007, Huttova et al. 2007, Metan et al. 2007, Paramythiotou et al. 2007, Sasar et al. 2007, 
Guardado et al. 2008, Krol et al. 2009, Cascio et al.  2010), however rare cases of community-
acquired A. baumannii meningitis have been reported (Chang et al. 2000, Taziarova et al. 
2007, Lowman et al. 2008, Ozaki et al. 2009). The clinical features of A. baumannii meningitis 
are similar to other bacterial meningitis, i.e. fever, altered consciousness, headache, and 
seizure (Rodri 2008). The mortality rates associated with A. baumannii meningitis are difficult 
to estimate due to the limited number of studies available and the lack of adequately sized 
study populations, however one retrospective study identified 51 cases of postsurgical A. 
baumannii meningitis in two tertiary care hospitals between 1990 and 2000 (Guardado et al. 
2008). These cases represented 10.9% of all meningitis cases at these intuitions and had a 
crude mortality of 33%, other authors have reported much higher (71%) crude mortality 
(Metan et al. 2007) after evaluating the postsurgical A. baumannii meningitis in 28 patients.     
 Outbreaks/clone involved 2.2.1
A. baumannii has been associated with a number of global outbreaks with the emergence of a 
number of epidemic strains. Three major epidemic European clones Clone I, Clone II and 
Clone III been recognised. Clone I and Clone II were responsible for the outbreaks in hospitals 
of countries of North Western Europe. Clone I has also been isolated from Italy, Poland, Czech 
republic, South Africa and Spain, whereas Clone II was isolated from France, Greece, Turkey, 
South Africa, Spain and Portugal. Clone III was isolated from Italy, Spain, France and 
Netherlands. The latter data suggest that these clones are being virulent and MDR, 
responsible for outbreaks that are difficult to control and therefore becoming endemic in 
hospitals (Van Dessel et al. 2004). 
 Military experience 2.2.2
A. baumannii is also a major cause of burn infections in military personnel, and in some cases 
it has been identified as the most common cause of burn site infection (22%), with 53% of 
isolates being MDR (Keen et al. 2010, Keen Iii et al.  2010).  Since the onset of conflict in Iraq 
and Afghanistan, a high of infection associated with MDR A. baumannii-calcoaceticus complex 
has also been reported amongst non-US military casualties evacuated to tertiary medical 
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centres (O'Shea, 2012). In UK MDR A. baumannii infections amongst British personnel 
returning from operational combat theatres was first reported following the survey of 30 
hospitals that had received patients directly from Iraq between March and October 2003 
(Jones et al. 2006). While 11 (37%) of the receiving hospitals reported the presence of MDR A. 
baumannii infections, their origins pre-dated the admission of military patients. However, 
several other strains of A. baumannii both outbreak and sporadic, had been isolated from 
patients evacuated from Iraq and were proving a persistent problem. From the onset of the 
conflict in Iraq in April 2003 and over the following 18 months, A. baumannii was isolated 
from 27 casualties evacuated from Gulf region and admitted to the military medical facility in 
Birmingham. Out of these 27 patients, 23 were military personnel and the rest of them were 
civilians (Jones et al. 2006). A. baumannii isolated from personnel associated with Iraq were 
PFGE typed and identified as a prominent strain, the T strain, first isolated in May 2003, which 
was different to the major circulating UK clones [South east (SE) clone, OXA-23 clone I and 
OXA-23 clone II]. The T strain isolated was MDR, susceptible to amikacin and tobramycin, but 
generally resistant to ampicillian, amoxicillin/clavulanic acid, gentamycin, ceftazidime, 
chloramphenicol, ciprofloxacin, cefotaxime, nitrofurantoin and trimethoprim.  
Whilst the original T strain isolates were carbapenem-susceptible, they possessed the gene 
for an OXA-51 like carbapenemase and since April 2005 some members of the T strain clone 
have been found to be carbapenem-resistant due to activation of the blaOXA-51.gene by ISAba1 
(Turton et al. 2006b). In a further analysis, a comparison of PFGE profiling of A. baumannii 
isolates from US and British Iraq causalities revealed that 25 British isolates includes 
representatives of the T strain, the OXA-23 clone II, and comparatively minor outbreak strain 
(Turton et al. 2006a). The 15 representative isolates of A. baumannii, isolated from inpatients 
at WRAMC, LRMC and US army field hospital in Baghdad included representatives of the T 
strain, OXA-23 clone II and the minor outbreak strain. The lack of the integrase gene in the 
rest of the nine US isolates indicated their sporadic origin. Both US and UK isolates were 
distinct from the most prevalent strains of A. baumannii, in hospitals in UK, namely 
representatives of the SE clone and OXA-23 clone I (Turton et al. 2004). Moreover, US 
personnel coming back from the Iraq war have shown the presence of multi-drug resistance A. 
baumannii. A. baumannii is also responsible for the multi-facility outbreaks described in 
France and USA, probably as a result of the transfer of colonised and infected patients from 
one facility to another (O'Shea, 2012). 
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 A retrospective study investigated Canadian forces soldiers critically injured in Afghanistan 
requiring mechanical ventilation and repatriation to Canadian hospitals (Tien et al. 2007). 
Between January 2006 and September 2007, six Canadian soldiers were admitted to field 
hospital in Kandahar after significant combat-related traumatic injuries requiring mechanical 
ventilation; these soldiers were evacuated from Afghanistan through LRMC to five different 
Canadian hospitals, four of them developed MDR A. baumannii VAP A. baumannii isolated from 
Canadian hospitals and from LRMC were found identical antibiotic susceptibility after typed 
by PFGE (Tien et al. 2007). Furthermore, a variety of environmental samples collected from in 
and around the field hospital in Kandahar, including soil samples and those from critical care 
areas (ICUs and operation room) in late 2005 were analysed. A. baumannii was not isolated 
from any of the environmental samples except from a ventilator air intake filter sample; the 
isolate was identical to the MDR A. baumannii isolated from all four patients in LRMC and 
Canada.  
 UK Acinetobacter spp. bacteraemia statistics 2.2.3
In the years between 2008-12, the incidence of Acinetobacter spp. bacteraemia fell by 33% 
from 1.8-1.2 per 100,000 populations (Figure 2.1). Total number of bacteraemia reported in 
the UK increased by 1% and Acinetobacter sp accounted 0.6% of mono-microbial blood 
stream infection in 2011 making it the 20th most commonly reported mono-microbial blood 
stream infection causing organism (HPA, 2013). However, in 2012 the Acinetobacter spp. 
bacteraemia cases reduced from 1026 to 710 reports, which is the lowest number of reports 
in one year over a decade. In fact this is the first year that less than 25% of Acinetobacter spp. 
bacteraemia were identified as A. calcoaceticus/baumannii, having decreased each year since 
2008. However the Acinetobacter sp reported as A. lwoffii have increased each year since (27-
37% in 2008-12). The incidence of Acinetobacter spp. bacteraemia was higher in males than 
females across all the age groups, and the 75 and over were the most vulnerable, closely 
followed by the infections in children <1 year of age (Figure 2.2). The overall rate of infection 
in England, Wales and Northern Ireland was 1.2 per 100,000 populations in 2012, with 
Northern Ireland having the highest reported incidence with 1.5 per 100,000 populations, 
followed by England (1.3) and Wales (0.3). Within England there were wide variations in 
reports from 0.8/100,000 in the North East region to 2.1/100,000 in the London region 
(Figure 2.3) (HPA, 2013). 
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Figure 2.1. Acinetobacter sp bacteraemia rates per 100,000 populations (England, 
Wales and Northern Ireland 2008-2012). 
 
 
Figure2.2.Acinetobacter sp bacteraemia age and sex rates per 100,000 populations 
(England, Wales and Northern Ireland 2008-2012)(HPA, 2013). 
 
Figure 2.3. Geographic distribution of Acinetobacter sp bacteraemia rates per 100,000 
populations (England, Wales and Northern Ireland 2008-2012). 
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 Antimicrobial Resistance 2.2.4
The emergence of multi-antibiotic resistant A. baumannii strains has been attributed not only 
to its ability to rapidly develop resistance mechanisms but also to the fact that it is well suited 
to genetic exchange.  
Therefore Acinetobacter belongs to a unique group of Gram negative bacteria characterised as ǲnaturally transformableǳ (Perez et al. 2007). Acinetobacter have been reported to be 
resistant to β-lactams   (Corvec et al., 2003, Fournier et al., 2006, Iacono et al., 2008, Perez et 
al. 2007, Ruzin et al. 2007), aminoglycosides, quinolones (Vila et al. 1995; Vila et al. 1997; 
Robicsek et al. 2005), tetracyclines (Perez et al., 2007, Ruzin et al., 2007), and polymyxins 
(Corvec et al., 2003, Fournier et al., 2006, Iacono et al., 2008, Perez et al., 2007, Ruzin et al. 
2007, Giamarellou, 2007). Despite the environmental distribution of Acinetobacter spp in 
nature, MDR resistant Acinetobacter has no habitat other than hospital environment (Espinal 
et al. 2011). 
MDR A. baumannii has been reported from different hospitals in Europe, USA, Japan, China, 
Hong Kong and Korea (McConnell et al. 2012). The surveillance data obtained by British 
Society for Antimicrobial Chemotherapy (BSAC) revealed the increasing resistance trends 
since 2002 in A. baumannii, with >30% of bacteraemic isolates in 2005 being resistant to 
piperacillin/tazobactam, gentamicin and with non-bacteraemic isolates being even more 
resistant (British Society for Antimicrobial Chemotherapy, 2007). MDR clones of A. baumannii 
have been isolated from 24 hospitals in the UK (Mostly in London area), which are resistant to 
piperacillin/tazobactam, gentamicin, ampicillin, piperacillin, ceftazidime, cefotaxime and 
ciprofloxacin, with most isolates also resistant to carbapenem (Turton et al. 2006b). The 
resistance of 226 strains found in the MYSTIC (Meropenem Yearly Susceptibility Test 
Information) collection when tested against carbapenems and comparators revealed that 
meropenem was the most active compound (76.1% susceptibility), followed by imipenem 
(74.7%) > gentamicin (51.9%) > ciprofloxacin (40.5%) >piperacillin/tazobactam (39.8%) > 
ceftazidime (38.1%) (Turton et al. 2006a). 
A variety of risk factors have been associated with MRD A. baumannii infections (Falagas and 
Kopterides, 2006, Carbonne et al. 2005). According to a multivariate analysis of a 20 case-
control study by Falagas and Kopterides (2006), antibiotics use was the most common risk 
factor identified in >50% of cases. Third generation cephalosporins and carbapenems were 
the most commonly implicated antibiotics, followed by fluroquinolones, amino-glycoscides 
11 
 
and metronidazole. However, Landman et al (Landman et al., 2002), found that the use of 
cephalosporins plus aztreonam, but no other antibiotics, was associate with the presence of 
MRD A. baumannii. Other risk factors include stays in ICU, length of ICU and hospital stay, 
gender, severity of illness and therapeutic interventions such as hydrotherapy, tracheostomy, 
transfusions, and placement of arterial and central venous catheters, Foley catheters, etc 
(D'Agata et al., 2000, Navon-Venezia et al., 2005, Falagas et al., 2006).  
The ability of A. baumannii to acquire antibiotic resistance mechanism helps this organism to 
grow and persist in the hospital environment which resulted in the emergence of global MDR 
strains especially the alarming reports describes infections caused by pan drug-resistant 
strains with resistance to all clinically used antibiotics (Taccone et al., 2006, Valencia et al. 
2009). These MDR strains proved to be challenge for the clinicians treating these infections 
and necessitate the development of novel strategies for preventing and treating infections 
caused by these strains. There are number of reviews which provide the comprehensive 
information on antibiotics resistance mechanism and clinical aspects of A. baumannii (Chopra 
et al., 2008, Peleg et al. 2008, Vila and Pachón, 2008, Gordon and Wareham, 2010, Fishbain 
and Peleg, 2010). The major reported resistance mechanism are summarise in Table. 2.2. A. 
baumannii have shown the remarkable capacity of acquire and rearrange genetic 
determinants that play a critical in pathobiology, the first that kind of report explaining the 
acquisition of genetic characteristics is the acquisition of the 86-kb AbaR1 resistance island, 
the acquisition of this island, which includes 45 resistance genes as well genetic traits coding 
for DNA mobilization functions could be explained by horizontal gene transfer from unrelated 
sources (Fournier et al. 2006). Another A. baumannii strains i.e. European Clone II strain 
ACICU harbour the AbaR2 resistance island (Iacono et al. 2008). More recently, a comparative 
study on genome wide analysis of ACICU and three strains belonging to A, B and C types 
determined by pulse field gel electrophoresis isolated during an outbreak at the National 
Institute of Health Clinical Centre. Snitkin et al (Snitkin et al. 2011), reported that the AbaR1 
resistance island responsible for the antimicrobial resistance. This report also revealed that A. 
baumannii has the ability to adapt to hospital environments not only by horizontal acquiring 
genetic traits responsible for the evolution of non-MRD ancestors into MRD outbreaks strains, 
but also by rearranging pre-existing genes. A. baumannii strains has the ability to shuffle, add 
and or delete genes which are responsible for the coding for important virulence factors, 
specially cell surface proteins and O-antigens and the expression of the functions needed to 
acquire essential nutrients such as iron (Snitkin et al. 2011). 
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Drug Class Resistance mechanism Examples 
Β-lactams Inactivating enzymes 
 
 
Decreased outer 
membrane  protein 
expression 
 
Altered penicillin-binding 
protein expression 
 
Efflux pumps 
Ⱦ-Lactamases (AmpC, TEM, VEB, PER,CTX-M, SHV) 
Carbapenemases (OXA-23,  -40, -51, -143-like, VIM, 
IMP, NDM-1, -2 ). 
CarO, 33-36kDa protein, OprD-like protein 
 
 
PBP2 
 
 
AdeABC 
Fluoroquinolones Target modification 
Efflux pumps 
Mutations in gyrA and parC 
AdeABC, AdeM 
Aminoglycosides Aminoglycoside modifying 
enzymes 
Efflux pumps 
Ribosomal methylation 
AAC, ANT, APH 
 
AdeABC, AdeM 
ArmA 
Tetracyclines Efflux pumps 
Ribosomal protection 
AdeABC, TetA, TetB 
TetM 
Glycylcylines Efflux pumps AdeABC 
Polymyxins 
(Colistin) 
Target modification Mutation in the PmrA/B two components system 
(LPS modification), mutation in LPS biosynthesis 
genes. 
Table 2.2: Major resistance mechanism found in A. baumannii. 
These finding suggest that non-MDR strains may serve as a source of antigenic variants that 
could play a critical role in the diversification and emergence of MDR A. baumannii clinical 
isolates,  Imperi and his colleagues (Imperi et al. 2011), findings supported that report, they 
found that A. baumannii has relatively small sized core genome and a rather large accessory 
genome that hosts numerous antibiotic resistance and virulence determinants and is possible 
could be acquired by horizontal gene transfer process. A. baumannii also possess an intrinsic 
class D oxacillinase belonging to the OXA-51-like group of enzymes responsible for over 40 
sequence variants (Alsultan et al. 2009), that gene helps the bacteria to hydrolyse penicillin’s 
(ampicillin, ticarcillin, benzylpencillin and peperacillin) and carbapenems (imipenem and 
meropenm), but do so only weakly (Peleg et al. 2008). A significant contribution to lactam 
resistance by OXA-51 like enzymes therefore requires the presence of an insertion element 
ISAbal upstream of the gene, which act as a strong transcriptional promoter (Turton et al. 
2006a). The most common enzymatic mode of carbapenem resistance is the production of 
oxacillinases encoded by genes of the blaOXA-23, blaOXA-40 and blaOXA-58 like lineage.  
In Europe the spread of MDR A. baumannii not restricted to hospitals in cities but also occurs 
on a national scale, mostly through inter-hospital patient transfer’s e.g the spread of Southeast 
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clone and the OXA-23 Clones I and II in southeast England (Coelho et al. 2006). International 
transfer of colonised patients has led to the introduction and subsequent epidemic spread of 
MRD A. baumannii strains from southern into northern European countries such as Belgium 
and Germany (Schulte et al. 2005). In a surveillance data (MYSTIC), from48 European 
hospitals from 2002-04, just 69.8% A. baumannii were susceptible to imipenem 73.1% 
susceptible to meropenem, however susceptibility to other antibiotics was very low i.e 
ceftazidime (32.4%), ciprofloxacin (34%) and gentamicin (47.6%) (Unal and Garcia-
Rodriguez, 2005). There is also a long history of A. baumannii outbreaks in USA, outbreaks of 
carbapenem resistant A. baumannii were observed in New York city in 1991 and 1992 (Go et 
al. 1994). In recent years, the industry supported surveillance data includes isolates of A. 
baumannii collected between 2004-05 from 76 centres throughout the USA revealed that only 
60.2% were susceptible to imipenem (Halstead et al. 2007). The outbreaks of A. baumannii 
also reported in Asia and Middle Eastern hospitals, rates of non- susceptibility (Anti-microbial 
surveillance program 2001-04) increased 25% for impienem and meropenem, 40% for 
cefepime and ceftazidime, 40% for ampicillin sulbactam, 35% for amikacin and 45% for 
ciprofloxacin(Gales et al. 2006). 
 Mechanisms of resistance 2.2.5
Acinetobacter sp show a wide range of antibiotic resistance mechanisms including:   β-lactamase activity;  alterations in outer membrane proteins (OMPs) (porins);  alteration of penicillin-binding proteins (PBPs);  increased activity of efflux pumps. (Corvec et al. 2003, Fournier et al. 2006, Iacono et 
al., 2008, Perez et al. 2007, Ruzin et al. 2007).  
 β-lactamase activity 2.2.5.1
I. Class A β-lactamases 
Although TEM-ͳ Ⱦ-lactamase is known to occur in A. baumannii, class A extended spectrum Ⱦ-
lactamases (ESBLs) have been reported recently (Vila et al., 1993, Poirel et al., 2005) , A. 
baumannii strains having PER-1, an ESBL demonstrate high level resistance to penicillins and 
extended spectrum cephalosporins and been reported in the organism responsible for 
outbreaks in France, Belgium and Bolivia hospitals (Celenza et al. 2006, Naas et al. 2006, 
Poirel et al. 2005) it has also been reported in USA (Hujer et al. 2006). A. baumannii, CTX-M-2 
an ESBL characterised by enhanced hydrolysis of cefotaxime and ceftriaxone.  
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II. Class B β-lactamases 
The increase in the number of metallo-beta-lactamases (MBLs) in A. baumannii results in the 
global emergence of resistance to Ⱦ-lactams (Walsh, 2005, Walsh et al. 2005). These are Class B Ⱦ-lactamases has the ability to hydrolyse carbapenems as well as every other beta-lactam 
antibiotic with the exception of aztreonam. They differ from Class A and D carbapenemases by 
having a metal ion in the active site, usually zinc which helps in catalysis (Walsh et al. 2005). 
III. Class C β-lactamases 
Acinetobacter sp, like other Gram negative organisms have a chromosomally encoded class C 
beta-lactamase. According to recent phylogenetic analysis chromosomal ampC genes in 
Acinetobacter spp, likely descend from a common Ⱦ-lactamases gene ancestor and are more 
closely related to each other than to ampC genes present in other species of bacteria, it is proposed that these represent a distinct family of Ⱦ-lactamases, the Acinetobacter-derived 
cephalosporinases (ADCs) (Hujer et al. 2005). The bla genes code for class C cephalosporinases 
that hydrolyse penicillins and narrow and extended spectrum cephalosporins, but not 
cefepime or carbapenems. Thus many clinical isolates of A. baumannii are resistant to 
ceftazidime (Hujer et al. 2005).  
IV. Class D β-lactamases Class D Ⱦ-lactamases are usually contains penicillinase (oxacillinases). Some OXAs (OXA 
ESBLs), are also able to hydrolyse extended spectrum cephalosporinases (Aubert et al. 2001, 
Walther-Rasmussen and Høiby, 2006).  
 Changes in outer membrane proteins (OMPs) and penicillin-binding proteins (PBPs) 2.2.5.2
The contribution of porins or outer membrane proteins (OMPs) and penicillin-binding 
proteins PBPs to antibiotics resistance in A. baumannii is not fully understood, laboratory 
studies however revealed the variability in the number of observed OMPs and PBPs (Cuenca 
et al. 2003, Fernández-Cuenca et al. 2003). The epidemic MDR A. baumannii from New York 
city revealed the presence of carbapenem resistant isolates with reduced expression of 37-, 
44-, and 47kDa OMPs results in the increased expression of class C cephalosporinases (Quale 
et al. 2003), relatively similar results have been reported from Madrid, where there was the 
loss of 22-kDa and 33-kDa OMPs combined with the production of OXA-24 resulted in the 
resistance to carbapenems (Bou et al. 2000). The resistance of A. baumannii to carbapenemsis 
also explained by reduced expression of PBP-2 as described for isolates from Seville, Spain 
(Cuenca et al. 2003, Fernández-Cuenca et al. 2003). 
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  Efflux pumps 2.2.5.3
Efflux pumps are a unique phenomenon in drug resistance, which is a single mechanism 
resulting in resistance against range of different classes of antibiotics (Perez et al., 2007). 
These efflux pumps mediate the efflux of compounds toxic to the bacterial cell, including 
antibiotics, i.e. coupled exchange with protons. Distinct families of efflux pumps found in 
different spp of bacteria namely the major facilitator superfamily, the resistance-nodulation-
cell division family the multidrug and toxic compounds extrusion superfamily and the small 
multidrug resistance superfamily. In A. baumannii, the Ade/ABC efflux pump which is a 
member of resistance-nodulation-cell division family and has been well characterised, 
Ade/ABC efflux pump, pumps aminoglycosides, tetracyclines, chloramphenicol, 
fluoroquinolones, cefotaxime, erythromycin and trimethoprim (Magnet et al., 2001). The over 
expression of Ade/ABC efflux pump results in high level of resistance to carbapenem in 
conjunction with carbapenem-hydrolysing oxacillinases (Marqué et al., 2005).  
 Additional Virulence Factors 2.2.6
When compared with other Gram-negative bacteria, relatively few virulence factors have 
been identified for A. baumannii. The best characterised virulence factor of A. baumannii is 
OmpA. Evidence that A. baumannii OmpA contributes to virulence was obtained in a random 
transposon mutagenesis screen where deficient strains were unable to induce apoptosis in a 
human laryngeal epithelial cell line (Choi et al., 2005). A purified OmpA localised to the 
mitochondria and induced apoptosis through the release of the proapoptotic molecules 
cytrochrome C and apoptosis-inducing factor suggesting that this may be one possible 
pathway by which A. baumannii induces damage to human airways cells during infection. The 
role of OmpA in adherence and invasion of epithelial cells may also contribute to the spread of 
A. baumannii during infection, as the bacterial load in the blood of experimental induced A. 
baumannii pneumonia were significantly higher in mice infected with wild type strain than in 
mice infected with an equal amount of an isogenic OmpA mutant (Choi et al., 2008). The 
OmpA protein also helps A. baumannii persist and grow in human serum as it has been shown 
that OmpA interacts with soluble inhibitors of the alternative complement pathway and allow 
the bacteria to avoid complement-mediated killing (Kim et al., 2009). However, OmpA is 
unlikely to be the one factor that contributes to serum resistance since other A .baumannii 
strains all with putative OmpA genes, have significantly different capacities for growth and 
survival in human serum (Antunes et al., 2011b).  
16 
 
A. baumannii have also been shown to secrete OmpA in response to alcohols found in 
sanitation products (Smith et al., 2004, Edwards et al., 2007a)  this may be associated with the 
emulsifying activity of OmpA, which could be useful in scavenging carbon for growth and 
survival under low nutrient conditions (Walzer et al., 2006). These bio-emulsifying proteins 
may also be helpful in bacterial adhesion, quorum sensing and the development of biofilms 
(Ron and Rosenberg, 2001).  Exposure to ethanol also serves as an environmental signal that 
controls the salt tolerance and increased pathogenicity when tested in Caenorhaditis elegans 
(Smith et al., 2004). The genomic and mutagenic analysis of the strain ATCC 17978 proved 
that enhanced ethanol mediated virulence response in Caenorhaditis elegans worms and 
Dictyostelium didcoideum amoebae are due to the presence of genes located in pathogenicity 
islands, some of which code for novel gene products (Smith et al., 2007).  The latter findings 
suggest that ethanol could play a global regulatory function; a hypothesis supported by the 
findings obtained using global RNA-sequencing (Camarena et al., 2010). This study revealed 
the identification of 49 ethanol-induced genes coding for metabolic functions, stress 
responses and virulence functions, suggests that ethanol affects the pathobiology of A. 
baumannii. These findings correlates with the findings of another study which states the 
presence of ethanol in the clinical settings may have an impact on pathobiology of A. 
baumannii (Edwards et al., 2007a). According to Leung et al (Leung et al., 2006a), the highly 
clonal hospital-acquired, multi drug resistant strains of A. baumannii existing in the UK appear 
to be less virulent than drug-sensitive community strains. Therefore, any enhanced effect on 
virulence due to alcohols used in health care setting may have major clinical implications.  
Another virulence factor is lipopolysaccharide (LPS), A. baumannii LPS contains a lipid A 
moiety, the carbohydrate core, and the receptor O-antigen. Recently the role of A. baumannii 
LPS was investigated by Luke et al (Luke et al., 2010), who used mutants lacking the LpsB 
glycotransferase that results in a highly truncated LPS glycoform containing only two 
carbohydrate residues bound to lipid A. This mutant showed decreased resistance to human 
serum and decreased survival in a rat model of soft tissue infection compared with the 
isogenic parent strain, indicating the role for the surface carbohydrate residues of LPS in 
pathogenesis.  
In addition to the LPS, the capsular polysaccharide has also been identified as a virulence 
factor in A. baumannii. The structure of capsular polysaccharide isolated from two clinical 
isolates revealed that a linear amino polysaccharide consisting of three carbohydrate residues 
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in one strain and a branched pentasaccharide in the other (Fregolino et al., 2011). Mutants 
that were deficient for growth in human ascites (peritoneal cavity) fluid because of 
transposon insertion in the ptk or eps A gene failed to produce a capsular-positive phenotype 
and showed decreased growth in both human serum and ascites compared with the wild type 
counterpart. Additionally, mutant strain (without capsule) cleared after 24 h post-infection in 
a rat soft tissue infection, whereas the isogenic parental strain persisted with > 107cfu/ml of 
exudative fluid (Russo et al., 2010); demonstrating that the capsular polysaccharide appears 
to play an important role in protecting bacteria from the host innate immune response.   
Lypolytic enzymes have also been implicated in A. baumannii pathogenicity. Lipolytic 
enzymes e.g phospholipases catalyse the cleavage of phospholipids, these enzymes are 
thought to contribute the pathogenesis of Gram-negative bacteria by helping in the lysis of 
host cells via cleavage of phospholipids present in the host cell membrane and by degrading 
phospholipids present at mucosal barriers to facilitate bacterial invasion. Removal of the two 
phospholipase D genes present in A. baumannii genome results in survival in serum and a 
reduced capacity for invading epithelial cells (Jacobs et al., 2010). 
Iron is abundant in biological systems however; the availability of ferric iron is relatively poor 
due to its poor solubility under aerobic conditions and its chelation by low molecular weight 
compounds e.g. heme, and by high  iron-binding proteins such as lactoferrin and transferrin. 
In iron limitation conditions, most of the aerobic bacteria express high affinity iron acquisition 
system which assist the production, export and uptake of Fe3+chelators known as 
siderophores (McConnell et al., 2012). Some bacteria have the ability to utilize heme or 
haemoglobin as an iron source and some are able to remove iron from transferrin or 
lactoferrin (Crosa et al., 2004, Wandersman and Delepelaire, 2004). A. baumannii does not 
bind transferrin and does not carry genetic determinants coding for the proteins involved in 
the acquisition of iron from transferrin or lactoferrin (Smith et al., 2007). However, ATCC 
19606T uses heme as an iron source (Zimbler et al., 2009). In strain ATCC 17978 a 
chromosomal cluster annotated as AIS_1608-AIS_1614, is a polycistronic operon involved in 
the transport of heme from the periplasm into the cytoplasm (Smith et al., 2007). In a more 
recent genetic analysis (Antunes et al., 2011b, Eijkelkamp et al., 2011), different A. baumannii 
strains can use this compound as an iron source suggesting the presence of a heme uptake 
and utilization system. These observations indicate that the A. baumannii, genome contains 
genes coding for products devoted to the capture and utilizing of heme, a host product that 
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could be available at sites where there is an extensive cell and tissue damage (Brachelente et 
al., 2007, Charnot-Katsikas et al., 2009, Corradino et al., 2010), or in severely injured patients 
(Peleg et al., 2008).  
A. baumannii may also require ferrous iron, available under low-oxygen conditions, because 
fully sequenced and annotated genomes show the presence of genes coding for Fe (II) 
transport systems (Antunes et al., 2011a), the functions of which remains to be tested.  A. 
baumannii also have the ability to form siderophores, the best characterised system is that 
mediated by the siderophores acinetobactin, initially described in the ATCC 19606T strain and 
has a highly related molecular structure to anguibactin, which is a high affinity iron chelator 
produced by Vibrio anguillarum 775 (Fish pathogen) (Yamamoto et al., 1994, Yamamoto et al., 
1999, Dorsey et al., 2004, Mihara et al., 2004). The only difference in these two siderophores 
is that anguibactin has a thiazoline group derived from cysteine, while acinetobactin contains 
oxazoline ring derived from threonine. In spite of this difference, the siderophores which are 
produced by these two different bacterial pathogens found in environments are also 
functionally related (Dorsey et al., 2004). The recent genomic analysis revealed that A. 
baumannii could contain more than one locus involved in siderophores biosynthesis 
(Eijkelkamp et al., 2011, Antunes et al., 2011a). In short, the available experimental and in 
silico observation indicate that A. baumannii can acquire iron either by using heme as an iron 
source or by capturing the metal with acinetobactin and/or more additional siderophores-
mediated systems. 
However, many of the environmental and physiological factors affecting the virulence 
phenotype of A. baumannii are unidentified and uncharacterized. Some Acinetobacter mutants 
harbour mutations impairing the expression of ABC transporters, an uncharacterised urease 
activity, and transcriptional regulators. Recently, it was reported that A. baumannii also sense 
and respond to the light an unexpected observation considering that of A. baumannii is non-
photosynthetic microorganism (Mussi et al., 2010). In addition, these observations lead to the 
hypothesis that the outcome of certain infections, such as surface exposed wound infections 
could depend on the exposure of bacteria to the light and temperature lower than 37°C. 
 Healthcare Associated Infections (HAI) 2.3
Generally speaking the pathogens that cause Healthcare associated infections (HAI) have two 
specific properties i.e. not only do they cause disease but they also persist in hospital 
environments for long periods (Dancer, 1999, Kramer et al., 2006), e.g. methicillin-resistant 
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Staphylococcus aureus (MRSA), Acinetobacter and vancomycin-resistant enterococci (Carling 
and Bartley, 2010, Kramer et al., 2006, Wagenvoort et al., 2011). Viruses such as novovirus 
and influenza, and fungi such as Candida albicans, also persist in hospitals for several weeks 
(Kramer et al., 2006). Gram-negative coliforms, e.g. E.coli and Klebsiella sp, are less robust but 
survive on dry, as well as wet surfaces, although this tend to be for shorter periods of time 
than  Acinetobacter (Kramer et al., 2006).  
Despite the ubiquity of Acinetobacter spp in nature, multidrug resistant Acinetobacter has no 
particular habitat other than hospital environment. Acinetobacter has the ability to survive on 
dry, inanimate surfaces, acquire resistance genes and tolerate biocides and antibiotics, A. 
baumannii is capable of spreading within health care facilities and its impact in combat zones 
and natural disaster areas throughout the world is increasingly evident. Since A. baumannii 
has the ability to grow on fingertips and inanimate objects such as glass, and plastic surfaces, 
even after exposure to dry conditions, during extended period of time and its ability to form 
biofilm it shows much resistance to antimicrobial stressors, antibiotics or cleaning Products 
(Espinal et al., 2011). The emergence of pathogenic Acinetobacter infections in military 
personnel sustaining injuries during Iraq and Afghanistan conflicts have provided an 
important contribution to the epidemiology of infections with Acinetobacter spp (O'Shea, 
2012). Pseudomonas aeruginosa is one of the most of important nosocomial pathogens, 
especially in intensive care units (ICUs) (Henrichfreise et al., 2007). Pseudomonas aeruginosa 
is one of the most difficult organisms to treat because of intrinsic and acquired antibiotic 
resistance. In Europe, P. aeruginosa was found to be the third most common isolate from 
nosocomial infections in (ICUs) (Henrichfreise et al., 2007). 
 Contamination of Surfaces in Healthcare Environments  2.3.1
Environmental screening has demonstrated that pathogens can survive on a variety of 
hospital surfaces (Getchell-White et al., 1989, Bhalla et al., 2004, Lemmen et al., 2004, Dancer 
et al., 2008, Kaatz et al., 1988, Wu et al., 2005, Kerr and Snelling, 2009). They can attached to 
droplets, skin scales or dust partials which may be intermittently dispersed through the 
atmosphere, ultimately settling on floors and other surfaces (Kramer et al., 2006). These 
include general surfaces such as shelves, and ledges, curtain, linen and cloths, telephone, 
computers, furniture and all items of clinical equipment, but some pathogens such as 
Pseudomonas spp, persist in damp places such as showers, baths and sinks, others e.g C. 
difficile and VRE, contaminate toilet areas or commodes (Lemmen et al., 2004, Kerr and 
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Snelling, 2009, Alfa et al., 2008, Noble et al., 1998). Dust associated microbes such as 
Acinetobacter spp. and MRSA settle on rarely cleaned or inaccessible surfaces, such as shelves, 
highly place equipment and computer keyboards, while coliforms such as Klebsiella and 
Serratia sp. are spread through air currents especially in hot dry summers (Dancer, 1999). 
Some items, e.g. lockers, sheets, beds and patient tables tend to host pathogens more 
frequently than others (Dancer et al., 2008, Malnick et al., 2008). This may be due to patients 
shedding from colonised sites, proper cleaning and/or frequent handling, but that will 
increase the risk of the infection for all the patients, especially patients with weak immune 
system, or those receiving antibiotics, in dwelling devices and/or surgery. The greatest 
infection risk for patients comes from surfaces beside or on beds (Bhalla et al., 2004, Dancer 
et al., 2008, Dancer et al., 2009, Wilcox et al., 2003). Furthermore, there are a number of 
studies that have an increased risk of acquiring a specific pathogen if a patient is admitted into 
a room previously occupied by a patient colonised or infected with the same organism 
(Carling and Bartley, 2010, Huang et al., 2006, Shaughnessy et al., 2011, Wilks et al., 2006).  
The ability of A. baumannii to resist desiccation and persist on hospital surfaces,  materials 
and medical devices has played a critical role in the emergence of this bacteria as a HAI 
(Villegas and Hartstein, 2003). A. baumannii has the ability to survive several days on dry 
surfaces and inanimate objects in hospitals, attached to the body parts of patients and can also 
survive on dust particles in dry conditions (Bergogne-Berezin and Towner, 1996, Davis et al., 
2005). Acinetobacter  has also be found on ventilators, mattresses, pillows, suctioning 
equipment, humidifiers, bed rails, bedsides, container of distilled water, nutrition equipment’s, urine collection jugs, intravenous, portable water, reusable arterial pressure 
transducers, the nodes of electrocardiographs, wash basins, sinks, infusion pumps, 
hygroscopic bandages, showers, stainless-steel trolleys, resuscitation equipment and tables, 
portable radiology devices, bed linen, soap dispensers, spirometers, temperature probes and 
soap dispensers (Paterson, 2006). 
 Biofilms 2.3.2
It is difficult to describe biofilms briefly, as they have many characteristics and mechanisms, 
ecologies, physiological and genetic heterogeneities, resistance to disinfectants, sanitizers and 
antimicrobials (Bales et al., 2013). Biofilms are defined as highly self-organized, three-
dimensional structure D community enclosed in a polymeric matrix or exopolymeric 
substances (EPS), constituting a protective mechanism to survive in harsh environments and 
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during host infection (Espinal et al., 2011, Jahid and Ha, 2012). Biofilms are composed of 
microorganisms attached to either each other, to living or non-biotic surfaces and may be 
embedded within a complex matrix of polysaccharides, proteins, nucleic acids and 
glycoproteins (Donlan and Costerton, 2002). 
For the effective eradication of microorganisms within a biofilm, higher concentrations of 
antimicrobial agent are often required when compared to their planktonic or free floating 
non- biofilm counterparts (Thomas et al., 2011), and often the antimicrobial concentrations 
required for the removal can be 100-fold of that required for removal microorganisms in the 
planktonic state (Rasmussen and Givskov, 2006). In the context of human health 80% of 
infections are suggested to be biofilm related (Davies, 2003, Blackwell, 2005). For example in 
chronic wounds, e.g. diabetic foot ulcers, pressure ulcers and venous leg ulcers biofilms are a 
central part of the evolution of the infection (James et al., 2007). The effective and efficient use 
of medical devices such as catheters, artificial valves etc. are often compromised by the  
formation of biofilms (Strelkova et al., 2012).   
 Biofilm Formation   2.3.2.1
Biofilm formation is not a single step process, it is a stepwise, dynamic process and different 
physical, chemical, genetic and biological processes are involved in the maturation of biofilm. 
Although it is not clear but more or less five to six steps are involved in biofilms formation 
(Jahid and Ha, 2012). These steps are:  
 reversible attachment to a produce surface; 
  irreversible attachment through producing quorum sensing ; 
 EPS production; 
 micro-colony formation; 
 colonization or maturation step; 
 dispersal. 
 Attachment 2.3.2.2
There are few genetic mechanisms known to be involved in the attachment steps to produce 
biofilm however, several studies have suggested that the bacterial cellular surface charge, 
surface hydrophobicity, produce hydrophobicity, van der Waals forces and electrostatic 
forces, simultaneously interact and adhere to the surface (Palmer et al., 2007, Ukuku and Fett, 
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2006). However, different environmental conditions triggers diverse pathways to which help 
the bacterial colonization. In general, force-generating movements might be required to form 
attachments to produce (Jahid and Ha, 2012).  The attachment also depends on the pathogenic 
and nutritional conditions of the host, hydrophobicity, cell surface charge and even bacteria to 
bacteria interactions (Ukuku and Fett, 2002). 
 Quorum-sensing (QS) signal 2.3.2.3
Bacteria initiating biofilm formation express a range of molecules which allow cell to cell 
communicate and coordination, a process known as Quorum-Sensing (QS) (Sperandio et al., 
2003). There are four identified QS system. Of these, Gram negative bacteria have 
autoinducer-1 (AI-1) that secretes N-acylhomoserine lactones (AHLs) (Miller and Bassler, 
2001) , and autoinducer-3 (AI-3) (Sperandio et al., 2003), while Gram positive bacteria have 
auto-inducer peptide (AIP) signalling pathways for intra-species communication. Both Gram 
positive and negative microorganisms express autoinducer-2 (AI-2), QS molecules furanosyl-
borate-diester to facilitate inter-species communication (Miller and Bassler, 2001).    
 EPS formation 2.3.2.4
The exopolymeric substances (EPS) present in biofilms may include polysaccharides, 
proteins, glycoproteins, glycolipids, extra cellular DNA, metal ions, divalent cations and other 
surface active components (Morris et al., 1997, Yadav et al., 2012). When microorganisms 
secrete a critical concentration of auto-inducer molecules, they form EPS at the surface of 
bacterial aggregates (Abee et al., 2011). Bacterial aggregates generate EPS to provide 
protection against environmental stresses e.g., antibiotics, disinfectants and irradiation (Van 
Houdt and Michiels, 2010). The generation of EPS facilitates adherence to biotic or abiotic 
surfaces, micro-colony formation, and the 3-dimensional surface of a mature biofilm (Danese 
et al., 2000, Van Houdt and Michiels, 2010).  
 Micro-colony formation 2.3.2.5
Following attachment bacteria begin to multiply and initiate communication by the formation 
of quorum-sensing molecules. At a certain level of quorum-sensing molecules, environmental 
cues stimulate the formation of EPS and bacteria continue to multiply within the EPS. Analysis 
of biofilms has revealed that once EPS production has been initiated, bacteria focus on the 
maturation of the biofilm and produce pili, flagella and fimbriae (Davey and O'Toole, 2000). 
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 Colonization or maturation steps 2.3.2.6
The final stage of biofilm formation is maturation; here biofilms develop into a self-organised 
complex structure containing a range of microenvironment. The final arrangement is in 
monolayers, a three dimensional structure consisting of bacteria surrounded by EPS, which 
has channels for nutrients and water flow (de Beer et al., 1994). 
 Dispersal 2.3.2.7
Dispersal or detachment of biofilms are due to various reasons, such as presence of QS 
molecules, nutrient accessibility, surface character changes, as well as physical forces from the 
surface (Kaplan, 2010).  Another studied revealed that bacterial growth, different enzymes 
produced by bacteria, external environmental influences, nutrient deprivation, bacterial 
autocidal activity  and human interactions are some of the factors results in dispersal or 
detachments of cells from biofilms.   
 Acinetobacter Biofilms 2.3.3
A. baumannii is able to form strong adherent biofilms that help the bacteria to survive for 
several weeks on abiotic surfaces resulting in contamination of hospital and medical 
instruments, e.g. incubator tubes, water lines, cleaning instruments, pillows and linen 
(Harrison et al., 2008, Donlan, 2008, Villegas and Hartstein, 2003, McConnell et al., 2012). 
Wroblewska et al (Wroblewska et al., 2008) reported that clinical strains of A. baumannii have 
the ability to form biofilms which act as a virulence factor. They used 34 clinical strains of A. 
baumannii isolated from patients hospitalized in two tertiary care hospitals for their studies. 
The isolates demonstrated a wide range of biofilm forming ability, with 12% high, 41% 
medium and 47% demonstrating a low level of biofilm production. 
Pirog et al (Pirog et al., 2002), reported that Acinetobacter spp.12S has the ability to grow and 
synthesize EPS on different carbohydrate substrates like mono and disaccharides, molasses 
and starch. They reported that the Acinetobacter spp. was grown on carbohydrate media 
containing no pantothenic acid (Vitamin B3), which is required for growth on C2 substrates. 
They used mixture of carbohydrate sources (0.01, 0.1, 0.5 and 1% v/v ethanol and 1% w/v 
glucose) and found that bacterial growth and EPS generation was higher when 0.01% ethanol 
with 1% glucose used. The EPS production was intensified as the content of the C2 substrate 
in the medium increased. He also reported that addition of low concentration (0.02% v/v) of 
acetate to the glucose-containing medium also stimulated the EPS synthesis. The biofilm 
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formation and attachment is variable among clinical isolates of A. baumannii; for example 
strains like ECII are more adherent than ECI to human bronchial tissue (Lee et al., 2006). 
Generally, A. baumannii adheres to biotic and abiotic surfaces via the same steps described for 
general biofilm formation. The associated EPS being composed of carbohydrates, proteins, 
nucleic acids and other macromolecules (McConnell et al., 2012). Donlan  & Costerton (Donlan 
and Costerton, 2002, Gaddy and Actis, 2009), hypothesized that A. baumannii persistence in 
medical environments, resistance to antimicrobials, and disease generation is closely 
associated with its ability to form biofilm on solid surface. Some of the A. baumannii clinical 
isolates also form complex biofilm structures on the surface of liquid media know as pellicles 
(McQueary and Actis, 2011, Marti et al., 2011), the pellicles and biofilm formation on abiotic 
surfaces are variable among A. baumannii clinical strains and there is a clear correlation 
established between the nature of substrate and bacterial surface properties (McQueary and 
Actis, 2011, Marti et al., 2011). Furthermore, there are significant variations in the amount of 
biofilm formation and type of cell arrangements formed on the abiotic surfaces. Some cell 
arrangements are highly organised, multi-layered and complex structures encased within a 
biofilm or EPS matrix, while some others are simple monolayers of bacteria attached in an 
organized or random manner (McQueary and Actis, 2011).     
A number of gene products have been proven to play a role in attachment and biofilm 
formation on abiotic surfaces e.g. pilus production mediated by the CsuA /BABCDE usher-
chaperone assembly system is required for the attachment and biofilm formation on the 
abiotic surfaces by the A. baumannii ATCC 19606T strain. This operon seems to be wide 
spread among clinical isolates and an indication that it is a common factor among different 
clinical isolates (Tomaras et al., 2003). The A. baumannii ATCC 19606T strain also has ability 
to produce alternative pili that may help in the interaction of this pathogen with bronchial 
epithelial cells (De Breij et al., 2010). Loehfelm et al (Loehfelm et al., 2008) reported that 
biofilm-associated protein (Bap), conserved in the clinical isolates and appears to be 
associated with the cell-cell interactions that support the development and maturation of the 
biofilm.  
In addition to (Bap), the A. baumannii clinical isolates also produce poly-Ⱦ-1-6-N-
acetylglucosamine (PNAG) for the development and maturation of the biofilm on glass 
surfaces by the cells cultured (Bentancor et al., 2012, Choi et al., 2009b). A two component 
regulatory system also reported in A. baumannii ATCC 19606T strain comprised of: a sensor 
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kinase encoded by bfmS, and a response regulator encoded by bfmR involved in bacteria-
surface interaction (Tomaras et al., 2008). The insertional inactivation of bfmR results in the 
loss of expression of cusA/BABCDE operon resulted in the lack of pili production and biofilm 
formation on plastic surfaces when they are grown in rich medium; however the inactivation 
of bfmS sensor kinase gene resulted in diminishment but not abolishment of biofilm formation 
(Tomaras et al., 2008). In the absence of BfmRS system the composition of culture media still 
influence the interaction of cells with abiotic surfaces, these finding indicates that the BfmRS 
system cross talks with other sensing components and suggests instead of one, there are 
multiple and different stimuli which could control the biofilm formation via BfmRS regulatory 
pathway (Tomaras et al., 2008). When compared to adherence to abiotic surfaces, much less is 
known about the factors that influence adherence and biofilm formation on biotic surfaces. 
Gaddy et al (Gaddy et al., 2009), reported that A. baumannii attaches to the human epithelial 
cells and C. albicans filaments, in a process that involve at least one OmpA, although OmpA 
play a vital role in biofilm development on plastic surfaces, this outer membrane also critical 
for the interaction of A. baumannii with human and Candida cells when the Candida are in its 
filamentous form. Candida, A. baumannii (ATCC 19606T) strain interactions are independent 
of pili assembled by the csu usher-chaperone system and lead to apoptotic death of the fungus 
filaments (Gaddy et al., 2009). These studies suggest that there is no direct correlation 
between biofilm formation on abiotic and biotic surfaces, and a wide variation exists in the 
cell-surface and cell-cell interactions that result in the adherence and biofilm formation by 
different A. baumannii clinical isolates. In addition, to that the role of pili in bacterial virulence 
and the pathogenesis of A. baumannii infections remains to be confirmed using appropriate 
derivatives and experimental infection models.  
Adherence and biofilm formation also responds to a wide range of environmental and cellular 
factor (Stanley and Lazazzera, 2004), e.g. it depends upon the presence and expression of 
antibiotics resistant traits, such as the blaPER-1 gene and a positive correlation exist between 
the presence and the expression of this gene and the amount of biofilm formed on the plastic 
surface and the adhesiveness of the bacteria to human epithelial cells (Lee et al., 2008), 
however another study revealed that only two out of 11 isolates carrying the blaPER-1 gene 
formed strong biofilms when compared with isolates lacking the genetic determinant (Rao et 
al., 2008). Other environmental factors, such as temperature and extracellular free iron 
concentration, which are relevant for the interaction of A. baumannii with the host, also effect 
biofilm formation on abiotic surfaces (McConnell et al., 2012).  
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Another mechanism controlling bacterial adherence and biofilm formation is cell population 
density. Accordingly, environmental and clinical isolates produce quorum sensing signalling 
molecules (Gonzalez et al., 2001, Gonzalez et al., 2009), these studies proved that a large 
number of isolates produce quorum sensing and signalling molecules which seem to belong to 
three types of molecules. Although none of these sensors belongs to a particular species, 
however the Rf1-type sensor is more frequently found in isolates belonging to the A. 
calcoaceticus-baumannii complex. Niu et al (Niu et al., 2008) proved that the A. baumannii M2 
clinical isolates produce an N-acyl-homoserine lactone [N-3-hydroxydodecanoyl-
homoserinem lactone], the product of the abaI auto-inducer synthase gene, which is vital for 
the fully developed biofilm on abiotic surfaces, abaI auto-inducer also helps this isolate to 
move in semisolid media. 
 Another factor which influences biofilm formation on abiotic surfaces is light, although 
unexpected since A. baumannii is a chemotroph not know to conduct photosynthesis (Mussi et 
al., 2010). This response is mediated by BlsA photoreceptor protein, which contains a BLUF 
domain and uses flavin adenine dinucleotide (FAD) to sense light, however the mechanism by 
which BlsA transduces the light signal and controls gene expression are not well known 
(Mussi et al., 2010). The A. baumannii response to light seems to have a global effect on the 
physiology of A. baumannii, affecting not only biofilm formation, but also motility and 
virulence. In addition, the differential response to light is mediated by changes in 
temperature, which result in differential transcription of blsA at ʹͺ and ͵͹ͼC and hence 
differentially affect light controlled phenotypes (Mussi et al., 2010). A. baumannii biofilm 
formation and adherence depends on range of bacterial factors and multiple signals or cues. 
However, the medical relevance of the data obtained using in vitro models is not clear, 
considering the lack of correlation between the biofilm phenotype of different clinical isolates 
and their outbreak, epidemic and antibiotic resistance nature (de Breij et al., 2009).  
 EPS characterisation 2.3.4
The polysaccharides present in EPS can be present as hetero-polysaccharides or homo-
polysaccharides. Hetero-polysaccharides are made up of a variety of monosaccharide’s 
arranged in repeating units,  a number of these structures have been characterised in recent 
years (Leroy and De Vuyst, 2004, Laws and Marshall, 2001). Furthermore, the variations in 
heteropolysaccharides is increased by the monomeric units being present in either Ƚ or Ⱦ 
configuration, in the pyranose (P) or furanose (f) forms or in either D-or L-absolute 
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configuration (De Vuyst et al., 2001). The repeating structure is the simplest form of 
polysaccharide and the first was isolated from St. thermophilus and characterised by Doco et 
al, (Doco et al., 1990) as: →͵Ȍ-Ⱦ-D-Galp-ȋͳ→͵Ȍ-[Ƚ-D-Galp-ȋͳ→͸Ȍ]-Ⱦ-D-Glcp-ȋͳ→͵Ȍ-Ƚ-D-
GalpNAc-ȋͳ→. 
 High performance anion exchange chromatography (HPAEC)            2.3.4.1
In order to identify the primary structure of the EPS repeat unit it is firstly necessary to 
identify the monomer composition. In recent years, a number of methods have been used for 
monosaccharide analysis including High performance anion exchange chromatography 
(HPAEC), which has been widely used as an alternative to GC analysis due to a number of 
advantages over the GC method. This technique was first highlighted by Rocklin and Pohl 
(Rocklin and Pohl, 1983) for the carbohydrate analysis, since than the application and 
effectiveness of that technique have been reviewed by number of scientist (Lee, 1990, Cataldi 
et al., 2000). The main advantage of that method is that it allows the determination of intact monosaccharide’s ȋinitial depolymerisation by acid hydrolysis is requiredȌ without pre or 
post column derivatisation, which greatly reduces analysis times whilst eliminating the 
decrease in  recovery often observed due to incomplete derivatisation (Currie and Perry, 
2006). 
 NMR analysis 2.3.4.2
NMR spectroscopy is used to determine the overall secondary structure of EPS by providing 
information on the basis on ring size (pyranose/furanose) and anomeric configuration ȋȽ/ȾȌ 
of the individual monomers and also determining the relative orientations of the monomeric 
units to each other. The NMR spectroscopy as a tool for the determination of carbohydrates 
structures is underlined by number of reviews published in recent years (Lee flang et al., 
2000, Bush et al., 1999). A key issue with NMR analysis is the removal of interfering 
substances. These can be classified as monomeric media components such as glucose and EPS 
equivalent substances that are often present in common media compositions such as yeast 
extract. Interference by these materials underlines the need for effective dialysis, the use of 
none interfering carbon sources and the use of media that are optimised for NMR analysis.  
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Figure. 2.4.1H NMR spectra of EPS from Lactobacillus helvetics Rosviski (Laws et al. 
2009). 
2.3.4.2.1 1H NMR analysis 
When analysing 1H NMR the spectra should be split and viewed as having structural reporter 
signals (up filed and down field) and a bulk region (Vliegenthart et al., 1983). This approach 
breaks down the spectra enabling the similar identification of individual sugars along with 
their structural features and linkage compositions. The up field, reports region contains 
resonances from structural motifs which include ring substituents such as acyl, alkyl and 
acetyl, ring substitutions such as N-acetyl amino groups and H6 signals of 6-dexoy sugars. The 
anomeric proton resonances are located in the down field, reporter region of the spectra 
between 4.4-5.5 ppm (Figure 2.4). Integration of the anomeric resonances can be used to 
estimate the number of different monosaccharide units present in the repeat unit structure. 
The remaining shift protons are situated in the bulk region located between 4.3-3ppm 
(Vliegenthart et al., 1983).  
2.3.4.2.2 13C NMR analysis 
13C NMR provides information on the carbon atoms that are connected to hydrogen atoms in 
the molecule (attached protons). The –CH3 and –CH groups both generates positive signals in 
the spectra whilst –CH2 groups display a negative signal. As with 1H NMR spectra, specific 
regions of interest relating to carbohydrate can also be identified in the 13C NMR emanating 
the ring carbons (C2-C5) are located between 65-85 ppm, while carbons substituted with 
either an amino or methyl group are shifted up filed. The anomeric carbons (C1) are shifted 
down field between 95-105 ppm due to glycosylation. The signals for the C6 atoms appear as –
CH2 and are therefore represented as negative signals between 60-70 ppm. 
 Weight-average Molecular Weight Determination (MALLS analysis) 2.3.4.3
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EPS of the bacterial species usually possess molecular mass ranges from 4 x 104 to 106 g mol-1 
(Vuyst and Degeest, 1999).The molecular mass is commonly recognised as one of the factors 
contributing in EPS functionally (Vuyst and Degeest, 1999). In general, the size of a 
polysaccharide is expressed by the number of monosaccharide units it contains, which is 
termed as the degree of polymerisation (DP). Previously, gel permeation chromatography 
(GPC) has been used to indicate a range of MW by comparison with controlled standard of a 
particular MW; however, this method needs large sample sizes and relies on the comparisons 
with standards. The current method used to determine MW and sizes of polysaccharides is 
high performance size exclusion chromatography with multi-angle laser light scattering (HP-
SEC-MALLS) (Wyatt, 1993). HP-SEC-MALLS works with the same principle of weight and size 
separation with GPC but instead of preparative columns the sample is run through smaller 
analytic scale columns. The sample then pass through an online ultraviolet (UV), light detector 
which provides information on the presence of any residual proteins and nucleic acids which 
may be present in the sample. The system is then coupled with both a MALLS and differential 
refractive index (RI) detectors which allow for the determination of the accurate molecular 
mass of the EPS without the requirement reference materials (Badel et al., 2011).  
 Fourier transform infrared spectrocopic (FTIR) 2.3.4.4
Fourier transform infrared (FTIR) spectroscopy is a rapid nondestructive method that has 
been applied to many biological systems (Schmitt and Flemming, 1998, Gómez-Zavaglia and 
Fausto, 2003). The techique is based on the principle that atoms in the molecules are not held 
rigidly apart and when subjected to infrared radiation (between 500 and 4000 cm-1), the 
molecule will absorb energy and the bond will subject to a number of vibrations. Hence the 
absorbtion spectrum contains information regarding the molecular structure of the sample. 
The region between 4000 and 500cm-1 holds the characteristic bands and is sutiable for the 
characterisation of microorganisms (Dittrich and Sibler, 2005, Schmitt and Flemming, 
1998).The wide and intensive carbohydrate or EPS bands are foundat wave number 950-
1200cm-1 which can be attributed to –C-O-C- group vibrations in the cyclic structure (Gómez-
Zavaglia and Fausto, 2003, Dittrich and Sibler, 2005, Lin et al., 2005). 
 Cleaning and disinfection 2.4
Cleaning is a process that removes foreign material e.g. soil, organic material, microorganism 
from an object, while disinfection is a process that reduces the number of pathogenic 
microorganism but not necessary bacterial spores from inanimate objects or skin to a level, 
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which is not harmful to health. Detergents are surfactants or a mixture of surfactants with 
cleaning properties in dilute solutions and they are composed of both hydrophobic and 
lipophilic parts, while disinfectant are substances that are applied to non-living objects to 
destroy microorganism that are living on the objects. Due to the environmental persistence of 
pathogens it is necessary to remove them through cleaning and/or disinfection (Dancer, 
1999), since they may contaminate hands or be transported by air currents to be deposited on 
patient or surfaces (Casewell and Phillips, 1977, Bhalla et al., 2004). There are numerous 
guidelines emphasizing the importance of cleaning but these generally offer little practical 
advice on how to achieve effective cleaning, or how often sites should be cleaned (Dancer, 
1999, Malik et al., 2003). There remains debate over cleaning in hospitals, because the link 
between cleaning and infection is hard to prove unequivocally. One reason being that there 
are other risk factors within the hospital environment e.g. hand hygiene, isolation facilities 
and antimicrobial prescribing (Dettenkofer et al., 2004). These factors mean that it is 
impossible to study cleaning in an independent scientific study and consequently determine 
the importance of cleaning towards overall infection rates (Dancer, 1999). The visual 
inspection of hospitals is not a reliable assessment of the infection risk for the patients (Malik 
et al., 2003, Dancer, 2004), as microbial contamination and visual dirt are not necessarily 
connected. In addition, cleanliness is often confused with cluttered cramped facilities and old 
and poorly maintained facilities (Dancer, 1999). There is still however a consensus that 
environmental cleaning is an essential component of infection controls (Carling and Bartley, 
2010) and there are some studies that support the importance of cleaning in the reduction of 
HAIs (Carling and Bartley, 2010). Enhanced cleaning is generally included in any infection 
control strategy in response to an outbreak. Cleaning has been identified as a major control 
component for outbreaks of MRSA, drug resistant Acinetobacter, VRE and C. difficile (Wu et al., 
2005, Morter et al., 2011, Wilks et al., 2006, Denton et al., 2004).  
Since contaminated hand touch sites are considered to constitute an infection risk for 
patients, cleaning schedules generally focus on these sites (Dancer, 2004). However it is 
known that staff, patients and relatives release MRSA into the hospital environment, despite 
significant efforts for its removal (Hardy et al., 2007). One study that targeted hand touch sites 
on two surgical wards for a year with high frequency detergent based approach reduced the 
number of acute MRSA infections by 50% (Dancer et al., 2009, Wilson et al., 2011). Dry or 
detergent based cleaning can remove microbes, but will not kill them. Consequently, the risk 
of cleaning transporting microorganisms is high. There are numerous examples of 
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contaminated cleaning cloths and equipment’s spreading contamination rather than removing 
it (Moore and Griffith, 2006, Barker et al., 2004, Scott and Bloomfield, 1990, Dharan et al., 
1999, Bergen et al., 2009). 
Disinfectants on the other hand can kill microbes but they are often expensive and may have 
environmental impacts (Dettenkofer et al., 2004, Kammerer, 2003).  However, where there is 
a high risk to patients there is no alternative but to instigate disinfection rather than simple 
cleaning. This has led to the introduction of disinfectants into cleaning regimes in healthcare 
environments. One study that introduced a copper-based disinfectant and microfiber regimen 
for cleaning of high-risk sites in intensive care units. A further study in an Irish intensive care 
unit focused on the frequency that MRSA was recovered from locations around non-infected 
and infected patients. Level 2 cleaning (detergent followed by 1% hypochlorite) was effective 
against MRSA initially, but sites soon become re-contaminated (Wilson et al., 2011, Aldeyab et 
al., 2009). Disinfectant based cleaning is routinely performed for healthcare environments 
containing C. difficile positive patients, as both part of the management of sporadic cases or as 
outbreak control (Wilcox et al., 2003, McMullen et al., 2007).  
There are now a wide range of disinfectants and disinfection technologies available to the 
healthcare sector however it is recognized that these are not alternative to traditional 
cleaning (Page et al., 2009), since no single process will remove all the relevant microbes from 
a healthcare environment. As new approaches have been utilized in healthcare settings 
concerns have been raised over the efficiency of methods such as, ozone, steam cleaning, 
microfibre, hydrogen peroxide and high-intensity light irradiation (Hardy et al., 2007, 
Nerandzic et al., 2010, Moore and Griffith, 2006, Berrington and Pedler, 1998, Falagas et al., 
2011, Davies et al., 2011, Griffith and Dancer, 2009, Diab-Elschahawi et al., 2010, Memarzadeh 
et al., 2010, Sweeney and Dancer, 2009). There are also significant doubts over the activity of 
disinfectants in the field, since laboratory testing does not necessary predict in situ use 
(Sattar, 2010). There are always toxicity and cost issues which require consideration and 
issues regarding cross-resistance between biocides and antimicrobial agents (Russell, 2004a, 
Kammerer, 2003).  
 Biocides and disinfectants 2.5
Biocides are chemical agents having a broad spectrum of antimicrobial activity, commonly 
used as environmental disinfectants or antiseptics for skin decontamination (Cozad and Jones, 
2003, Sopwith et al., 2002).  There is a wide range of biocides commonly used in healthcare 
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settings, with many being combined to form commercial products. Some of the important 
biocides are discussed below.  
 Alcohol 2.5.1
Alcohol is commonly used as ethyl or isopropyl alcohol. Both of these are rapidly bactericidal 
against vegetative organism as well as being tuberculocidal, viricidal and fungicidal but have 
no activity against spores (Fraise et al., 2012). They are most active when used at a 
concentration of 60-90% (Morton, 1950, Boyce and Pittet, 2002). The activity of alcohol is 
probably due to its ability to denature proteins. The disadvantage of alcohols is their 
flammability and need to be used with care and stored appropriately. Alcohols are most 
commonly used in hands sanitizers and as a surface disinfectant.  
 Quaternary ammonium compounds (QACs) 2.5.2
The first commercially available QACs having antimicrobial property were benzalkonium 
chlorides. However, due to its inactivation by organic material and hard water and lower 
virucidal and tuberculocidal activity it lost favour as a disinfectant. It is believed that that their 
activity is due to inactivation of cell metabolic pathways and denaturation of proteins. More 
recently developed QACs have better tolerance of hard water and are bactericidal and 
virucidal against lipophilic viruses. QACs are used extensively in general disinfectant products 
for surfaces and for hand sanitation.  
QAC are cationic surface active detergents widely used for the control of microorganism in 
clinical and industrial environments and used in the disinfection of hard surfaces 
(Labuschagne and Albertyn, 2007). They are amphoteric surfactants and contains one 
quaternary nitrogen that is associated with at least one major hydrophobic substituent  such 
as alkyl groups or substituted alkyl groups, represented with R, and an anion such as CI or Br, 
represented with X (Fig 2.5) (Gilbert and Moore, 2005).
 
Figure 2.5.The general structure of QACs. 
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Jacobs and co-workers (Jacobs et al., 1916),  published a paper describing the antimicrobial 
activity of quaternary ammonium compounds and later in 1935 it was  shown that aliphatic 
groups with 8 – 18 carbons possesses antibacterial activity (Hegstad et al., 2010).The primary 
target of QACs seems to be the cytoplasmic (inner) membrane of bacteria (Hegstad et al., 
2010). QACs are thought to adsorb to the relatively anonic bacterial cell walls, diffuse through 
the cell wall and binds to the cytoplasmic membrane (Hegstad et al., 2010, Sandt et al., 2007, 
Ioannou et al., 2007). Here they cause the disorganisation of cytoplasmic membrane which is 
thought to result in the leakage of intracellular material and ultimately causing cell death 
(Ioannou et al., 2007). The positively charged nitrogen group interacts with the phospholipids 
followed by the hydrophobic tail that integrates into the hydrophobic membrane core 
(Ioannou et al., 2007, Hegstad et al., 2010). Here they cause the disorganisation of the 
cytoplasmic membrane resulting in the release of intracellular molecules such as potassium 
ions and other intracellular low molecular weight material. QACs cause leakage of the cellular 
material purely because they adsorb to the cell membrane in large amounts causing damage 
(Ioannou et al., 2007). Bacterial cells surface carries a negative charge which are stabilized by 
cations such as Mg2+ and Ca2+ and many of the QACs also have the cationic property which 
helps them to exploit the interactions of Ca2+ and phospholipids with the cell membrane 
(Gilbert and Moore, 2005), they proposed a model for the adsorption of the QACs to bacterial 
cell membrane. The positively charged quaternary ammonium chloride with the head groups 
of acidic phospholipids and subsequently the hydrophobic tail integrates into the hydrophilic 
membrane core (Figure. 2.6).  
 
Figure.2.6. Mechanism of action of quaternary ammonium chloride disinfectants 
(Gilbert and Moore, 2005). 
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 Bi-guanides 2.5.3
The antiseptic agent polyhexamethylene biguanide also known as polihexanide or PHMB has 
been used for over 60 years with no evidence of the development of resistance (Moore and 
Gray, 2007). There are no commercially available PHMB antiseptic/antimicrobial solutions or 
gel available on the UK Drug Tariff. However, in Europe Sterasept (Serag-Wiesner KG), is the 
only solution available as an approved finished drug product with antiseptic/antimicrobial 
effects. The common recommendation for infections with Gram negative pathogens is to use 
the higher concentration (0.1% v/v) (Dissemond et al., 2010). PHMB has little toxicity and has 
been found safe and effective in applications as treatment of eye infections and sanitising 
swimming pools (Motta et al., 2004, Motta and Trigilia, 2005). Studies in 1998 and in 2005 
(total of 3,529 patients), revealed that skin sanitising to PHMB is low (~0.5%), even though 
the tested drug concentrations (2.5-5%) were five to ten times the concentration normally 
used in wound applications (Schnuch et al., 2007). In short, PHMB has good clinical safety 
(Disch et al., 2007, Mulder et al., 2007, Bruckner et al., 2008), targeted action on bacterial cell 
(Sørensen et al., 2003, Ousey and McIntosh, 2009), biocompatibility index >1 (Müller and 
Kramer, 2008), no know risks of resorption (Kaehn, 2010), low risk of contact sensitisation 
(Schnuch et al., 2007) and sustainability of the active pharmaceutical ingredient (Lee et al., 
2004a). It is a fast acting biguanide sharing smilarities with antimicrobial peptides AMPs 
produced by many cells within wound, such as keratinocytes and inflammatory neutrophils, 
where they are thought to help the cells against infection (Sørensen et al., 2003, O'Hanlon and 
Enright, 2009, Ousey and McIntosh, 2009). However, PHMB does not interfere with the 
protein that makes up the animal cell membranes therefore; it has some specific antimicrobial 
action that does not affect the animal cell integrity. It is thought PHMB when adhered to the 
target cell membrane causes them to leak potassium ions and other dissolved ions from the 
cytoplasm causes cell death (Yasuda et al., 2003, Gilbert, 2006). PHMB has the effect on both 
the planktonic and biofilm bacteria (Seipp et al., 2005, Pietsch and Kraft, 2006, Harbs and 
Siebert, 2007) and its action on the bacterial cell membrane also means that the efflux pump 
is unable to remove that so intracellular bactericidal concentrations are maintained (Kingsley 
et al., 2009). Once PHMB inside the cell, it has been proved that PHMB binds to DNA and other 
nucleic acids, suggesting it may also damage or inactive bacterial DNA (Allen et al., 2004).  
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 Chlorine releasing agents 2.5.4
Commonly used chlorine releasing agents include hypochlorites and sodium 
dichloroisicyanourate (NaDCC). They are rapidly bactericidal, virucidal, tuberculocidal and 
sporicidal (Rutala and Weber, 1997, Griffiths et al., 1999). Chlorine releasing demonstrate 
poor activity at low concentrations under dirty conditions because they are relatively easily 
inactivated by organic matter, it is therefore important that they are used on clean surfaces. 
The use of chlorine based disinfectants is specified in UK guidance (DoH and HPA, 2009, Pratt 
et al., 2007) where products delivering 1,000ppm free available chlorine are specified for 
cleaning associated with patients with C. difficile infections, in the presence of blood 10,000 
ppm FAC is recommended (Boyce and Pittet, 2002).  
 Aldehydes including glutaraldehyde. 2.5.5
Aldehydes are used in healthcare settings predominantly as formaldehyde or glutaraldehyde.  
Formaldehyde has excellent antimicrobial activity including cidal activity against vegetative 
bacteria, mycobacteria. Viruses, fungi and bacterial spores.  However, due to its toxicity it is 
no longer used except for fumigation of high-risk areas such as category 3 rooms. 
Glutaraldehyde is widely used in healthcare settings as an endoscope disinfectant. It is 
bactericidal and virucidal but only slowly sporicidal requiring three hours to produce a 
greater reduction. Concerns’ regarding its toxicity and potential carcinogenicity has reduced 
its use in healthcare environments (Boyce and Pittet, 2002).  
 Hydrogen peroxide 2.5.6
Hydrogen peroxide acts by the production of free hydroxyl radicals which denatures cell walls 
and essential bacterial enzymes resulting in bactericidal activity.  It is bactericidal including 
sporicidal, virucidal, fungicidal and tuberculocidal.  Hydrogen peroxide is an irritant chemical 
and has been implicated in corneal damage therefore, it is not used widely (Fraise et al., 
2012). 
 Peracetic acid 2.5.7
Peracetic acid is a strong oxidizing agent and has rapid bactericidal activity against range of 
vegetative organisms and spores. It is also veridical, fungicidal and tuberculocidal. Peracetic 
acid can be used as a liquid or generated in situ through aqueous reaction of 
tetraacetylethylenediamine (TAED) and a peroxide generator (Pan et al., 1999, Davies and 
Deary, 1991). Its mode of action is same as other peoxidases and oxidizing agents. Its 
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disinfectant property based on the release of active oxygen, the sensitive sulfhydryl and 
sulphur bonds in proteins, enzymes and other metabolities are oxidised and the double bonds 
are reacted results in the rupture of the cell wall, so it is effective against outer membrane 
lipoproteins, and facilitating its action against Gram-negative bacteria (Kitis, 2004). 
 Iodophors 2.5.8
These agents are complexes of iodine and a carrier resulting in a product, which allows sustained release of iodine. )t is the free iodine, which mediates this agent’s antimicrobial 
activity by disrupting protein and nucleic acid synthesis. The mostly used iodophor is 
povidone iodine and it is free iodine, which gives this product its antibacterial activity. 
Iodophors are bactericidal, virucidal and mycobactericidal but have poor sporicidal activity 
and variable anti-fungal activity (Fraise et al., 2012). 
 Phenolics 2.5.9
Carbolic acid (Phenol) was used by Lister as an antiseptic and its antibacterial activity are 
well known. Halogenated derivatives of carbolic acid are known as phenolics and tend to have 
improved antibacterial properties compared with the parent compound. Phenolic 
disinfectants are bactericidal, fungicidal and tuberculocidal although different compounds 
vary in their activity. However, the poor activity against blood borne viruses has limited the 
use of these disinfectants (Fraise et al., 2012).  
 Biocidal Surfaces and Coatings 2.5.10
Since high frequency touch sites are rapidly re-contaminated, surfaces or coating with 
prolonged biocidal activity might be useful in preventing recontamination (Aldeyab et al., 
2009, Page et al., 2009, Brady et al., 2003). The problem with coating constituents is that it can 
wear off over time, degrade or simply fail due to the accumulation of organic soil, which might 
also encourage unforeseen long-term health problems in exposed persons or additional toxic 
effects on the environment (Page et al., 2009). There are also antimicrobial coatings for 
textiles (clothes, sheets and curtains), furniture, equipment (computers and catheters), hand 
touch sites (handles, pens etc.) and surfaces (floors and doors) (Page et al., 2009, De Muynck 
et al., 2010). There has also been interest in the use of metal-based surfaces e.g.  copper, zinc, 
silver or titanium (Nanda and Saravanan, 2009, Weaver et al., 2008, Taylor et al., 2009, 
O'Hanlon and Enright, 2009, Casey et al., 2010, D'Arcy, 2001).  
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There are also electrostatic and inhibitory surfaces that repel microbial adhesion and even 
products marked as self-cleaning coatings (Shepherd et al., 2010, Page et al., 2009, Parkin and 
Palgrave, 2005). Further examples include coatings composed of nano-silver particles 
combined with titanium dioxide to form highly reactive TiO2 Ag particles (Page et al., 2009), 
these particles can be applied on range of surfaces under low temperatures, which means that 
virtually all environmental surfaces in a hospital could be treated (Su et al., 2009). It is also 
possible to incorporate organic biocides into surfaces to provide some antimicrobial activity. 
By far the commonest organic based treatment is the use of Triclosan, a variety of Triclosan 
impregnated materials has been available in the supermarkets since 1997 (Page et al., 2009). 
One concern that has been raised regarding the use of these surfaces in healthcare settings is 
that they may provide false assurance if not tested properly and may lead to staff reducing 
their normal cleaning regimes (Dancer, 2010).  
 Microbial Responses to Biocides 2.6
Despite the increase in the usage and variety of biocidal products available, there has not been 
a significant increase in understanding of how bacteria respond to biocides. In particular, the 
bacterial response to the post use residues that persist at concentrations below recommended 
level in healthcare environments remain largely unknown.  Another issues is the fact that the 
preferred mode of living for most microorganisms is as surface-adherent communities or 
biofilms (Leung et al., 2012), which are known to be more resistant to biocides (Potera, 1999). 
This contrast with the fact that most biocide testing is carried out against planktonic 
microorganism (Leung et al., 2012). 
Bacteria have a variety of mechanisms at their disposal to reduce the cytoplasmic 
concentration of biocides (Maillard, 2007). However, it has been difficult to producing stable 
bacterial resistance to high biocide concentrations (Suller and Russell, 1999, Fitzgerald et al., 
1992). The use of step wise biocide concentration increases have resulted in bacteria with 
increased minimum inhibitory concentrations (MIC), but rarely at in-use concentrations 
(Thomas et al., 2005, Suller and Russell, 1999, Lear et al., 2006, Walsh et al., 2003b). 
Alternative approaches which more closely mirror the way biocides are employed i.e. the 
exposure of high inoculums to high biocidal concentrations have produced some adaption but 
not as effectively as stepwise training (Walsh et al., 2003b, Thomas et al., 2000).  
Although it is not easy to develop resistant mutants to high biocide concentrations, exposure 
to low concentrations may induce low-level resistance in bacteria. The induction of bacterial 
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resistance to almost all biocides has been documented, but particularly none-oxidizing ones 
such as phenolics, bis-biguanides and quaternary ammonium compounds (Russell, 2004a, 
Moken et al., 1997, McMurry et al., 1998). Although, the induction of oxyR and soxRS regulons 
following exposure to oxidising agents has been described (Chapman, 2003). 
In a range of studies the biochemical basis of tolerance has been identified e.g. benzalkonium 
chloride induced the expression of qacA and qacB genes (Paulsen et al., 1998), Aase et al 
(2000) observed that repeated benzalkonium chloride exposures resulted in the expression of 
pmf-driven efflux pumps, which allowed the bacteria to reduce the cytoplasmic concentration 
of the biocide (Aase et al., 2000). There have also been a number of studies demonstrating 
bacterial resistance to bisphenol, triclosan and chlorhexidine (McMurry et al., 1998, Russell, 
2004b, Sanchez et al., 2005). Chuanchuen et al (Chuanchuen et al., 2001), reported the 
induction and expression of an efflux pump in P. aeruginosa following triclosan exposure, 
resulting in high-level resistance to both triclosan and ciprofloxacin. However, such induced 
bacterial strains have not been observed in practice (Russell, 2003). The induction of efflux 
pump mechanisms following low concentration, biocide exposures appears to be the primary 
mechanism of biocide resistance (Lear et al., 2002, Poole, 2005). A point emphasized by 
Paulsen et al (Paulsen et al., 1998), who suggested that the emergence of the qacA gene 
resulted from the use of chlorhexidine. 
The expression of a range of E. coli genes was modified by exposure to low concentration of 
polyhexamethylenebiguanides (PHMB) (Allen et al., 2006). Firstly, at the ultra-structure level 
(outer membrane, periplasm and cytoplasmic membrane), which is not surprising due to the 
action mechanism of PHMB. Secondly, exposed bacteria lost their ability to produce repair pili 
and flagella, presumably due to increased exposure to the biocide. Thirdly, bacteria expressed 
the heat shock response, DNA damage (SOS) response and other DNA metabolism associated 
genes, presumably to repair significant DNA damage.    
However, the most frequent mechanism for the biocide resistance is the use of efflux pumps 
which reduce intracellular concentrations to sub-toxic levels (Borges-Walmsley and 
Walmsley, 2001, Hegstad et al., 2010). Gilbert and Moore ((Gilbert and Moore, 2005), 
reported that efflux pumps are capable of removing QACs from the membrane core and 
effectively reducing the effectiveness of the QACs. These pumps operated by ATP driven 
transporters and proton pump antiporters.  
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The proton pump antiporters contains one of the three classes of antiporters, the resistance 
nodulation division family (RND), small multidrug resistance family (SMR) and the major 
facilitator superfamily (MF), while ATP driven antiporters contains the ATP binding cassette 
(ABC) (Putman et al., 2000, Borges-Walmsley and Walmsley, 2001, Kumar and Schweizer, 
2005). Efflux pumps found in both the Gram positive and Gram negative bacteria but the 
efflux mediated resistance is more complex in Gram negative bacteria because of the complex 
nature of the cell wall (Sidhu et al., 2002, Kumar and Schweizer, 2005). The ABC transporters 
are rare in bacteria and are involved in uptake as well as efflux systems where energy is 
provided by hydrolysis of ATP (Putman et al., 2000, Borges-Walmsley and Walmsley, 2001, 
Kumar and Schweizer, 2005). The proton pump antiporters function by transporting biocides 
out of the cells by the help of transmembrane electrochemical gradient of protons or sodium 
ions, proton motive force and only differ in size (Putman et al., 2000). The MF transporters 
found in both Gram positive and Gram negative bacteria and composed of about 400 amino 
acids that are arranged into 12-14 membrane spanning helices (Putman et al., 2000, Borges-
Walmsley and Walmsley, 2001, Kumar and Schweizer, 2005) and the Staphylococcus QacA and 
QacB proteins are part of this family proteins (Kumar and Schweizer, 2005, Gaze et al., 2005). 
The RND transporters are composed of around 1000 amino acids and have similar helix 
structures as the MF (Kumar and Schweizer, 2005), they operate with periplasmic membrane 
fusion proteins and an outer membrane protein, allowing the transport of toxic compounds 
out through both inner and the outer membrane of Gram negative bacteria(Putman et al., 
2000). QACs resistant genes in the Staphylococcus genus are also widely spread amongst the 
clinical isolates (Bjorland et al., 2005). The small multidrug resistant family (SMF) includes, 
qacH, qacG, qacJ and smr and is found on non-conjugated and large conjugated (Bjorland et al., 
2001, Bjorland et al., 2003), and this protein consist of 4 predicted transmembrane segments 
(Fig. 1.7). The multidrug transport pumps do not have specificity for a specific product which 
could potentially mediate the cross-resistance to a number of antimicrobial agents (Bowler et 
al., 2001). Putman et al (Putman et al., 2000), reported that several multidrug transporters 
can be present within the same bacterium and the availability of these different transporters 
may contribute to bacterial resistance against wide range of biocides.  
 Biocide resistance in clinical settings 2.6.1
The emergence of bacterial resistance to biocides is not a new phenomenon and has been 
investigated since the introduction of biocides in clinical settings. Clinical isolates 
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demonstrating biocide resistance have been associated with triclosan baths and hand washes, 
the use of chlorhexidine and QACs, and silver and silver sulfadiazine (Webster et al., 1994). 
There have also been a number of reports highlighting the failure of disinfectants used for 
clinical application (Anderson, 1989, Russell, 2004a, O'Rourke et al., 2003) although it is not 
clear if these are associated with resistance or poor application.  
The resistance characteristic of environmental isolates (Lear et al., 2002)collected from 
biocide manufacturing sites demonstrated that apart from intrinsically resistant 
Pseudomonas, few genera showed resistance to triclosan or para-chloro-meta-xylenol. 
Although increased MIC was observed, the bacterial isolates remained susceptible to practical 
concentration (Lear et al., 2002). 
Griffiths et al (Griffiths et al., 1997), demonstrated that Mycobacterium chelonae isolated from 
endoscope washer disinfector had developed resistance to the in-use (2% v/v) concentration 
of glutaraldehyde, but remained susceptible to other aldehydes (Fraud et al., 2001). 
Glutaraldehyde resistance was associated with minor modifications to the outer cell walls of 
these strains (Walsh et al., 1999, Fraud et al., 2001). Further in-vitro studies indicated that 
changes in the cell wall arabinogalactan/arabinomannan content of M. chelonae was 
responsible for the glutaraldehyde resistance observed in these strains (Manzoor et al., 1999). 
There have also been a number of studies demonstrating bacterial resistance to bisphenol, 
triclosan and chlorhexidine (McMurry et al., 1998, Russell, 2004b, Sanchez et al., 2005). 
Chuanchuen et al (Chuanchuen et al., 2001), reported the induction and expression of an 
efflux pump in P. aeruginosa following triclosan exposure, resulting in high-level resistance to 
both triclosan and ciprofloxacin. However, such induced bacterial strains have not been 
observed in practice (Russell, 2003). The induction of efflux pump mechanisms following low 
concentration, biocide exposures appears to be the primary mechanism of biocide resistance 
(Lear et al., 2002, Poole, 2005). A point emphasized by Paulsen et al (Paulsen et al., 1998), 
who suggested that the emergence of the qacA gene resulted from the use of chlorhexidine. 
There have also been a number of studies demonstrating bacterial resistance to bisphenol, 
triclosan and chlorhexidine (McMurry et al., 1998, Russell, 2004b, Sanchez et al., 2005). 
Chuanchuen et al (Chuanchuen et al., 2001), reported the induction and expression of an 
efflux pump in P. aeruginosa following triclosan exposure, resulting in high-level resistance to 
both triclosan and ciprofloxacin. However, such induced bacterial strains have not been 
observed in practice (Russell, 2003). The induction of efflux pump mechanisms following low 
41 
 
concentration, biocide exposures appears to be the primary mechanism of biocide resistance 
(Lear et al., 2002, Poole, 2005). A point emphasized by Paulsen et al (Paulsen et al., 1998), 
who suggested that the emergence of the qacA gene resulted from the use of chlorhexidine. 
 Biofilms and Biocide Resistance 2.6.2
Bacterial growth as a biofilm often contributes to the failure of biocides and disinfection 
(Espinal et al., 2011). The highly organized structure and polymeric matrix of a biofilm 
provides a protective mechanism allowing bacteria to survive the harsh environments created 
by biocides and biofilm formation represents an important virulence factor (Espinal et al., 
2011). Effective disinfection in the presence of a biofilm often requires higher concentrations 
of antimicrobial agents when compared to planktonic bacteria (Thomas et al., 2011). The 
antimicrobial concentrations required for biofilm inactivation can be 100 times that required 
for inactivation of removal planktonic cells (Rasmussen and Givskov, 2006).   
These impacts may be species specific for example the efficacy of ortho-pthalaldehyde was 
reduced against Mycobacterial biofilms but not against P. aeruginosa ones (Berkelman et al., 
1984). Survival of bacteria in biofilms has been identified as contributing to a number of 
outbreaks, e.g. P. aeruginosa resistance to iodophores, Serratia marcescens resistance to 
benzylkonium chloride and chlorhexidine.  Recently a major outbreak of Pseudomonas 
infections in a neonatal unit in Northern Ireland was associated with biofilms in water 
distribution system(RQIA, 2012).  
However many hospital associated infections are caused by bacteria associated in biofilms 
and yet most laboratories are not using biofilm test to assess the efficacy of biocides 
(Cookson, 2005), and there are currently no European standards for the testing of 
disinfectants against biofilm for healthcare applications. 
 Evaluation of biocides 2.7
The testing of biocides has received considerable attention for many years with a range of 
formal standard published world wide (Fraise et al., 2012). However, many of these 
techniques are designed for rapid determination of basic bactericidal activity and as such are 
not particularly useful for the generation of research data. However, more sophisticated 
approaches for evaluating the impact of biocides on both both planktonic cells and biofilm 
forming cells are available, specifically the Bioscreen C technology system (by Growth Curves 
Ab Ltd) and the MBEC systems (Innovotech Inc, Canada).   
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 Bioscreen C technology system 2.7.1
The Bioscreen system monitors the live growth of microorganism by measuring turbidity of 
the liquid growth medium in the 100 honey comb wells at specific temperature and with or 
without shaking. These meaurments are done by realtime recording of the optical density of 
the cultures under investigation. The mesurment interval can be set from minute to hours. 
The reader consist of three inter-related systems i.e. mechanical transport, incubator and 
optical system (Figure 2.7). The incubator tray assembly holds the honeycomb plates in the 
correct position. The assembly shuttles left from the plate loading section into the 
measurment compartment, where light is passed through each well of the plate and the 
detector makes the OD readings. Incubator maintains the plates at the chosen temperature by 
circulating the heating-cooling liquid continously through the incubator. A halogen lamp 
produces light which then passes through the chopper wheel. The light path is turned 90 
degrees by a mirror, than pass through the filter wheel. The correct filter is chosen by making 
the appropiate entry during the experiments set up (Wide band filter 480-520nm used for the 
turbidity meaurment). Filtered light moves through an optical fibre to the lens assembly in the 
measurement compartment, below the honeycomb plates. Light passes through the bottom of 
each well and results are collected by the detector and trasfered to PC attached with the 
system (Figure 2.7). 
The Bioscreen technology generates large amounts of data which requires processing. A 
number of modelling approaches have been developed to transform Bioscreen data into key 
characteristics such as minimum inhibitory concentrations (MIC) (Lambert and Lambert, 
2003, Lambert and Pearson, 2000b) and minimum biocidal concentrations (MBC).  The MIC 
being the minimum concentration of a biocide required to prevent microbial growth, whilst 
the MBC is the the minimum concentration of a biocide required to kill microbial cells.  
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Figure 2.7. The Bioscreen system. 
 MBEC system 2.7.2
Biofilm forming bacteria are phenotypically distinct from suspended planktonic cells of the 
same genotype. Biofilm growth reactors are engineered to produce biofilms with specific 
characteristics, however by altering the engineered system or operating conditions 
characteristic of biofilm can be changed. Microscopically a biofilm is a sheet like structure 
with some architectural details and the purpose of MBEC system is to grow consistent, 
representative biofilms amenable to testing and evaluation (Harrison et al., 2010). The MBEC 
system consists of a polystyrene lid, with 96 downward-protruding pegs (Figure 2.8), that 
exactly fit into the wells of a 96-well plate and was originally designed for the rapid and 
reproducible assay for evaluating of biofilm susceptibility to antibiotic (Ceri et al., 1999a, 
Smith et al., 2012) and have been integrated into the testing of biocides particularly for 
Pseudomonas sp. The biofilm is established on pegs under batch conditions (no flow of 
nutrients in and out of the individual well) with gentle mixing. The established biofilm is then 
transferred into a new receiver plate for disinfectant efficiency testing. Additional efficiency is 
added by including the neutralizer controls within the assay device, and due to small volume 
of samples used (200µl) for testing of expensive biocides it is more economical and efficient 
than other approaches.  
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Figure.2.8. The MBEC biofilm growth system (Innovotech Inc, Canada). 
 Wound dressing 2.8
Chronic wounds (e.g. diabetic lower limb and pressure ulcers) are generally heavily colonised 
with pathogenic bacteria. The healing of these wounds depends on adjusting the equilibrium 
between the host-immune system and the pathogens present in the wound environment 
(Stephen-Haynes, 2004). Within wound microorganisms exist in either a free 
floating/planktonic state or as part of a biofilm associated with the wound bed (Thomas et al., 
2011).  
Many multi drug resistant organisms (MDROs) are also often associated with chronic and 
acute wounds. Topical antimicrobials are often the first approach applied to bio burden 
control, in wounds where there are clear signs of a progressive infection however; systematic 
antibiotics are generally applied (Bowler et al., 2012). Several factors determine the efficiency 
of systematic antibiotics such as: the extent of blood flow to the wound, the extent of 
antibiotic-resistance, the bacterial species present, the presence of biofilms (Zubair et al., 
2011). Where MDROs have colonised the wound, the efficacy of systematic antibiotics 
treatment is uncertain. In this case the topical application of antiseptics and disinfectants may 
present a viable alternative due to their broader spectrum of activity and lack of bacterial 
resistance. By combining antiseptic and disinfectant agents with wound dressings it is 
possible to achieve a managed delivery of antimicrobial agents into the infected wound bed 
(Ovington, 2007).  
There is large range of antimicrobial dressings available with varying claims of antimicrobial 
efficacy. Current approaches for the evaluation of antimicrobial wound dressings vary 
significantly in terms of media used, inoculum and sample size (Tkachenko and Karas, 2012), 
which may make direct comparison between dressing difficult (Chopra, 2007). In addition the 
presence of biofilms within wounds complicate the testing of these dressings, particularly 
when  of our current knowledge of bacterial biofilm is based on in vitro observations of 
bacterial adherence to solid surfaces. This is a marked contrast to the situation in a chronic 
Pegs 
 
Wells 
45 
 
wound where bacteria reside within a wound beds rather than attached to well defined solid 
surface (Werthan et al., 2010).  
 Wound dressings 2.8.1
There are lot of different dressing available for treatment of wounds, the use of wound 
dressing depend upon the characteristics of wound and the mode of dressing itself, below 
are some example of different wound dressing. 
a) Semi-permeable film dressings 
These dressing consist of a thin polyurethane type film, which is coated with adhesive layer, 
which help the dressing to adhere with the skin. These dressing are semi permeable which 
allow transmitting of moisture but do not adsorb the exudates, these film dressing provide a 
protective environment which is impermeable to bacteria and liquids and can stay in place for 
up to 7 days (Abdelrahman and Newton, 2011). 
b). Non-adherent contact layer dressings  
Non-adherent dressings applied directly onto the wounds to provide an interface with the 
secondary dressing or pad. They are usually made up of fine woven mesh, which allow 
exudates to pass through. Some of the non-adherent dressing contains paraffin or silicone to 
improve the non-adherence (Abdelrahman and Newton, 2011). Due to increasing concerns of 
non-adherent dressing about pain on dressing removal and risk of sensitivities the use of non-
adherent dressing are less in modern day wound management (Lewis et al., 2001). 
c). Hydrocolloid dressings  
These are described as interactive as they use wound fluid to form a moist gel at the wound 
interface, these dressing consist of gelatins, pectins and carboxymethylcellulose which form 
the hydrocolloid base, which is then secured onto a backing of polyurethane film or foam, 
hydrocolloids, have a low moisture transmission rate of less than 300mg/m2/24 hours 
(Seaman, 2002). Depending upon the level of exudates these dressing can stay up to 6 days. 
e). Hydrofibre dressings 
These dressing consist of insoluble polymers with high water contents making them ideal 
dressings to facilitate autolytic debridement of necrosis and slough. These are better for dry 
necrotic wound that require hydrating and debridement, whilst hydrocolloids debride tissues 
in sloughy, exuding wounds. A new sliver coating hydrofibre dressing Aquacel Ag and Acticoat 
is widely used now days due to the broad-spectrum antimicrobial activity of ionic silver to the 
proven exudate handling technology of hydrofibre (Harding et al., 2001).   
46 
 
f). Foam dressings 
Foam dressing is made up of polyurethane or silicone, which helps them to handle large 
volumes of wound fluid. There properties vary from adhesive to non-adhesive formulation 
with varied thickness (Abdelrahman and Newton, 2011). Some modern foam dressing proved 
to be effective as cavity filters, when applied on wounds foam has the ability to adsorb 
exudates, preventing pooling and skin leakage, and maintain the low adherence to facilitate 
easy painless removal (Flores and Kingsley, 2007).  
 Antimicrobial dressings 2.8.1.1
The spread of infection in the individual has a serious implications for patient wellbeing and 
act as a pathogenic reservoir results in increasing the risk of cross contamination. Accurate 
differentail diagnosis and treatment with appropiate systemic antibiotics is essential (EWMA, 
2006, WUWHS, 2007), bacteria resistant to topical antibiotics should be avoided (WUWHS, 
2008), adjuvant topical antimicrobial dressings may be used to help reduce the wound 
bioburden (EWMA, 2006, WUWHS, 2007). However, critical colonisation and localised, 
subclinical infection remain an issue and are significant contributors for wound healing 
(Edwards and Harding, 2004, Warriner and Burrell, 2005). In recent years, dressing that 
contains andrelaese the antimicrobial agents at the wound surface has been in use (White and 
McDermott, 2001, Cooper, 2004), these dressing has the ability to provide continues relaese 
of the antimicrobial agents at the wound surface to provide a long lasting antimicrobial action 
in combination with maintenance of physiologically mosist enviornment for healing 
(Ovington, 2007). Table 2.3 explain the range of antimicrobial wound dressing available in the 
market. 
 
Table.2.3 Examples of antimicrobial dressings (Ovington, 2007). 
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2.8.1.1.1 Iodine dressings 
Iodine has been used as antimicrobial agent for a long time, iodine mixed with polymeric 
cadexomer starch vehicle has been used as a topical gel or paste, the cadexomer moiety 
provides exudate adsoption from the wound which results in the slow release of free iodine 
(Ovington, 2007). Like all the other antiseptics, iodine effects multiple sites in microbial cells, 
resulting in cell distruption and cell death (WUWHS, 2007). However, its antimicrobial 
efficiancy, chemical stability, toxicity to host tissues and the ensuing effect on patient comfort 
has been debated (Wilson et al., 2005). It has been reported that povidone-iodine is not as 
effective as some other biocides against Staphylococcous epidermis within in vitro bioflims 
(Presterl et al., 2007). Iodine mixed with polymeric cadexomer proved to be a biofilm 
supression without significant damage to the host (Akiyama et al., 2004, Rhoads et al., 2008), 
but pain has been reported as a side effect of its use (Hansson, 1998).  
2.8.1.1.2 Silver dressings 
Silver (Aquacel Ag) based dressing are widley used in wound care (Klasen, 2000b, Klasen, 
2000a, Demling and Desanti, 2001, Ip et al., 2006), the only side effects reported is skin 
discolouration and irritation (White and Cooper, 2005). A new sliver coating hydrofibre 
dressings Aquacel Ag and Acticoat is widely used due to the broad-spectrum antimicrobial 
activity of ionic silver to the proven exudate handling technology of hydrofibre (Harding et al., 
2001). Questions have been concerns for the long use of silver on wounds especially in infants 
(Denyer, 2009), but to date no pathological consequences of silver used dressing has been 
reported, except some reports about the systemic uptake and deposition of silvers in organs 
(Denyer, 2009, Wang et al., 2009).   
2.8.1.1.3 Honey dressings 
Manuka honey dressing also used for the treatment of wound care. These dressing has been 
successfully used for the treatment of recalcitrant wounds within the maxillofacial unit and 
proved resistant to antibiotics. These honey coated dressing has been used directly on the 
wound and can be used for 2-3 days without changing (Visavadia et al., 2008). The exact mode 
of action of honey dressings not fully understood, however it is hyperosmolar and thus 
restricts the availability of environmental water to bacteria and other organisms (Molan, 
2001), which results to cell disruption and death. Another property of honey is the release of 
hydrogen peroxide as the honey is diluted by exudates (Molan, 2004). However some honeys 
varieties particularly the Manuka and Leptospermum has the ability to retain their 
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antimicrobial property even without the release of hydrogen peroxide (Cooper et al., 2002b, 
Cooper et al., 2002a), which is thought to be phytochemical component (Molan, 2002).  
2.8.1.1.4 PHMB dressings 
Recently polyhexamethylenebiguanide (PHMB) has been introduced which has effect on the 
microbial cell metabolism. PHMB is a fast acting biguanide compounds composed of synthetic 
mixture of polymers, having structural similarities to the antimicrobial peptides AMPs 
produced by many cells within the wounds, such as keratinocytes and inflammatory 
neutrophils, where they are thought to help the cells against infection (Sørensen et al., 2003, 
Ousey and McIntosh, 2009). AMP has a broad spectrum of activity against bacteria, viruses 
and fungi including cell death by disrupting cell membrane integrity (Moore and Gray, 2007). 
They are proved to be effective against Pseudomonas aeruginosa and Staphylococcus aureus 
which are common in many chronic wounds (Abdelrahman and Newton, 2011). PHMB 
product ranges includes TelfTM AMD drain, Kendall AMD antimicrobial foam having higher 
percentage of PHMB impregnated 0.5%, Biocellulose PHMB-donating dressings e.g Suprasorb 
X+PHMB, which contains 0.3% PHMB. In vitro and in vivo studies have proved that dressing 
or products containing PHMB reduces wound pain rapidly and effectively (Daeschlein et al., 
2007, Galitz et al., 2009), reduces wound malodour (Daeschlein et al., 2007), reduces MMP-
induced pre-wound breakdown (Cazzaniga et al., 2007, Werner et al., 2004), reduces slough 
within wound (Mueller and Krebsbach, 2008), increases keratinocyte and fibroblast activity 
(Wiegand et al., 2007), increases formation of granulation tissue (Mueller and Krebsbach, 
2008),  and helps remove non-viable tissue (Kaehn, 2009).  
2.8.1.1.5 Evaluation of antimicrobial dressings 
Current approaches for the evaluation of antimicrobial wound dressings vary significantly in 
terms of media used, inoculum and sample size (Tkachenko and Karas, 2012), which may 
make direct comparison between dressing difficult (Chopra, 2007). In addition the presence 
of biofilms within wounds complicate the testing of these dressings, particularly when our 
current knowledge of bacterial biofilm is based on in vitro observations of bacterial adherence 
to solid surfaces. This is a marked contrast to the situation in a chronic wound where bacteria 
reside within a wound beds rather than attached to well defined solid surface (Werthan et al., 
2010).  
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3 METHODOLOGY 
3.1 Materials 
3.1.1 Chemicals  
Unless otherwise stated all chemical used in this study were sourced from either Fisher 
Scientific Ltd or Sigma-Aldrich Ltd. Biological grade chemicals were used whenever possible.  
3.1.1.1 Biocides 
A range of biocides and biocidal products were employed in this investigation and are 
outlined below: 
 Ethanol (CH3CH2OH)(Absolute alcohol 99%, Fisher Scientific Ltd);  Iso-propylalcohol (IPA, propan-2-ol, CH3CHOHCH3, 99.8%, Fisher Scientific Ltd);  Methanol (CH3OH, 99.8+%,  Fisher Scientific Ltd );  Benzethonium Chloride ȋηͻͺ%, Sigma-Aldrich Ltd);  Benzalkonium Chloride (>95%, Sigma-Aldrich Ltd);  Barquat MB-50 (Alkyl (C14 50%, C16 10%, C12 40%) Dimethyl Benzyl Ammonium 
Chloride, 80% w/v, Lonza Ltd);  Bardap 26 (N,N-Didecyl-N-methyl-poly(oxyethyl) ammonium propionate, 80% w/v, 
Lonza Ltd);  PHMB (Polyhexamethylenebiguanide, 50% w/v, Arch Chemicals Ltd). 
3.1.2 Microbiological media 
The following microbiological media were used throughout this study: 
 Tryptone Soy Agar (TSA, LabM Ltd) Prepared by dispersing 37g in one litre of distilled 
water prior to autoclaving.  Tryptone Soy Broth (TSB, LabM Ltd) Prepared by dispersing 30g in one litre of distilled 
water prior to autoclaving.  Maximum Recovery Diluent (MRD, LabM Ltd) Prepared by dispersing 9.5g in one litre.  DE neutraliser broth (DE, LabM Ltd) Prepared by dispersing 39g in one litre. 
Unless otherwise stated all media and solutions were  prepared in double distilled water.  
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3.1.2.1 Mineral media 
To enable successful EPS characterisation a carbohydrate free mineral media was developed 
(Table 3.1). 
Components K2HPO4 (NH4)2SO4 MgSO4.7H2O NaCl CaCl2 FeCl3 
Casein 
hydrolysate 
g/L 4.5 1 0.2 0.1 0.1 0.02 0.05 
Final pH of the media adjusted to pH 7.0. 
Table: 3.1 Mineral media supplemented with Casein. 
3.2 Standard microbiology techniques 
Unless otherwise stated all microbiology investigations were carried out via a set of standard 
microbiological techniques. Growth and enumeration of bacteria was carried out employing 
Maximum Recovery Diluent (MRD, LabM Ltd) in conjunction with Tryptone Soya Broth (TSB, 
LabM Ltd) or Tryptone Soya Agar (TSA, LabM Ltd). All cultures were incubated at 37oC for 24 
hours under aerobic conditions. Cultures were plated out via either pour, spread or spiral 
plating (Wasp II Spiral Plater, Don Whitley Scientific Ltd). All culture media, diluents and heat 
stable components were sterilised via autoclaving at 121oC for 15 minutes, heat labile 
components were sterilised via filtration through sterile 0.45µm filters (Sartorius Ltd).  
3.3 Microbial Cultures 
A wide range of microbial cultures, both type strains and isolated strains were employed in 
this investigation. These cultures are outlined in Table 3.2, cultures were preserved at -80oC 
on Microbank beads (Prolab Diagnostics Ltd). These beads were revived on TSA under 
standard conditions.  
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Species 
Culture 
Collection 
Short 
Identifier 
Source 
Acinetobacter 
baumannii 
NCIMB 19606 Type Oxoid Ltd 
ACCB 63608 UK-HS 
Strain provided by Dr M. Wren 
UCLH, London. 
CIP 105742 742 
Pasteur Institute, Paris, France. CIP 106882 882 
CIP 107292 292 
OXA-23 Clone 
1 
Clone 1 
Strains provided by Dr J. Turton, 
LHCAI, HPA Colindale, London. OXA-23 Clone 
2 
Clone 2 
Staphylococcus aureus 
(MSSA) 
ATCC 6538 6538 Oxoid Ltd 
S. aureus (MRSA) 
ATCC 4300 4300 Oxoid Ltd 
NCTC 13142 13142 HPA, London, UK. 
N/A 
7F/C7 Isolated from mobile phones 
(White et al 2013). 9B/F6 
Pseudomonas 
aeruginosa 
ATCC 15442 15442 Oxoid Ltd. 
N/A 
I 
Isolated from dressing removed 
from infected wounds. 
II 
III 
IV 
V 
Table 3.2 Bacterial strains used in this investigation 
3.4 Chemical Analysis 
3.4.1 Ethanol and IPA analysis 
The quantitative determination of ethanol and IPA was performed via a QuantiChrom Ethanol 
Assay Kit (Universal Biologicals (Cambridge) Ltd). Sample ethanol and IPA concentrations 
were determined by comparison with a standard curve (Figure 3.1). 
 
Figure 3.1. Ethanol Assay Standard curve. 
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3.4.2 Glucose and lactate analysis 
The glucose and lactate concentration in samples was determined using a PicoTrace analyser 
(Trace Analytics GmbH).  
3.4.3 Total carbohydrate analysis 
The phenol/sulphuric acid procedure employed for total carbohydrate analysis was based on 
that described by (Dubois et al., 1956). The carbohydrate content of a sample is determined 
by comparison with a glucose standard curve. In order to carry out the analysis 1 ml of phenol 
solution (5% w/v) was added to 1ml of the test solution (unknown or standard). Immediately 
after the addition of phenol, 5ml of concentrated sulphuric acid is added rapidly (~15-30sec) 
and mixed. The reaction mixture is incubated at 70°C for 20 minutes, mixed then and placed 
in a 10°C water bath for a further 10 minutes. Finally the absorbance of the solution at 490nm 
is measured and compared against a glucose standard curve (25-300ppm) to determine the 
carbohydrate content of the unknown sample (Figure 3.2).  
 
Figure 3.2. Carbohydrate Assay Standard curve. 
3.4.4 Exopolysaccharide (EPS) extraction 
Three methods for the extraction and characterization of A. baumannii EPS were employed 
during this study: 
1. Poly-Ⱦ-(1-6)-N-Acetylglucoseamine (PNAG) method(O'Toole and Kolter, 1998); 
2. EDTA method (Sheng et al., 2005); 
3. Trichloroacetic acid method (Marshall et al., 2001). 
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3.4.4.1 Poly-β-(1-6)-N-Acetylglucoseamine method 
To determine if A. baumannii has the ability to produce PNAG, the bacteria strains were grown 
on plates containing Congo red agar composed of brain heart infusion agar (Oxoid, UK) 
supplemented with 5% sucrose and 0.8 mg/ml of Congo red (Sigma Chemical ltd. UK) as 
described by (Handke et al., 2004). On these plates PNAG synthesizing cells produced red 
colonies, whereas PNAG deficient cells produced white colonies. After screening, PNAG 
producing strains were grown in a 6-litre culture of mineral media supplemented with 1% 
v/v ethanol and incubated at 37°C for 72 hours with continuous shaking at ~90-110rpm. 
Bacterial cells were collected by centrifugation at 9000g for 15 minutes and resuspended in 
100ml of 20mM EDTA buffer (pH 8.0) containing lysozyme (500mg), and incubated at room 
temperature for 30min. DNAase I (25mg) and RNAase A(100mg) were then added, and the 
suspension incubated at room temperature for 1hour and then 37°C for 2 hours. The cells 
were then removed by centrifugation and the EPS precipitated with 3 volumes of ethanol at 
4°C for 24-48 hours. The precipitate was recovered by centrifugation at 9000g for 15 minutes 
and then suspended in ultrapure water and dialysed using 2000 MWCO dialysis tubes (Sigma 
Aldrich Ltd) against ultrapure water for 72 hours at 4°C, with three changes of water per day 
to remove the small natural sugars. The extracted material was freeze dried and stored for 
further analyse by 1H NMR. 
3.4.4.2 EDTA method 
EPS can be classified by its proximity to the cell surface. Capsular or cell bound-EPS tightly 
linked via a covalent or non-covalent association with cells and free EPS which is not directly 
attached to the cell surfaces (Wingender et al., 1999).  Bacteria were grown and harvested as 
described for the PNAG method. In this case however, the cell pellets were used for the 
extraction of the bound EPS and the supernatant was used for the extraction of free EPS. Cells 
were harvested from the culture media by centrifugation at 5000rpm for 15min at 4°C. Bound 
EPS was extracted from the cell pellet using EDTA method as described by Sheng et al (2005) 
with some modification, which reduced the release of nucleic acids by preventing cell lysis. 
Cells were washed twice with 0.9% w/v NaCl to remove the traces of the media. The washed 
cells were resuspended in 1:1 volume of solution 0.9% w/v NaCl and 2% w/v EDTA and 
incubated for 60min at 4°C. The supernatant used for the extraction of bond EPS was 
centrifuged at 10,000xg for 60min at 4°C and then filtered through a nitrocellulose 
membrane.  
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To determine the free EPS the supernatant was recentrifuged at 10,000g for 30min at 4°C to 
remove residual cells and then the EPS was precipitated by mixing the supernatant 3 volumes 
of ethanol at -20°C for 18h. Precipitated EPS was recovered by centrifugation at 10,000g for 
15min at 4°C. The extract was resuspended in ultrapure water and dialysed against ultrapure 
water to removed ethanol using 2000 MWCO dialysis tubes (Sigma Aldrich Ltd). The extracted 
material was freeze dried and stored for further analysis e.g. 1H NMR, FTIR and MALLS 
analysis. 
3.4.4.3 Trichloroacetic acid method 
The isolation of exopolysaccharide (EPS) was carried out by the method described by 
(Marshall et al., 2001), with some modifications. The procedure involves a series of ethanol 
precipitations, centrifugation and dialysis. Samples of overnight bacterial culture (5 litres) in 
mineral media were heated at 80°C for 20-30min and then left to cool at room temperature. 
Following cooling trichloroacetic acid (TCA, Sigma Aldrich, UK) was added until the TCA 
concentration of the sample reached 14% (w/v) and the sample was then left at 4°C 
overnight. The samples were then centrifuged at 25,000g (Avanti J-26 XPI centrifuge, Coulter 
ltd UK, High Wycombe, UK) for 35 minutes at 4°C to remove cells and proteins. An equal 
volume of chilled absolute ethanol was then added to the supernatant which was then left for 
48 hours at 4°C to allow the precipitation of the crude EPS. After precipitation the sample was 
centrifuged, as above, and the pellet retained. To remove the traces of DNA, RNA and other 
nucleic acids remnants from the pellets, the pellet was re-dissolved in 10 ml of phosphate 
buffer saline (PBS) containing 10mM MgCl2, 1mM CaCl2, 100µg/ml of RNAase (Sigma Aldrich, 
UK), and 100µg/ml of DNAase (Sigma Aldrich, UK),  incubated at 37°C for 2-3 hours. To 
remove protein contamination 100ml of protease (20µg/ml) (Sigma Aldrich, UK), was added 
and again incubated at 37°C for 2-3 hours. The solution was then heated to 80°C for 30mins to 
inactivate the enzymes and finally centrifuge at 25,000g, 4°C for 30min.  The resulting 
supernatant was then subjected to ethanol precipitation. After 24 hours of precipitation at 4°C 
the sample was centrifuged, as above, and the pellet retained. The pellet was then dissolved in 
ultra-pure water and dialysed against ultra-pure water for 72 hours at 4°C, with three 
changes of water per day to remove the small natural sugars. The extracted EPS was then 
characterized by solid state NMR, FTIR, MALLS analysis and further characterised by HPEAC.  
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3.4.4.3.1 Preparation of dialysis tubing  
Dialysis tubing was prepared by boiling in deionised water (500ml) containing EDTA (0.186g) 
(Sigma Aldrich, UK), and sodium carbonate (10g) for 10 minutes. The tubing was then rinsed 
before boiling again with deionised water and store at 4°C in deionised water.  
3.4.5 Structural characterisation of Exopolysaccharides 
A range of analytical techniques were employed to characterise the EPS recovered from the 
bacteria under investigation.  
3.4.5.1 NMR analysis 
All the 1H NMR spectra of extracted EPS were generated on either a Bruker Avance DPX4000 
400.13 or a Bruker Avance DPX500 500.13MHz by Dr. Neil Mclay. All the samples of EPS were 
prepared either in deuterium dioxide (D2O) or DMSO (GOSS Scientific Instruments Ltd, 
Nantwich, UK) and the spectra were acquired using Bruker pulse sequences at a temperature 
of 70°C unless otherwise stated. Chemical shifts were expressed in ppm relative to an internal 
standard of acetone.  
The solid state 13C NMR were performed by Department of chemistry, University of Durham, 
UK using a Varian VNMRS spectrometer operating at 100.56 MHz for 13C.  The peaks between 
170 and 180 ppm are typical of carboxylic acid or ester carbons.  Those between 50 and 70 
ppm are in the region for ether or alcohol.  Signals in the range 60 to 110 ppm are typically 
polysaccharide or EPS.  Cellulose for example would have a C1 signal around 105 ppm, C4 80-
90 ppm (crystalline ~88, amorphous ~84 ppm and broad), C2, C3 and C5 around 75 ppm and 
C6 around 63 ppm.  The 130-140 ppm band is probably C=C (possibly, =CH at 130, CH2= at 
135 ppm).   
3.4.5.2  Molecular Weight Determination (MALLS analysis) 
The weight average molecular weight (Mw) and polydispersity (Mw/Mn) of the pullulan 
standard and extracted EPS were determined by HP-SEC-MALLS analysis. It should be noted 
that dn / dc values for control samples have previously been determined at University of 
Huddersfield. Solutions of 1mg/ml were prepared in deionised water. Upon complete 
dissolution samples were filtered through 0.2µm PTFE Puradisc syringe filters (Whatman UK 
Ltd). Filtered samples (200µm) were injected (using a 7125i injection port, Rheodyne LLC, 
California, USA) onto an analytic size exclusion column (Polymer Labs Aquacel-OH-Mixed-H 
8µm particle size, 300 x 7.5mm Polymer Laboratories, UK). Ultrapure water delivered by 
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HPLC pump (Prominence LC-20 AD, Shimadzu, Milton Keynes, UK) at 1mL/min, neutral 
analytes were eluted and passed through by series of detectors. The samples first pass 
through a UV detector (Prominence SPD-20A, Shimadzu) with a wavelength set to 260nm; 
this identifies the presence of any residual DNA present in the sample. The concentration of 
sample was then detected by a refractive index (RI) detector (Optilab Rex, Wyatt technology, 
Santa Barbara, USA) and finally the weight-average molecular weight is measured using 
multi-angle laser light scattering (MALLS) photometer with the laser set to 690nm  (Dawn 
OES, Wyatt Technology, Santa Barbara, USA). The chromatographic conditions are outlined 
below: 
 Pump -Prominence LC-20AD;  Flow rate -1mL/min;  Mobile Phase  -Ultrapure water;  Injection Volume-200µL;  Column-Plaquagel-OH-Mixed-H 8µm, 300x 7.5mm;  Detector Calibration Constant-2.0x10-5 (V-1);   Detectors -UV, RI and MALLS;  Run Time-45mins. 
3.4.5.3 FTIR spectra of EPS  
Fourier transform infrared spectroscopic (FTIR) method has been used for EPS 
characterisation (Nicolet 380 FTIR). For this purpose 1mg of the sample was used at room 
temperature. Trasmission spectra was recorded using at least 32 scans with 4cm-1 rsolution in 
the spectral range 4000-5004cm-1. (FTIR) spectroscopy is a rapid nondestructive method that 
has been to many biological systems (Schmitt and Flemming, 1998, Gómez-Zavaglia and 
Fausto, 2003). The techique is based on the principle that atoms in the molecules are not held 
rigidly apart and when subjected to infrared radiation (between 500 and 4000 cm-1), the 
molecule will absorb energy and the bond will be subject to number of vibrations. Hence the 
absorbtion spectrum contains information regarding the molecular structure of the sample. 
All the absorption spectra of the extracted samples were recorded between 4000 and 500cm-1 
with a FTIR spectrometer (Magna-IR 750, Nicolet Instrument, USA). The region between 4000 
and 500cm-1 holds the characteristic bands and is sutiable for the characterisation of 
microorganisms (Dittrich and Sibler, 2005, Lin et al., 2005). The wide and intense 
carbohydrate or EPS bands are found at wave number 950-1200cm-1 which can be attributed 
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to –COC- group vibrations in the cyclic structure (Gómez-Zavaglia and Fausto, 2003, Dittrich 
and Sibler, 2005, Schmitt and Flemming, 1998).  
3.4.5.4 Monomer analysis  
Monomer analysis was carried out using High Performance Anion Exchange Chromatography 
with a Pulsed Amperometric Detector (HPAEC-PAD, Dionex now Thermo Fisher Scientific 
Inc). Isolated EPS (3 mg) was suspended in 2 mL of 4M trifluoroacetic acid (TFA) (Sigma 
Aldrich, UK) in a pressure tube and heated at 120oC for 2 hours. After 2 hours the samples 
were cooled to room temperature and evaporated to dryness under a constant stream of 
nitrogen at (60oC). The dried sample was reconstituted with ultra-pure water 1-1.5ml and 
was used directly for HPAEC-PAD. 
Reconstituted, hydrolysed EPS samples were the injected (AS50 Autosampler, Dionex Co.) 
into the HPAEC. Sodium hydroxide (8mM, Isocratic) delivered by a gradient pump (GS50 
Gradient pump, Dionex Co.) at 0.5ml/min was used to elute the monosaccharide’s through the 
PAD detector (ED50 Electrochemical detector, Dionex Co.). The monosaccharide standards 
used to obtain the linear calibration data were prepared to the specific concentrations in 
deionised water and were run using the chromatographic conditions listed below:  
 Pump -GS50 Gradient pump;  Flow rate-0.5mL/min;  Mobile Phase - 8mM Sodium Hydroxide;  Injection Volume - 200µL;  Column-CarboPac PA203 x 150mm;  Detector – PAD;  Run Time-20mins. 
3.5 Experimental procedures 
3.5.1 Determination of the Minimum Bactericidal Concentration (MBC) of alcohols 
and containing hand gels 
Initially the MBC of ethanol and IPA was determined in 96 well plates, each well containing 
200µl µl of TSB, 50µl of a 2x103 cfu/ml A. baumannii culture and 50µl of alcohol solution to 
generate a concentration gradient 80-40% v/v. Following a 5min contact time the wells were 
sub-cultured under standard culturing conditions. The MBC being identified as the lowest 
concentration from which no viable cells could be cultured. Further investigations utilised 
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lower concentration of alcohols and also included had gels. In this case 10ml of MRD 
containing 0.1-5% v/v of ethanol, ethanol based hand rub (Salvo gel), IPA, or IPA based hand 
rub (Purell) and 50µl of 2x103 cfu/ml A. baumannii were incubated under standard conditions 
(n = 4). After 24 hours incubation the number of bacteria present were enumerated.  
3.5.2 Alternative media for the EPS production 
In the search for carbohydrate free media for the growth and production of EPS from A. 
baumannii mineral media (Table 3.2) was supplemented with (0.01- 0.5% w/v) Lactalbumin 
(Oxoid Ltd), casein (Oxoid Ltd) or casein + lactalbumin. These milk derived complex nitrogen 
sources were chosen because the EPS isolation and characterisation methodologies employed 
in this work have already been applied to bacteria grown in milk based media (Laws et al., 
2008). Media was inoculated with  50µl of 2x103 cfu/ml. A. baumannii and incubated under 
standard conditions After 24 hours incubation the number of bacteria present were 
enumerated (n = 4).  
3.5.3 Assessment of ethanol and IPA as sole carbon sources 
The impact of ethanol and IPA on the growth of A. baumannii was investigated using mineral 
media supplemented with 0.001, 0.01, 0.03 and 0.05% (v/v) ethanol or IPA. Controls were 
also run with 1% w/v glucose. Media was inoculated with  50µl of 2x103 cfu/ml A. baumannii 
and incubated under standard conditions. After 24 hours incubation the number of bacteria 
present were enumerated. To confirm that alcohol was being metabolised, the batch growth 
experiments described above were repeated with either 1% (v/v) ethanol or IPA under 
standard conditions. After 24 hours incubation the concentration of alcohol remaining was 
determined (n = 4).   
3.5.4 Determination of MICs using the Bioscreen automated growth instrumentation 
The Bioscreen technology (Oy Growth Curves Ab Ltd) is a computer-controlled 
incubator/reader/ shaker able to monitor bacterial growth via increases in optical density 
(OD) in real time. It employs a 100 well micro-plate format, with two plates being utilised per 
run, allowing up to ǲ200 tests being run simultaneouslyǳ. In this investigation the Bioscreen 
instrument was employed to determine the MIC or alcohols and other biocides.  
To determine the MIC of a particular biocide a dilution series was created down the plate 
using the biocide prepared in mineral media, a typical concentration series would be 10% - 
0.625% (v/v).  Once prepared 50µl of a 103cfu/ml suspension of the desired bacteria were 
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added in all of the wells and shaken at 37°C for 24 hours with reading taken at 1 hour 
intervals. In order to determine the minimum biocidal concentration at the end of the 
Bioscreen run 100µl was transferred from each well to another Bioscreen plate containing DE 
neutralising broth (LabM Ltd). The DE plate was then incubated under standard conditions 
for 24 hours after which each well was plated out onto TSA to determine the presence of 
absence of live organisms.  
In order to generate MIC values from the Bioscreen output the approach described by 
Lambert and Pearson (2000) was employed. Firstly the area under the OD time curve (Figure 
3.3.) is determined using the trapezoidal rule performed in Microsoft Excel. Comparison of the 
test curve with that of the positive and negative control allows the calculation of a fraction 
area (fa) (Equation 3.1). Once a range of fractional areas have been calculated they can be 
plotted against the log of the biocide concentration (Figure 3.4) to allow analysis via a 
modification of the Gompertz function (Equation 3.2). This function was fitted to the data 
using the solver function in Excel; this allowed the MIC to be calculated from the constants M 
and B (Equation 3.3). 
 
Figure 3.3. A typical Bioscreen OD vs. time curve     (                          )                                                                                
Where: AreaT = Area under the test curve, AreaNC = Area under the negative control and 
AreaPC= Area under the positive control. 
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Figure 3.4. A typical fa vs. Log concentration curve                                                                                       
Where: A = Lower asymptote of y, C is Distance between upper and lower asymptote (Approx. 
1), B = Slope parameter X = Biocides concentration and M = Log Concentration of the inflexlon 
point.                                                                                             
Where: B = slope function, M = is the log concentration at the inflexion point. 
3.5.5 Hydrophobicity of planktonic cells 
Evaluation of hydrophobicity of planktonic cells was carried out using the microbial adhesion 
to n-hexadecane (MATH) test (Mattos-Guaraldi et al., 1999). In short, overnight cultures 
grown at 37°C in mineral media were centrifuged in a bench micro centrifuge to generate a 
pellet. The pellet was dispersed in MRD to an OD at 550nm of 0.8. Five millilitre of this 
bacterial suspension was overlaid with 100ml of Tween 80 (5mg/ml, Sigma Aldrich Ltd). After 
1-2 min of agitation by vortexing, the phases were allowed to separate for 15minutes at room 
temperature. The absorbance of the aqueous phase was then measured at 550nm. The 
hydrophobicity test was performed directly on planktonic cells or after three washing in MRD 
in order to remove EPS (Campanac et al., 2002). Results were expressed as the percentage of 
cells excluded from the aqueous phase determined by the equation (Equation 3.4):                                                                                       
Where A0 and A are, respectively, the initial and final ODs of the aqueous phase.  
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Strains were considered as: strongly hydrophobic when the values obtained were >50%, 
moderate hydrophobic for values ranging between 20% and 50% and hydrophilic when 
values were <20%.  
3.5.6 ATP dependent test for hydrophobicity confirmation 
An alternative approach to the MATH test was developed employing ATP content by using the 
ATP dependent biomass detection kit (3M-clean trace, 3M health care, Germany). The test was 
performed as described for the MATH test except that the ATP content of the aqueous phase 
was used instead of the absorbance at 550 nm.  
3.5.7 Quantitative estimation of Biofilm The method of O’Toole (O'Toole et al., 2000), was employed for the quantitative estimation of 
biofilms, this method uses crystal violet to stain biofilms attached to a surface, with the extent 
of the biofilm being proportional to the amount of crystal violet retained.  A single colony of A. 
baumannii was removed from a stock plate and grown on in 20ml of TSB under standard 
conditions to a level of 107 cfu/ml. 50µl of this overnight culture was placed in the wells of a 
96 well plate along with 50µl of mineral media and incubated under standard conditions. 
Following incubation the wells were washed four times with sterile distilled water and 
allowed to air dry for 5-10 minutes. Following drying 100µl of crystal violet was added in each 
well and the plate was left at room temperature for 30min. The plate was again washed four 
times with sterile distilled water and air dried for 5-10min. following drying 200µl of ethanol 
was added to each well to extract the retained crystal violet, 125µl of this ethanol was then 
transferred to a clean 96 well plate. The amount of crystal violet extracted was then 
determined by absorbance at 540nm on a plate reader (Multiskan EX, Thermo Labsystems). 
All the strains were classified into the following categories: non-adherent (0), weakly 
adherent (+), moderate adherence (++) and strongly adherent (+++) based on the absorbance 
(Ab) of the bacterial film using the approach outlined by Stepanovi et al (Stepanovi et al., 
2000). The classification process is outlined below: 
Abtest ζ Abcontrol    Non-adherent 
AbcontrolζAbtest ζ ʹ xAbcontrol               weakly adherent 
2 xAbcontrolζ Abtestζ Ͷ x Abcontrol  Moderately adherent 
4 x Abcontrolζ Abtest    Strongly adherent 
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3.5.8 Drip flow reactor (DFR) for the continuous growth of biofilm 
A drip-flow biofilm reactor (DFR) (BioSurface Technologies Corporation) was used to grow A. 
baumannii biofilms under low shear conditions close to the air-liquid interface using the 
approach described by  Stewart et al (Stewart et al., 2001, Werner et al., 2004).This system 
was used to grow biofilms on glass slides using minimal media enriched with both ethanol 
and glucose. These biofilms were established by operating the reactors in batch mode for 6h 
at room temperature, these were allowed to mature for an additional 48h with a continuous 
flow of minimal medium over inclined glass coupons set at a 10° angle as described by 
Werner et al, 2004 (Werner et al., 2004).  
After 48 hours the glass coupons were removed, drained to remove any planktonic cells and 
fixed with 2.5% v/v formalin and stained with ethidium bromide (500mg/ml) (Sigma Aldrich, 
UK) for 15min. Slides then washed with d.H2O and stained with fluorescent brighter 28 or 
calcoflour white (0.1% w/v) (Sigma Aldrich, UK) and observed under a fluorescent 
microscope. Fluorescent brighter 28 or calcoflour white stain (Sigma Aldrich, UK), reacts with 
the carbohydrates in EPS to give a blue colour whilst the bacterial cells are stained red by the 
ethidium bromide.  
 
Figure 3.5. Drip flow biofilm reactor (Goeres et al., 2009) 
3.5.9 MBEC Biofilm cultivation 
The MBEC systems (InnovotechInc, Canada) as originally described by (Ceri et al., 1999b) was 
used to test biofilms against biocides. The MBEC system consists of a polystyrene lid, with 96 
downward-protruding pegs, that exactly fit into the wells of a 96-well plate (Figure 3.6). In 
order to grow A. baumannii biofilms on the MBEC system an inoculum was prepared by 
suspending bacteria from overnight TSB broth cultures in 0.9% w/v NaCl to match a 
1McFarland standard. The standard inoculum was then diluted 3 folds in growth media to 
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achieve an initial viable count of approximately 1x107cfu/ml, 150µl of this inoculum was then 
transferred into each well of a 96 well plate. The inoculated plate was then incubated 
overnight at 37°C on a shaker at 5 rpm. Following this initial incubation, biofilms were rinsed 
with 0.9% w/v NaCl to remove the loosely attached planktonic cells. Biofilm formation was 
evaluated by breaking 2-3 pegs from the MBEC system and recovering the associated biofilm 
into 200µl of 0.9% w/v NaCl via 5 minutes of ultra-sonication. The number of recovered 
bacteria was determined by plating out under standard conditions.  
 
Figure 3.6. The MBEC biofilm growth system (Innovotech Inc, Canada). 
The method of (Harrison et al., 2008) (Figure 3.7), was followed to determine the MBCb, using 
A. baumannii biofilms prepared as described above. Serial dilutions of the biocides of interest 
were prepared in 200µl mineral media using 96-well microtiter plate. After rinsing the biofilm 
plate was placed into the biocide wells and incubated overnight at 37°C on a shaker with 
speed of 5 rpm.  After incubation the biofilm plate was transferred into a 96-well recovery 
plate containing DE neutraliser broth (LabM Ltd) for 20 minutes. Biofilms were then 
recovered by sonication into MRD and then serially diluted and plated out on TSA and 
incubated under standard conditions.  
3.5.9.1 Biofilm formation in the presence of biocides  
Serial dilutions of the biocides of interest were prepared in 200 µl mineral media using 96-
well micro titer plate, 50µl of a 103 cfu/ml A. baumannii suspension was added to each well 
and a sterile MBEC plate attached, the completed plate was the incubated overnight at 37°C on 
a shaker with speed of 5 rpm. After incubation the MBEC plate was rinsed and then 
transferred to a 96-well recovery plate containing DE neutraliser broth (LabM Ltd) for 20 
minutes neutralisation. After neutralisation the whole MBEC plate was sonicated for 5mins. 
Minimum bactericidal concentrations (MBCb) for the biofilms were then determined by 
reading the optical density at 650nm of the recovery plates, using Thermomax micotitre plate 
reader with Softmax pro data analysis software or via ATP determination.  
Pegs 
 
Wells 
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Figure. 3.7. Determination of minimum bactericidal concentrations for biofilms 
(Harrison et al, 2008). High-throughput screening may be used to identify synergistic antimicrobial interactions that kill microbial bioﬁlms. Starting from cryogenic stocks, the desired bacterial strain was streaked 
out twice on TSA (a), and colonies from the second subcultures were suspended ingrowth medium to match a 1.0 
McFarland optical standard (b). This standardized suspension, diluted 30-fold in TSB, served as the inoculum for 
the CBDs. The inoculated devices were assembled and incubated on a gyrorotary shaker (c), which facilitated the 
formation of ͻ͸ statistically equivalent bioﬁlms on the peg surfaces ȋdata not shownȌ. Bioﬁlms were rinsed with 
0.9% NaCl (d), and surface-adherent growth was veriﬁed by viable cell counting ȋeȌ. Antimicrobials were set up in ǲcheckerboardǳ arrangements in microtiter plates ȋfȌ, and the rinsed bioﬁlms were inserted into these challenge plates for the desired exposure time ȋgȌ. Following antimicrobial exposure, bioﬁlms were rinsed and inserted into recovery plates. Bioﬁlm cells were disrupted into the recovery medium by sonication (h), and the 
recovery plates were incubated for 24 h before the OD650 values of recovered cultures were read in a microtiter plate reader ȋiȌ. This allowed the FBC index to be calculated, and this was used to identify ǲcandidateǳ synergistic 
interactions (j). Candidates were validated by repeating the testing process (as outlined in steps a-h), but instead of qualitative measurements, bioﬁlm cell survival was quantiﬁed by viable cell counting on agar plates ȋkȌ. 
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3.5.10 . Evaluation of antimicrobial wound dressings 
3.5.10.1 Bacterial strains 
All strains of S. aureus and P. aeruginosa identified in Table 3.2, along with six strains of A. 
baumannii (Type, UK-HS, Clone I and Clone II, 882 and 292) were used to evaluate the 
effectiveness of the antimicrobial wound dressings.  
3.5.10.2 Culture conditions 
Stock suspensions were prepared by taking cultures from TSA stock plates and dispersing 
these in sterile conical flask containing 10 ml of MRD and 5 g of glass beads by gentle shaking 
on an orbital shaker. The OD of the suspension was adjusted to be equivalent to a 0.5 
McFarland standard at 600 nm in a spectrophotometer. This OD approximated to a 1-
1.5x108cfu/ml suspension. A working suspension of 1-1.5x105cfu/ml was then prepared in a 
simulated wound fluid (SWF) composed of a 50:50 suspension of MRD and foetal calf serum 
(Sigma-Aldrich Ltd).  
3.5.10.3 Antimicrobial dressings  
Four commercially available dressings were selected for evaluation:   A Manuka honey based dressing (Actilite, Advancis medical, UK);  A PHMB based dressing (Suprasorb, Lohmann and Rauscher, Germany);  A nanocrystalline silver coated dressing (NSCD) (Acticoat, Smith & Nephew Medical 
ltd, UK);  Anionic silver coated dressing (ISCD) (Aquacel Ag, Convatec, UK). 
3.5.10.4 Antimicrobial activity against planktonic cells 
This approach is based on the international standard for the evaluation of antimicrobial 
plastics (BS ISO22196:2007). A 16cm2 (4x4 cm) portion of dressing was placed on a sterile 
plastic sheet in the base of a sterile Petri dish. The dressing was then inoculated with 400 µl of 
test suspension before being covered with another layer of sterile plastic sheet. The 
inoculated dressings were then incubated for 24 hours at 37°C at 90 % humidity. After 24 
hours, the number of surviving bacteria was determined by stomaching the inoculated 
dressings in 10 ml of a validated neutraliser and plating out the neutraliser on TSA under 
standard conditions. In addition, the dressing, base layer and top layer of plastic sheet were 
overlaid with TSA to determine the number of surviving bacteria remaining on these surfaces. 
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The fraction of surviving bacteria was then determined by means of comparison with controls 
as described in BS ISO22196:2007. 
3.5.11.5 Antimicrobial activity against immobilised cells 
An in vitro collagen wound model (CWM) mimicking conditions in chronic wounds and soft 
tissue infections (Brackman et al., 2011) were employed. Matrices of polymerized rat-tail 
collagen type I (BD Biosciences UK) were prepared in 15-ml tubes following the manufacturer’s protocol for eukaryotic cell culturing. For ͳͲ ml of collagen matrix solution 
(3.8mg/ml), 1ml of phosphate buffer saline (PBS) was mixed with 0.019 ml of NaOH (1M) and 
0.7 ml of bacterial suspension (1-1.5x105 cfu/ml) in SWF and kept on ice until required. 
Finally 8.27 ml of collagen from cold collagen stock (4mg/ml) was added and, after mixing, 
1ml aliquots of collagen matrix were transferred to the wells of a 24 well polystyrene plate 
(Fisher Scientific, UK). To polymerise the collagen, the microtiter plate was placed in an 
incubator at 37 °C for 1 hour.  
To test the antimicrobial activity of the test dressings, dressing were cut aseptically to fit the 
well diameter and placed on top of polymerized collagen gel. The plates were then incubated 
for 24 hours at 37°C at 90 % humidity. Following incubation the dressings were removed and 
the number of surviving bacteria was determined by dissolving the collagen matrices by 
adding 1ml of collagenase solution (1mg/ml in PBS from Clostridium histolyticum (Sigma 
Aldrich, UK) to the collagen gel followed by incubation at 37°C for 30-60min. The suspension 
was then mixed thoroughly and re-incubated for 60-80min, until complete digestion. The 
solution from each well was then transferred to 10 ml of a validated neutraliser and the 
fraction of surviving bacteria determined by plating out the neutraliser on TSA under 
standard conditions. In addition, the dressings were overlaid with TSA to determine the 
number of surviving bacteria remaining on these surfaces. The fraction of surviving bacteria 
was then determined by means of comparison with controls as described in BS 
ISO22196:2007. 
3.6 Data processing and statistical analysis 
All general data processing was carried out employing Microsoft Excel. Statistical analysis was 
carried out via SPSS V.20 (IBM Corporation, USA). Due to the large number of comparisons, 
which increases the risk of Type I error, and the difference in variance, the Games-Howell post 
hoc test was used to identify significant differences between variables (Field, 2013). 
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4 Results and discussions 
 The impact of alcohol on the growth, survival and EPS generation of A. baumannii 4.1
A range of alcohols e.g. ethanol and isopropanol (IPA) are employed in healthcare settings as 
antiseptics, disinfectants and components of biocidal blends. The presence of these 
compounds in healthcare settings potentially represents a carbon source for the growth of 
Acinetobacter sp if present at sub-lethal concentrations. There is a considerable body of data 
indicating that Acinetobacter sp have a range of metabolic responses to alcohols (See section 
2.2.6). Consequently the growth response of Acinetobacter sp to alcohols provides an insight 
into the survival of these pathogens in healthcare environments. Initial investigations 
focussed on the Type strain (ATCC 19606) and the UK Hospital Strain (UK-HS) using a range 
of media and alcohol concentrations.  
 Effect of alcohols and alcohol containing hand gels on bacterial growth 4.1.1
Initial investigations focussed on the impact of alcohols and alcohol containing hand gels on 
the growth of Type and UK-HS strains. Concentration profiles of ethanol and IPA from 80-40% 
were prepared in 96 well plates containing TSB and a bacterial inoculum of 10µl of a 2x103 
cfu/ml culture. Following a 5 minute contact time the wells were sub-cultured under standard 
conditions for 24 hours, the minimum biocidal concentration (MBC) being identified as the 
lowest concentration from which no viable cells could be cultured (Table 4.1). In the case of 
the Type strain the MBC was 50% for both ethanol and IPA, however in the case of the UK-HS 
the MBC for IPA was higher at 55%.  
Bacterial 
Strain 
Ethanol IPA 
Concentration (v/v) 
Type  50% 50% 
UK-HS 50% 55% 
Table . 4.2. MBC for Ethanol and IPA.   
Further investigation of the ability of A. baumannii strains to grow and survive in the presence 
of alcohols were carried out in Maximum recovery diluent (MRD), since this provided a lower 
organic load than the Trypton soya agar (TSB) employed previously. The impact of alcohol, 
alcohol based hand rub (Salvo gel), isopropanol alcohol (IPA) and isopropanol alcohol based 
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hand rub (Purell gel) on both the Type strain and UK Hospital Strain (UK-HS) was investigated 
by growing them in MRD supplemented with the alcohols and gels at 0.1%-5% v/v under 
standard conditions.  The amount of hand gel employed was adjusted to provide the required 
alcohol concentration. Both strains exhibited a decrease in growth as the concentration of 
both ethanol and IPA increased (Figure 4.1). This impact on growth was most pronounced in 
the case of the Type strain with inhibitory impacts becoming obvious at 1% v/v, in the case of 
UK-HS growth was not obviously impacted until the concentration reached 3% v/v (Table 
4.2).  Both strains failed to grow when the concentration of either ethanol or IPA was 
increased above 5%. The impact of the alcohol based hand gels was less consistent (Figure 
4.2), particularly the case with UK-HS where the impact of Purell gel was significantly lower 
than that seen with the equivalent concentration of ethanol. These differences are likely to be 
due to the additional components present in alcohol gels e.g. glycerol.   
 
 
Figure: 4.1. Effect of alcohols on Acinetobacter growth.  
*Cfu/ml= Colony forming units/ml, Standard deviation, n=4. 
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Figure: 4.2. Effect of different alcohol gels on Acinetobacter growth. *Cfu/ml= Colony forming units/ml, 
Standard deviation, n=4. 
Treatment 
Significance at 95% CL 
UK-HS Type 
Ethanol Cont>0.1%>1%=3%>5% Cont>0.1%>1%=3%>5% 
IPA Cont=0.1%=1%=3%>5% Cont>0.1%>1%>3%=5% 
Salvo Cont>0.1%>1%>3%>5% Cont>0.1%>1%=3%>5% 
Purell Cont>0.1%>1%>3%<5% Cont>0.1%>1%>3%>5% 
Table 4.2. Significance differences in alcohol growth data. 
 Alternative media for Acinetobacter sp growth 4.1.2
The growth of Acinetobacter sp in TSB and MRD allowed preliminary investigations of the 
impact of alcohols on their growth. However in order to study the response of these bacteria 
to biocides and their generation of EPS a defined media which supported the growth of 
Acinetobacter sp without interfering with biocidal impacts or the analysis of EPS was required. 
Initially a basic mineral media with 1% glucose (See section.3.1.2.1) was chosen. In order to 
provide nitrogen source casein, lactalbumin or casein + lactalbumin were evaluated. These 
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milk derived complex nitrogen sources were chosen because the EPS isolation and 
characterisation methodologies employed in this work have already been applied to bacteria 
grown in milk based media (Laws et al., 2008).  These initial tests were carried out on the 
Type strain and UK-HS. When casein and/or lactalbumin were employed at concentrations 
ranging from 0.01% to 0.5% w/w all strains were able to grow to between log 7.5 to 
8.25cfu/ml in overnight cultures which equates to between a 4.1 to 5.2 cfu/ml increase over 
and above the mineral media control (Figure 4.3). This indicates that although, a complex 
nitrogen source is required for growth, 0.01 % w/w of either lactalbumin or casein was 
sufficient to stimulate extensive growth in the presence of a suitable carbon source.  
 
Figure: 4.3. Impact of complex nitrogen sources on bacterial growth. *Cfu/ml= Colony forming units/ml, 
Standard deviation, n=4, Control = Mineral media, Cas = Casein, Lac = lactalbumin. 
 Impact of ethanol and IPA as sole carbon sources 4.1.3
The impact of ethanol and IPA on the growth of the Type strain and UK-HS was investigated 
using mineral media supplemented with 0.001, 0.01, 0.03 and 0.05% (v/v) ethanol or IPA. 
Controls were also run with 1% w/w glucose. Under these conditions both bacteria were able 
to grow using both alcohols as a sole carbon source. However, as the alcohol concentrations 
increased the growth of the Type strain decreased significantly indicating inhibition (Figure 
4.4, Table 4.3), whilst the UK-HS was able to maintain growth across the range of alcohol 
concentrations tested, with some significant changes evident across the alcohol 
concentrations (Figure 4.5, Table 4.3).  
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Figure: 4.4. Effect of carbon source on the Type strain. *Cfu/ml= Colony forming units/ml, Standard 
deviation, n=4. 
 
Figure: 4.5. Effect of carbon source on UK-HS. *Cfu/ml= Colony forming units/ml, Standard deviation, n=4, 
Treatment 
Significance at 95% CL 
Type UK-HS 
Ethanol Cont>0.001%=0.01%>0.03%>0.05% Cont>0.001%=0.01%=0.03%=0.05% 
IPA Cont>0.001%=0.01%>0.03%>0.05% Cont>0.001%=0.01%=0.03%>0.05% 
Table 4.3 Significance differences in growth at low alcohol concentrations.  
To establish a broader understanding of the consumption of alcohol across all Acinetobacter 
strains available and to confirm that alcohol was being metabolised, batch growth 
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experiments with mineral media supplemented with either 1% v/v ethanol or IPA were run 
and monitored from alcohol removal (Figure 4.6). These experiments confirmed the inability 
of the Type strain to utilise alcohols at these concentrations. All other strains were able to 
remove over 90% of both ethanol and IPA in 24 hours with the exception of the UK-HS which 
only consumed approximately 40% of either alcohol during this period.  
 
Figure: 4.6. Percentage removal of 1% v/v ethanol and IPA during batch growth (Bioassay Kit). Standard 
deviation, n=4, 
 Determination of the MIC of alcohols 4.1.4
In order to provide a more sophisticated understanding of the impact of alcohols on the 
growth of A. baumannii the Bioscreen technology was employed to determine the relevant 
MICs (See section 3.5.4). All seven A. baumannii strains were employed using mineral media 
supplemented with methanol, ethanol, IPA or glucose at a range of concentrations (0.63-10% 
v/v). The concentration range was selected to sit between the MBC (Table 4.1) and the 
concentrations able to support independent growth (Figures 4.4 to 4.6). Methanol was 
included to determine if the number of carbons in an alcohol had an impact on its biocidal 
efficiency and glucose was included as a positive control. MIC values were calculated from 
Bioscreen outputs using the approach described by (Lambert, 2001). Typical Bioscreen 
outputs can be found in Figure 4.7 along with the associated fractional area relationships 
(Figure 4.8), the remaining outputs can be found in the appendix. In all but one case (Clone 1) 
methanol generated the highest MIC of the three alcohols investigated. The response to the 
two alcohols in general use within Healthcare environments varied across the range of strains 
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tested, with Clone 2 being most sensitive to both alcohols and 882 being the least sensitive 
(Table 4.4).  
 
 
Figure.4.7. Bioscreen output for UK-HS grown on ethanol. 
 
Figure 4.8. Fractional area and concentration plot for UK-HS. 
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Figure 4.9. MIC data for all Acinetobacter strains. Standard deviation, n=3. 
Ethanol IPA 
Min Max Min Max 
Strain 
Conc           
(% v/v) 
Strain 
Conc         
(% v/v) 
Strain 
Conc          
(% v/v) 
Strain 
Conc           
(% v/v) 
Clone 2 3.2 882 9.0 Clone 2 3.1 882 8.3 
Table 4.4. Minimum and maximum MIC data for Ethanol and IPA. Standard deviation, n=3. 
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 Discussion 4.1.5The MBC’s determined here are below the in use concentrations recommended for alcohols 
(60-70%) (Fraise et al., 2012) but are at the concentration below which antimicrobial activity 
is known to decrease (McDonnell and Russell, 1999). The impact of ethanol in the presence of 
other carbon sources has been investigated by a number of authors (Pirog et al., 2002, Smith 
et al., 2004), a situation that mirrors the experiments reported above employing TSB and 
MRD. Pirog et al (Pirog et al., 2002) reported on Acinetobacter strains that were unable to 
grow solely on alcohols without supplementation with pantothenic acid (Vitamin B3), a 
situation not reflected in the growth of Acinetobacter strains investigated here where most of 
those investigated were able to grow on either ethanol or IPA as the sole carbon source. 
However, the Type strain grew poorly when provided with significant amounts of alcohol as a 
sole carbon source (Figure 4.7) suggesting in this case supplementation may be necessary.  
The growth of Acinetobacter strains on minimal media with ethanol as a sole carbon source 
without supplementation is well established (Navon-Venezia et al., 1995, Walzer et al., 2006) 
a situation reflected in the growth of the clinical strains investigated here.  
Enhanced pathogenicity due to the presence of alcohol has been reported for Acinetobacter 
spp (Smith et al., 2004) again in the presence of other carbon sources. The positive impact of 
ethanol was reduced as the concentration was raised to 5% and became negative above 5% 
(Smith et al., 2004), a trend that is reflected in the data collected here (Figures 4.1 and 4.2). 
Enhanced growth of Acinetobacter strains at alcohol concentrations at or around 1% has been 
reported by a number of authors (Smith et al., 2004, Edwards et al., 2007a). Edwards et al 
(Edwards et al., 2007b), reported the enhancement of growth and virulence in the presence of 
ethanol and found the significant increase in growth when the minimal media is 
supplemented with ζ1% of four commercially available hand rubs i.e Purell, Spirogel, 
Softalind and Skinman. They reported that the unknown factor which enhanced pathogenicity 
and virulence to A. baumannii was secretion of proteins in response to alcohols. One of these 
proteins was identified as OmpA, which was recognized as having emulsifying activity, which 
could be useful in scavenging carbon for growth from complex energy sources such as 
hydrocarbons. The secretion of OmpA by A. baumannii following exposure to 0.5% v/v 
ethanol in minimal media has also been described by Walzer et al (Walzer et al., 2006), 
suggesting that it may be the important response to growth and survival under low nutrient 
conditions. These bioemulsifiers protein may also be helpful in bacterial adhesion, quorum 
sensing and the development of biofilms (Ron and Rosenberg, 2001).  
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The MIC determined for ethanol and IPA for the clinical strains investigated are towards the 
upper end of published values for alcohol MICs on bacteria in general that range from 1 to 5% 
(Oh and Marshall, 1993, Mazzola et al., 2009, Wadhwani et al., 2008). One published value for 
A. calcoaceticusof4.4% (Mazzola et al., 2009) is broadly similar to the values generated during 
this study with the exception of 882 which had an MIC of approximately double this value 
(Table 4.4). Interestingly these authors indicated that the presence of glycerine, a common 
component of alcohol hand gels increased the MIC by ≈50%, an observation that aligns with 
the reduced impact of Purell gel observed here.  
 Key Findings 4.1.6 A carbohydrate free minimal media employing alcohols as sole carbon sources has 
been developed. 
 The MBC of ethanol and IPA for all strains ranged from 50 to 55% v/v.  
 The MIC of ethanol and IPA for all clinical strains ranged from 3.1 to 9.0% v/v.  
 The Type strain was significantly more sensitive to alcohols and less able to use 
ethanol or IPA as their sole carbon source.  
 Strain 882 was the most resistant strain when exposed to ethanol and IPA.  
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 A Biofilm formation 4.2
 Quantitative determination of biofilm formation 4.2.1
The ability of all available strains of A. baumannii to form biofilms was assessed via the crystal 
violet/ethanol method (See section. 3.5.7). All strains were grown in mineral media 
supplemented with either 1% v/v of glucose, ethanol or IPA. For the purpose of comparative 
analysis of test results, the classification of (Stepanovi et al., 2000) was followed. The crystal 
violet/ethanol method was supplemented by direct enumeration of adhered bacteria. Of the 
strains investigated the Type strain proved to be none adherent, followed by the UK-HS which 
was uniform weakly adherent (Table 4.5). All other strains were strongly adherent when 
grown on ethanol and IPA but Clone 1, 2 and strain 742 had reduced adherence when grown 
on glucose (Table 4.5).  Adherence and biomass content were positively correlated (Figure 
4.10) with highly adherent strains having two orders of magnitude greater biomass than 
weakly adherent strains.  
 
Figure 4.10. Biofilm formation and associated levels of biomass of seven strains of A. baumannii on 
different carbon sources i.e. 1% v/v  Ethanol, IPA and Glucose in mineral media. *Cfu/ml = Colony forming 
units/ml, No adherence (0), Weak adherence (+), Moderate adherence (++), Strong adherence (+++). 
 Formation of biofilms on MBEC surfaces 4.2.2
The ability of the MBEC plastic surfaces to support Acinetobacter biofilms and the ease with 
which cells can be recovered from these surfaces was assessed using UK-HS, Clone 1, Clone 2 
and 882 strains grown in mineral media supplemented with either 1% v/v ethanol, methanol 
and glucose. The biofilms formed by these bacteria were removed from the MBEC pegs via 
sonication (5, 10 and 30minutes) (Figure 4. 11 a-d).  All strains investigated generated 
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significant biofilms on pegs (>log 5 cfu/ml) irrespective of the carbon source. The only 
exception being the UK-HS which generated an order of magnitude lower recoverable 
bacteria. Across all the strains investigated 5 minutes sonication being sufficient to recover 
adhered cells.  
Bacterial 
strains 
Carbon 
source 
CV test 
Log10 
(cfu/ml) 
Type 
Ethanol 
0 2.06 
UK-HS + 4.10 
882 +++ 7.08 
Clone 1 +++ 6.75 
Clone 2 +++ 6.92 
742 +++ 6.50 
292 +++ 6.45 
Type 
 
IPA 
0 2.03 
UK-HS + 4.06 
882 +++ 6.06 
Clone 1 +++ 6.63 
Clone 2 +++ 6.65 
742 +++ 6.83 
292 +++ 6.05 
Type 
Glucose 
0 2.08 
UK-HS + 3.88 
882 +++ 6.88 
Clone 1 ++ 5.83 
Clone 2 ++ 5.83 
742 + 4.11 
292 +++ 6.66 
No adherence (0), Weak adherence (+), Moderate adherence 
(++), Strong adherence (+++). 
 
Table.4.5. Effect of different carbon sources i.e. 1% v/v Ethanol, IPA and Glucose in mineral media on 
biofilm forming capacity of seven strains of A. baumannii using the crystal violet/ethanol method. (See 
section. 3.5.7). *Cfu/ml = Colony forming units/ml, Standard deviation, n=3. 
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(a). UK-HS, ACCB 63608 
 
(b). OXA-23 Clone 1 
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(c). OXA-23 Clone II
 
(d). CIP 106882    
Figure: 4.11. Biofilm growth on MBEC surfaces and effect of different sonication time or biofilm removal 
from MBEC surfaces of different A. baumannii strains. *TVC = Total viable counts. 
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 Assessment of hydrophobicity 4.2.3
Hydrophobicity has been associated with the ability of bacteria to adhere to surfaces and form 
biofilms. An evaluation of the hydrophobicity of A. baumannii was carried out using the 
microbial adhesion to n-hexadecane (MATH) test (Mattos-Guaraldi et al., 1999). All strains 
were cultured in mineral media with ethanol, IPA or glucose as carbon sources. Two different 
methods were employed to evaluate the MATH of all the strain; a qualitative method 
(spectroscopic method OD 550 nm) and quantitative methods (Total viable counts (TVC) and 
ATP determination). These tests demonstrated that all the strains were hydrophobic with the 
exception of the Type strain (Figure 4.11). Of the strains tested Clone 1 and 882 were strongly 
hydrophobic (> 50%), UK-HS and Clone 2 were moderately hydrophobic (>20%<50%) and 
Type stains being hydrophilic (<20%) (Figure 4.11). However, when grown on glucose all the 
strains became moderately hydrophobic (>20%<50%) while Type strain remained 
hydrophilic (<20%) (Figure. 4.12). 
Hydrophobicity determinations were also performed, to determine the impact of media 
composition on culture hydrophobicity. Three different media were investigated i.e. mineral 
media with ethanol, trypton soya broth (TSB) and a simulated wound fluid (SWF) containing 
foetal calf serum (FCS). In this case, the TVC method was replaced with an ATP determination. 
Both of the tests proved that Clone 1 and 882 were strongly hydrophobic (>50%), UK-HS and 
Clone 2 were moderately hydrophobic (>20%<50%) and the Type strain was hydrophilic 
(<20%) (Figure. 4.13) when grown on mineral media with ethanol as a carbon source. 
However when grown on TSB and SWF Clone 1, 882,UK-HS and Clone 2 become moderately 
hydrophobic (>20%<50%) whilst the Type strain remained hydrophilic (<20%).  
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Figure. 4.12. Hydrophobicity determination of different A. baumannii strains on 
different carbon sources i.e. 1% v/v Ethanol, IPA and Glucose in mineral media using 
Microbial adhesion to hydrocarbon (n-hexadecane) test (MATH). (a). Spectroscopic 
method OD 550nm. (b). Standard deviation, n=3. 
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a) 
b)  
Figure. 4.13. Comparisons of hydrophobicity of different A. baumannii strains on 
different media i.e. Mineral media with 1% v/v Ethanol, TSB and SWF using Microbial 
adhesion to hydrocarbon (n-hexadecane) test (MATH).  (a). Spectroscopic method OD 
550nm. (b). ATP dependent test.  Standard deviation, n=3. 
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 Total carbohydrate estimation 4.2.4
Batch growth experiments were performed to determine if biofilm forming strains were 
generating EPS with a total carbohydrate estimation being used as a measure of this 
generation. A range of carbon sources (glucose, ethanol and IPA) were used along with the 
two strong biofilm forming strains 882 and Clone 1 identified in Section 4.2. The procedure 
used for total carbohydrate contents was based on that described by (Dubois et al., 1956). 
Alongside EPS generation the consumption of the carbon sources, biomass production and 
lactate production were also monitored. When glucose was employed as the carbon source 
glucose concentration was deducted from the total carbohydrate measurements to determine 
the free EPS concentration. Both strains demonstrated a classic batch growth curve on all 
three carbon sources with a limited lag phase. The incubation period was not long enough for 
a death or decline phase to occur.  
In all cases (882 and Clone 1) EPS generation was associated with the exponential phase of 
biomass growth and although EPS generation stopped once biomass generation had ceased, 
there was no evidence that this carbohydrate was utilised as a carbon source during the 
stationary phase (Figures 4.14 and 4.15). This contrasts with the primary carbon sources, 
which reduced to zero during the exponential growth phase or the lactate evolution which 
increased during exponential growth and then was metabolised back to zero during the 
stationary phase (Figures 4.14 and 4.15).   
The amount of EPS produced across all carbon sources and strain was broadly similar (0.35 to 
0.4 mg/l) as was the amount of biomass produced (Log 9 to 9.5 cfu/ml). On a weight-by-weight basis EPS generation accounted for ≈ Ͳ.ͲͲͶ% of the carbon source consumed 
regardless of the nature of the carbon source. The only major difference in the batch growth 
profiles was in the lactate profiles with 882 producing approximately four times as much as that produced by ͺͺʹ on glucose or that produced by Clone ͳ on any of the carbon sources ȋ≈ 
0.4-0.45 mg/l c.f. 0.1-0.15 mg/l). (Figures. 4.14 )    
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(a). 882 ethanol  
 
(b). 882 IPA 
 
(c). 882 Glucose 
Figure. 4.14. Total carbohydrate estimation, ethanol removal and biomass production by 882 on carbon 
source (a). 1% v/v Ethanol. (b). 1% v/v IPA. (c). 1% v/v Glucose. ). *Cfu/ml = Colony forming units/ml, 
Standard deviation, n=3. 
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(a). Clone 1 Ethanol. 
 
(b). Clone 1 IPA. 
 
(c). Clone 1 Glucose. 
Figure.4.15. Total carbohydrate estimation, ethanol removal and biomass production by Clone 1 on 
carbon source (a). 1% v/v Ethanol. (b). 1% v/v IPA. (c). 1% v/v Glucose. ). *Cfu/ml = Colony forming 
units/ml, Standard deviation, n=3. 
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 Scanning electron microgram (SEM) of A. baumannii strains 4.2.5
In order to directly visualise A. baumannii biofilms the high biofilm forming strains i.e.882 and 
Clone 1 were grown on plastic surfaces using mineral media enriched with either glucose, IPA 
or ethanol as a carbon source, with the Type strain being used as a control. SEM revealed that 
both 882 and Clone 1 formed biofilms on the plastic surfaces on all the carbon sources. 
However the Type strain did not form any obvious biofilm (Figure 4.16), an observation 
which supports the results of the crystal violet/ethanol method for biofilm formation. 
 
 ETHANOL    IPA    GLUCOSE 
Figure. 4.16: Scanning Electronic Microgram of biofilm forming strains of A. baumannii 
grown in mineral media supplemented with 1 % v/v ethanol, IPA and glucose. 
 
 
 
 
 
Type strain Type strain Type strain 
Clone I Clone I Clone I 
CIP 106882 CIP 106882 CIP 106882 
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 Drip flow reactor (DFR) and fluorescent microscopy 4.2.6
A. baumannii biofilms (Type strain, 882 and Clone 1) were grown on glass slides using the 
drip-flow reactor fed on minimal medium with ethanol, IPA or glucose as a carbon and energy 
source. Glass coupons were after either 24 or 48hours, drained and fixed for fluorescent 
microscopy. Consistent with the SEM observations both the strains were able to form biofilm 
on all the carbon sources. i.e. ethanol, IPA and glucose. In this case the generation of EPS could 
be directly visualised by the blue/white fluorescence of the calcofluor white carbohydrate 
stain. The formation of the biofilm and associated EPS is seen as a blue colour around the red 
bacterial cells. The biofilm starts forming after 24 hours; however biofilm was more obvious 
after 48 hours of continuous growth in the drip flow reactor. Type strain did not form any 
biofilm however; both the biofilm forming strains i.e. 882 and Clone 1developed stronger 
biofilms with more obvious EPS when the carbon source was ethanol and IPA as compared to 
the glucose (Figures 4.17 - 4.19). Biofilms with a more compact structure were seen with 882 
than Clone 1 on all the carbon sources (Figure 4.17 - 4.19). 
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(A) 
 
(C) 
 
(E) 
Figure. 4.17. Fluorescent microscopy (x 1000) of 
A. baumanii Type strain grown in mineral media 
supplemented with 1 % v/v ethanol, IPA and 
glucose. (A). Ethanol 24hours. (B). Ethanol 
48hours. (C). IPA 24hours. (D). IPA 48hours.  (E). 
Glucose 24hours. (F). Glucose 48hours. EPS or 
biofilm visualised by the blue/white colour 
around the red A. baumannii strain. 
 
(B) 
 
(D) 
 
(F) 
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(A) 
 
(C) 
 
(E) 
Figure. 4.18. Fluorescent microscopy (x 1000) of 
A. baumannii CIP 106882 strain grown in 
mineral media supplemented with 1 % v/v 
ethanol, IPA and glucose. (A). Ethanol 24hours. 
(B). Ethanol 48hours. (C). IPA 24hours. (D). IPA 
48hours.  (E). Glucose 24hours. (F). Glucose 
48hours. EPS or biofilm visualised by the 
blue/white colour around the red A. baumannii 
strain. 
 
 
 
(B) 
 
(D) 
 
(F) 
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(A) 
 
(B) 
 
(C) 
Figure. 4.19. Fluorescent microscopy (x 1000)of 
A. baumannii OXA-24 Clone I strain grown in 
mineral media supplemented with 1 % v/v 
ethanol, IPA and glucose. (A). Ethanol 24hours. 
(B). Ethanol 48hours.(C). IPA 24hours. (D). IPA 
48hours.  (E). Glucose 24hours. (F). Glucose 
48hours. EPS or biofilm visualised by the 
blue/white colour around the red A. baumannii 
strain. 
 
 
 
(D) 
 
(E) 
 
(F) 
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 Discussion 4.2.7
A. baumannii is known to form strong adherent biofilms that allow the bacteria to 
survive for several weeks on abiotic surfaces in healthcare settings (Harrison et al., 
2008, Donlan, 2008, Villegas and Hartstein, 2003, McConnell et al., 2012). Biofilm 
formation amongst clinical strains has been identified as a virulence factor 
(Wroblewska et al., 2008). However, as observed here, biofilm formation amongst A. 
baumannii strains is not consistent; Wroblewska et al (Wroblewska et al., 2008) 
investigated 34 clinical strains from patients hospitalized in two tertiary care hospitals. 
The isolates demonstrated a wide range of biofilm forming ability, with 12% high, 41% 
medium and 47% demonstrating a low level of biofilm production. A similar variation in 
adherence was observed when the adherence of clinical isolates to human bronchial 
tissue was investigated (Lee et al., 2006). In the case of the strains investigated here 
(Table 3.1) a greater number demonstrated a high level of adherence with the strength 
of adherence being dependent on the carbon source. Wroblewska et al (2008) did not 
consider the impact of carbon source on biofilm formation, but the data collected by 
current study clearly shows that alcohol based carbon sources increase adherence, with 
71% of strains being highly adherent when fed on alcohol as the sole carbon source 
with only the Type strain and UK-HS remaining poorly adherent regardless of carbon 
source. Lee et al (2006) observed lower levels of adherence for Clone 1 than Clone 2 
onto epithelial cells, when tested here for adherence to plastic surfaces no differences 
between Clones 1 and 2 was seen. Other authors (McQueary and Actis, 2011) have 
shown the Type strain to be comparable in its ability to form biofilms but in this case 
TSB was employed as a growth media, emphasising the importance of the carbon source 
on biofilm formation.  
The variations between strains and the impact of carbon source on biofilm formation 
was mirrored in the hydrophobicity data, where there were clear differences between 
strains (Figures. 4.12) and the use of alcohol as a sole carbon sources generated greater 
hydrophobicity than glucose, SWF or TSB (Figure. 4.13).  This correlation between 
biofilm formation and hydrophobicity is to be expected since plastic surfaces are 
hydrophobic in nature (McQueary and Actis, 2011). Authors such as McQueary and 
Actic (2011) found no correlation between hydrophobicity and biofilm formation on 
plastic commenting that this was at variance with observations on Listeria and Neisseria 
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spp. Pompilio et al (Pompilio et al., 2008), tested 40 clinical isolates of 
Stenotrophomonas maltophilia strains to investigate the correlation between the 
adherence and the biofilm formation on polystyrene and cell surface hydrophobicity 
and motility, they found that most of the strains were able to adhere and form biofilm 
and there is a positive correlation was observed between the hydrophobicity and levels 
of both adhesion and biofilm formation. Out of eleven (27.5%), of the strains proved to 
be hydrophobic, with hydrophobicity greatly increased as S. maltophilia attached to the 
substratum. 
The MATH test has also been used to monitor the cell surface hydrophobicity of 
nosocomial pathogen Pseudomonas aeruginosa as it grew in the presence of 
benzalkonium chloride (Machado et al., 2011). They reported that the strain OO14 
increased in hydrophobicity as the cells grew in resistance to the disinfectant. Bos et al 
(Bos et al., 1999) used the MATH test on dental colonisers such as Streptococcus and 
Actinomyces and found that the presence of divalent calcium cations increased the 
adhesion to hexadecane and chloroform. Costa, et al (Guimaraes et al., 2006) and Di 
Bonaventura, et al (Di Bonaventura et al., 2008), reported that hydrophobicity of the 
bacterial surface is an important factor for adherence and colonization of bacteria to 
both living (epithelial mucous tissues) and non-living surfaces (medical devices). 
Umamaheshwari and Jain, (Umamaheshwari and Jain, 2004), reported that the 
hydrophobic cell surface components may serve as a binding target for antibacterial 
lipobeads. Rosenberg (Rosenberg, 2006), reported that hydrophobic surface property of 
the bacteria play a vital role in growth on hydrophobic materials, initial biofilm 
formation, adhesion to host cells, aggregation and flocculation and it is the one of many 
parameters which determines the ability of a cell to adhere, invade and cause damage.  
However, McQueary and Actic (2011) employed TSB as a growth media which as can be 
seen here does not favour biofilm formation in some A. baumannii strains. When the 
Type strain and more hydrophobic strains such as 882 and clone 1 were grown on 
plastic surfaces and visualised via SEM, the less hydrophobic Type strain was unable to 
maintain a significant biofilm suggesting that when grown on a more minimal media the 
Type strain was unable to maintain a biofilm on a hydrophobic surface, indicating a 
direct correlation between hydrophobicity and biofilm formation.  
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A number of gene products have been proven to play a role in attachment and biofilm 
formation on abiotic surfaces e.g. pilus production mediated by the CsuA/BABCDE 
usher-chaperone assembly system is required for the attachment and biofilm formation 
on the abiotic surfaces by the A. baumannii Type strain. This operon seems to be wide 
spread among clinical isolates and an indication that it is a common factor among 
different clinical isolates (Tomaras et al., 2003). However McQueary and Actic (2011) 
demonstrated that even in the presence of this gene significant strain to strain 
variations in biofilm formation were evident. The Type strain also has ability to produce 
alternative pili that may help in the interaction of this pathogen with bronchial 
epithelial cells (De Breij et al., 2010). Loehfelm et al (Loehfelm et al., 2008) reported 
that biofilm-associated protein (Bap), conserved in the clinical isolates and appears to 
be associated with the cell-cell interactions that support the development and 
maturation of the biofilm. In addition to (Bap), the A. baumannii clinical isolates also 
produce poly-Ⱦ-1-6-N-acetylglucosamine (PNAG) for the development and maturation 
of the biofilm on glass surfaces by the cells cultured (Bentancor et al., 2012, Choi et al., 
2009b). A two component regulatory system also reported in A. baumannii Type strain 
comprised of: a sensor kinase encoded by bfmS, and a response regulator encoded by 
bfmR involved in bacteria-surface interaction (Tomaras et al., 2008). The insertional 
inactivation of bfmR results in the loss of expression of cusA/BABCDE operon resulted in 
the lack of pili production and biofilm formation on plastic surfaces when grown in rich 
medium (LB broth), however the inactivation of bfmS sensor kinase gene resulted in 
diminishment but not abolishment of biofilm formation (Tomaras et al., 2008). In the 
absence of BfmRS system the composition of culture media still influence the 
interaction of cells with abiotic surfaces, these finding indicates that the BfmRS system 
cross talks with other sensing components and suggests instead of one, there are 
multiple and different stimuli which could control the biofilm formation via BfmRS 
regulatory pathway (Tomaras et al., 2008). However, all Tomaras et als (2008) work 
was carried out using the Type strain with glucose as a carbon source, consequently the 
differences seen here with ethanol and other strains was not investigated.  
Another mechanism controlling bacterial adherence and biofilm formation is cell 
population density. Accordingly, environmental and clinical isolates produce quorum 
sensing signalling molecules (Gonzalez et al., 2001, Gonzalez et al., 2009), these studies 
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proved that a large number of isolates produce quorum sensing and signalling 
molecules which seem to belong to three types of molecules. Although none of these 
sensors belongs to a particular species, however the Rf1-type sensor is more frequently 
found in isolates belonging to the A. calcoaceticus-baumannii complex. Niu et al (Niu et 
al., 2008) proved that the A. baumannii M2 clinical isolates produce an N-acyl-
homoserine lactone [N-3-hydroxydodecanoyl-homoserinem lactone], the product of the 
abaI auto inducer synthase gene, which is vital for the fully developed biofilm on abiotic 
surfaces, abaI auto inducer also helps this isolate to move in semisolid media.  
Glass represents a hydrophilic rather than a hydrophobic surface for biofilm production 
and has been used by some authors (McQueary and Actis, 2011) as a contrast to 
polystyrene in biofilm studies. In this investigation glass slides in a drip flow reactor 
were employed to investigate biofilm formation by the high biofilm forming strains 882 
and Clone 1 and the low biofilm forming Type strain. The drip flow system is a more 
representative approach for assessing biofilm formation on glass since the bacteria have 
to adhere to the substrate in order to stay in the system. In contrast to McQueary and Actic’s ȋʹͲͳͳȌ these hydrophobic strains were able to form and maintain significant 
biofilms on glass under low shear conditions with no obvious difference between 
glucose or alcohol as a carbon source (Figures. 4.17, 4.18). The hydrophilic Type strain 
was also able to form biofilms on glass, these were less extensive when fed alcohols, 
particularly IPA than the two hydrophobic strains. Significant variations in the amount 
of biofilm formed and the cell arrangements present on abiotic surfaces have been 
reported for A. baumannii (McQueary and Actis, 2011). Some cell arrangements are 
highly organised, multi-layered and complex structures encased within a biofilm or EPS 
matrix, while some others are simple monolayers of bacteria attached in an organized 
or random manner (McQueary and Actis, 2011).  In the case of the strains investigated 
here only monolayers were formed under either static (Figures.  4.17, 4.18) or low 
shear environments. 
Edwards et al (Edwards and Harding, 2004) reported that A. baumannii is able to 
readily metabolized low concentrations of ethyl alcohol and secreted a range of proteins 
including OmpA, which is recognized as having emulsifying activity. The secretion of 
OmpA by A. baumannii following exposure to 0.5% ethanol in minimal media has also 
been described by Walzer et al (Walzer et al., 2006), suggesting that it may be the 
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important response to growth and survival under low nutrient conditions. These 
bioemulsifying proteins also assist in bacterial adhesion, quorum sensing and the 
development of biofilms (Ron and Rosenberg, 2001). Generally, A. baumannii adheres to 
biotic and abiotic surfaces via the same steps described for general biofilm formation. 
The associated EPS being composed of carbohydrates, proteins, nucleic acids and other 
macromolecules (McConnell et al., 2012). Pirog et al (Pirog et al., 2002), reported that 
Acinetobacter spp.12S has the ability to grow and synthesize EPS on different 
carbohydrate substrates like mono and disaccharides, molasses and starch. He reported 
that the Acinetobacter spp. were grown on carbohydrate media containing no 
pantothenic acid (Vitamin B3), which is required for growth on C2-substrates. He used 
mixture of carbohydrate sources (0.01, 0.1, 0.5 and 1% ethanol and 1% glucose) and 
found that bacterial growth and EPS generation was higher when 0.01% ethanol with 
1% glucose used. The EPS production was intensified as the content of the C2 substrate 
in the medium increased. The author also reported that the addition of low 
concentration (0.02%) of acetate to the glucose-containing medium also stimulated the 
EPS synthesis. The growth of the Acinetobacter strains at the expense of alcohol as the 
sole carbon source without any complex media supplements has already been identified 
as a characteristic of hydrophilic, strongly adherent strains such as 882 and Clone 1 
(Section 4.1.3).  
The formation of polysaccharide based EPS by these strains at the expense of alcohols 
as well as glucose is evident from the drip flow biofilms where the EPS is stained by the 
carbohydrate selective stain calcofluorwhite (Figures. 4.18- 4.19), indicating that these 
strains are able to synthesise complex carbohydrates from C2 and C3 alcohols in 
minimal media. Interestingly the Type strain did not generate any obvious EPS 
suggesting that the hydrophobic biofilm forming strains adhere to glass through the 
generation of EPS, whilst the hydrophilic Type strain employs an alternative approach 
such as the use of pili as outlined by McQueary and Actic (2011). The formation of 
biofilm was observed as a blue colour around the red bacterial cells that starts forming 
after 24 hours, however biofilm was more obvious after 48 hours of continuous growth 
in a drip flow reactor. Both the strains developed strong biofilms when the carbon 
source was ethanol or IPA as compared to the glucose and can be seen easily by the 
fluorescent microscopy. In addition A. baumannii strains 882 developed more compact 
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biofilm as compared to Clone 1 on all the carbon sources (Figures 4.17 - 4.19). The 
generation of EPS is associated with cell growth as can be seen from the batch growth of 
these strains, the resulting EPS is not utilised as a carbon source after formation and is 
produced during growth along with lactate. The formation of acid from glucose is a 
common observation for A. calcoaceticus-baumannii complex as is the consumption of 
lactate as a sole carbon source (Nemec et al., 2011), in this case acid is also produced 
from C2 and C3 alcohols.  
 Key findings 4.2.8 There is significant variation in biofilm forming capacity amongst the strains 
investigated;  Growth on alcohols as sole carbon increased the biofilm forming capacity of 
some strains over media containing glucose as a sole source of carbon;  Strong biofilm formers (882 and clone 1) were also strongly hydrophobic and 
able to establish biofilms on both plastic and glass surfaces;  Carbohydrate based EPS was generated during biofilm formation and growth on 
alcohols;  The EPS generated during growth was produced alongside lactate during the 
growth phase but was not degraded during the stationary phase.  
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 EPS Characterisation 4.3
 Poly-β-(1-6)-N-Acetylglucoseamine (PNAG) method 4.3.1
Growth on Congo red plates was used as an indication of the generation of PNAG by A. 
baumannii. All the available strains (Table. 3.2) were screened with only Clone 1 and 
882 generating red colonies indicating the ability to produced PNAG.  This is consistent 
with the identification of these strains as strong biofilm formers (See  
Table. 3.2). These two strains were then taken forward for a more detailed isolation and 
characterization of PNAG (See section 3.4.4.1) by the 1H NMR. However, 1H NMR spectra 
did not contain any evidence for the presence of PNAG (Figure 4.20, a & b) suggesting 
that these strains produced PNAG at a levels below that extractable by the approach 
(please see Figure 4.21 for comparison).  
 
(A) 
 
(B) 
Figure: 4.20: 1H NMR spectrum of PNAG  or EPS from (a). 882 (b). Clone 1. 1H NMR 
spectra on either a Bruker Avance DPX4000 400.13 or a Bruker Avance DPX500 500.13MHz. Spectra was 
acquired using Bruker pulse sequences at a temperature of 70°C. 
D2O 
Internal Acetone standard 
D2O 
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Figure: 4.21: 1H NMR spectrum of PNAG (Choi et al., 2009a). 
 EDTA method 4.3.2
EPS can be classified by its proximity to the cell surface. Capsular or cell bound-EPS is 
tightly linked via a covalent or non-covalent association whereas free EPS is not directly 
attached to the cell surfaces (Fig. 4.22) (Wingender et al., 1999). Clone 1 and 882 grown 
in 6-litre culture of mineral media supplemented 1% ethanol and incubated at 37°C for 
48-72 hours with continuous shaking at ~90-110 rpm. EPS was separated using the 
method of Sheng et al (Sheng et al., 2005) with some modification (See section. 3.4.4.2). 
The resulting EPS was characterised via 1H NMR along with weight average molecular 
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weight determinations using HP-SEC-MALLS and FTIR.
 
Figure. 4.22. Distribution of Bond and free EPS surrounding bacteria.  
 Weight-Average molecular Weight Determination (MALLS) 4.3.2.1
A standard material (pullulan) of known molecular weight and low polydispersity was 
chosen to ensure the accuracy of the instrumentation. Pullulan is a linear 
homopolysaccharide consisting solely of glucose units. The Mw of the pullulan standard 
is 800,000g mol-1(Brittain, 1997) with a polydispersity (Mw/Mn) of 1.23 and a dn/dc 
value of 0.148ml/g (Figure 4.23). Both the strains i.e. Clone I and 882 revealed the high 
molecular weight compounds. In case of CIP 106882 MALLS analysis (Figure 4.24a) 
indicated a Mw of 62,333Da and a polydispersity (the size of a polysaccharide is 
expressed by the number of monosaccharide units it contains, which is termed as the 
degree of polymerisation (DP) (Mw/Mn) of 1.632. In the case of Clone 1 (Figure 4.24b) 
the Mw was 96,500Da while the polydispersity (Mw/Mn) was recorded as 2.24.  
 
Figure. 4.23. A chromatogram of the Pullulan standard (800,000 Mw). 
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(A) 
 
(B) 
Figure. 4.24. A chromatogram of EPS produced by (a). 882 (b). Clone 1. 
 FTIR spectra of EPS 4.3.2.2
The region between 4000 and 500cm-1 holds the characteristic bands for carbohydrates 
and is suitable for the characterisation of microorganisms (Schmitt and Flemming 
1998). The wide and intensive carbohydrate or EPS bands were found at wave length  
950-1200cm-1 which were attributed to –COC- group vibrations in the cyclic 
structure(Gómez-Zavaglia and Fausto, 2003). FTIR spectra for free and bound EPS from 
Clone 1 and 882 have signals in the region of 950-1200cm-1 which is attributed to the 
vibrations of C-0-P and C-O-C stretching of a diverse polysaccharide groups, and the 
bands at 1260cm-1 and 1080cm-1 exhibit the strecthing of P=O of phophoryl and 
phosphodiester groups from phosphorylated proeins, plyphosphate products and 
nucleic acids. There are also several bands in the region of 1450-1700 cm-1 which 
reffers to the amide groups of the proteins (Figure 4.25. a-d). 
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(a) Free EPS from 882                                  (b). Bound EPS from 882 
 
(c). Free EPS from Clone I.   (d). Bound EPS from Clone I. 
Figure. 4.25 (a-d): FTIR spectra of free and bound EPS from 882 and Clone 1. 
Fourier transform infrared spectrocopic (FTIR) . Trasmission spectra was recorded using at least 32 
scans with 4cm-1 rsolution in the spectral range 4000-5004cm-1.  Carbohydrate or EPS bands are found at 
wave number 950-1200cm-1. 
 The 1H NMR 4.3.2.3
Signals that can be attributed to EPS lie between the regions of 4-5.5ppm. Spectra of the 
free EPS from both the strains does not show any signals for EPS or carbohydrate, 
however the bound EPS results revealed that bacterial strain 882 generate weak EPS 
signals in the designated region, there were five anomeric protons (arbitrarily 
designated A-E from left to right) and one ring proton (B2). The B and C overlapping 
each other while D and E next to each other and B2 peak is next to the D2O peak. 
Similarly in case of Clone 1, 1H NMR revealed weak EPS signals in the designated region, 
there were five anomeric protons (arbitrarily designated A-E from left to right) and one 
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ring proton (B2). The A and B were clear and C+D AND E+B2 next to each other (Figure 
4.24. a, b). The 1H NMR results are consistence with the MALLS analysis (4.3.2.1) that 
the EPS extracted from both species by this approach were not of high molecular weight 
consequently they generated weak NMR signals(Figure 4.26. a, b). 
 
 (A) 
 
(B) 
Figure:  4.26:  1H NMR spectrum of  Bound EPS from (a). 882  (b).Clone 1. 1H NMR 
spectra on either a Bruker Avance DPX4000 400.13 or a Bruker Avance DPX500 500.13MHz. Spectra was 
acquired using Bruker pulse sequences at a temperature of 70°C. 
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 Trichloroacetic acid (TCA) method 4.3.3
The isolation of exopolysaccharide (EPS) was carried out by the method described by 
(Marshall et al., 2001), with some modifications. The additional steps include the use of 
RNAase, DNAase and protease to minimize impurities in the EPS which interfere with 
NMR spectra and lead to the false positive results. The method is referred to as the 
ethanol method and it involves a series of ethanol precipitations, centrifugation, dialysis 
and freeze drying. .  
 Weight-Average molecular Weight Determination (MALLS) 4.3.3.1
Both Clone 1 and 882 generated high molecular weight compounds and there were two 
distinct peaks other than the standard (Figure 4.25. a,b). In the case of Clone 1 MALLS 
(Figure 4.27b) analysis produced a Mw of 2,620,000Da while the polydispersity (Mw/Mn) 
was recorded as 2.62, whilst in the case of 882 (Figure 4.27 a) the Mw was 1,270,000 Da 
while the polydispersity (Mw/Mn) was recorded as 1.87.  The MALLS analysis indicates 
that TCA method extracts high molecular weight materials than the EDTA method by 
both of the strains i.e. Clone 1 and 882 using TCA method as compared to EDTA method.  
In case of Clone 1, the TCA method produced products with molecular weight of 
2,620,000Da rather 96,500 Da by EDTA and 882 produced products with molecular 
weight of 2,620,000 Da rather than 96,500 Da by the EDTA method.  
 FTIR spectra of EPS 4.3.3.2
The region between 4000 and 500cm-1 holds the characteristic bands and is sutiable for 
the characterisation of microorganisms (Schmitt and Flemming, 1998). Intensive 
carbohydrate or EPS bands were found at wave number of 950-1200cm-1 which were 
attributed to –COC- group vibrations in the cyclic structure (Gómez-Zavaglia and Fausto, 
2003). In EPS extracted from both Clone 1 and 882 strong signals were generated in the 
region of 950-1200cm-1  (Figure 4.28) which is attributed to the vibrations of -C-0-P- 
and --C-O-C- stretching of a diverse polysaccharide groups, which revealed that there 
are carbohydrate present in the both of EPS samples.  
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 The 1H NMR and 13C NMR 4.3.3.3
Signals in the regions (4-5.5ppm) associated with the presence of EPS were present in 
the 1H NMR spectra of both strains investigated. In both the cases A and B were clear 
and C+D AND E+B2 next to each other (Figure 4.29 a, b). In both the strains i .e. 882 and 
Clone 1, 13C NMR spectra also revealed signals in the polysaccharide region i.e. 60 to 
110 ppm. Starting from left of the spectra, we have first signal at 105 ppm for C1, than at 
87ppm for C4, 75ppm for C2, C3 and C5 carbons and C6 has signal in the range of 
63ppm (Figure 4.30 a, b). The results of our 1H NMR consistence with our previous 
results MALLS and FTIR (See sections. 4.3.3.1 and 4.3.3.2) that EPS were of high 
molecular weight resulting in better signals with 1H NMR. 
      () 
(a)                          (b) 
Figure. 4.27. MALLS chromatogram of EPS produced by (a). 882 (b).Clone 1. 
 
 
 
 
 
 
(a)               (b) 
Figure.  4.28.  FTIR spectra of EPS from (a). 882 (b). Clone 1. Fourier transform infrared 
spectrocopic (FTIR) . Trasmission spectra was recorded using at least 32 scans with 4cm-1 rsolution in the 
spectral range 4000-5004cm-1.  Carbohydrate or EPS bands are found at wave number 950-1200cm-1. 
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(a) 
 
(b) 
Figure: 4.29.  1H NMR spectrum of  EPS from (a). 882 (b). Clone 1. 1H NMR spectra on 
either a Bruker Avance DPX4000 400.13 or a Bruker Avance DPX500 500.13MHz. Spectra was acquired 
using Bruker pulse sequences at a temperature of 70°C.  
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using Bruker pulse sequences at a temperature of 70°C. 
 
 
 
 
 
 
 
 
 
(a) 
 
 
 
 
 
 
 
 
 
(b) 
Figure: 4.30.  13C NMR spectrum of  EPS from (a). 882 (b). Clone 1. 13C NMR were 
performed using a Varian VNMRS spectrometer operating at 100.56 MHz for 13C.  Signals in the range 60 
to 110 ppm are typically polysaccharide or EPS.  C1 signal around 105 ppm, C4 80-90 ppm, C2, C3 and C5 
around 75 ppm and C6 around 63 ppm.   
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 Monomer analysis using HPAEC-PAD 4.3.3.4
After the confirmation from MALLS, FTIR and NMR (Section 4.3.3.1-3) of the presence of 
EPS, HPAEC was employed to provide an insight into the composition of the 
polysaccharide. Monomer analyst using HPAEC-PAD is frequently utilised as a 
alternative option to the GC-MS method of detection. HPAEC-PAD is often used as it 
involves a simple, quick and efficient one step acid hydrolysis procedure. As the 
monomer gives different responses upon their interaction with the PAD in the HPEAC 
system (dependent of the pKa of the sugars), so the three different sugars standard i.e  
galactose, mannose and rhamnose were run to compare the test results. The similarities 
of the peaks observed in the HPAEC-PAD chromatogram (Fig. 4.31 a, b) were 
determined by comparing of the sample with standard compounds. Peaks from both the 
strains i.e. 882 and Clone 1 were identified as rhamnose and galactose.  
 
(a) 
 
(b) 
Figure. 4.31. HPAEC- chromatogram of EPS. (a).  882 (b). Clone 1. EPS samples were 
injected (AS50 Autosampler, Dionex Co.) into the HPAEC. Sodium hydroxide (8mM, Isocratic) delivered 
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by a gradient pump (GS50 Gradient pump, Dionex Co.) at 0.5ml/min was used to elute the 
monosaccharides through the PAD detector (ED50 Electrochemical detector, Dionex Co.). 
 Discussion 4.3.4
The formation of EPS is a key step in the ability of A. baumannii to adhere to biotic and 
abiotic surfaces, and is implicated in increased virulence, antibiotic resistance, reduced 
phogocytosis, disinfection tolerance and extended environmental persistence. For the 
isolation and characterization of EPS from two strains of A. baumannii known to be 
strong biofilm formers (See section 4.1) three different extraction techniques were 
employed. In order to prevent interference from the growth media a carbohydrate free 
mineral media with an alternative carbon source (ethanol) known to support the 
biofilm formation of these strains was employed.   
A. baumannii strains able to produce PNAG have been identified (Choi et al., 2009b), 
along with a cluster of four genes, pga A, B, C, and D. The authors were able to transfer 
the pga locus from A. baumannii to a PNAG negative E. coli strain which results in the 
synthesis of PNAG in the transformed strain. The presence of PNAG like molecules has 
also been reported in some E. coli and S. epidermidis (Wang, X. et al., 2004, Maira-
Latran.T. et al., 2002). Analysis of Clone 1 and 882 for PNAG was inconclusive, whilst its 
presence was indicated by growth on Congo red attempts to isolate PNAG was 
unsuccessful due to either its absence or the generation of low concentrations. These 
results indicate that if Clone 1 and 882 do generate PNAG they do so at a level that 
suggests it is not a major component of the EPS they generate. Loehfelm et al (Loehfelm 
et al. 2008) reported that the A. baumannii clinical isolates also produced poly-Ⱦ-1-6-N-
acetylglucosamine (PNAG) for the development and maturation of the biofilm on glass 
surfaces (Bentancor et al. 2012, Choi et al. 2009b). Given the importance of PNAG in 
biofilm maturation it is likely that Clone 1 and 882 are able to produce PNAG but at 
concentrations below that detectable by this analysis.  
Both the EDTA and TCA methods for EPS extraction were able to generate high MW 
material with Clone 1 producing the higher MW material in both cases. The TCA method 
isolated much higher MW material than the EDTA method suggesting that the EDTA 
method may be degrading the EPS resulting in smaller molecules, which may in turn 
result in the loss of material during dialysis which will contribute to the small amount of 
material available for NMR analysis.  
110 
 
The TCA method has been successfully applied to EPS characterisation of Lactobacilli 
and Bifidobacteria (Salazar et al. 2009, Laws et al. 2008). These EPS recovered from the 
A. baumannii are within the range of MWs recorded for Bifidobacterium sp using the 
same approach (Leivers et al. 2011). The MALLS and FTIR data indicate the presence of 
high molecular weight compounds in the extracted EPS from the two strains under 
investigation. The 1H NMR and 13C NMR and HPAEC analysis indicates that this EPS is 
carbohydrate based and contains both galactose and rhamnose. These results correlate 
with the finding of (Yadav et al. 2012), who reported FTIR analysis of A. baumannii 
sugar and sugar derivative peaks falls in the region of 1000-1100cm-1. They also 
reported that the EPS produced by biofilm forming strains of A. junii (BB1) were 
primarily composed of neutral sugars (73.21%), amino acids ȋ.ʹ͵%Ȍ, Ƚ-amino acids (11-
13%), uronic acid (10%) and aromatic amino acids (1.23%) with three main sugars 
residues being present i.e. galactose, mannose and arabinose. The presence of galactose 
being consistent with the results reported here for Clone 1 and 882.  
 Key findings 4.3.5 PNAG could not be extracted from EPS material generated by the two strong 
biofilm forming strain of A. baumannii i.e. Clone 1 and 882;  Clone 1 and 882 are able to generate high MW EPS when grown on mineral 
media with ethanol as a sole carbon source;  Of the EPS extraction methods employed the TCA method was most successful 
from the perspective of the amount of material recovered and it’s MW;  In all cases analysis, in particular NMR, was hampered by the low solubility of the 
extracted material with the use of solid state NMR partially overcoming these 
problems;  In both cases the EPS extracted contained both galactose and rhamnose sugars.   
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 Impact of QAC and PHB 4.4
 Determination of MIC and MBC concentration of QAC and PHMB 4.4.1
The Bioscreen system was used to determine the MICs of a range of quaternary 
ammonium compounds (QACs) and PHMB against the strong biofilm forming strains 
Clone 1 and 882. These strains were grown in mineral media supplemented with either 
ethanol or glucose. MIC values were calculated from Bioscreen outputs using the 
approach described by Lambert and Pearson (2002) (See Appendix). When grown on 
glucose both strains (Clone 1 and 882) were least sensitive to PHMB (Figure 4.30) and 
most sensitive to Barquat. In the case of ethanol as sole carbon source the differences 
between biocides was less pronounced (Figure 4.32), in the case of Clone 1 
Benzathonium chloride was the most effective, in the case of 882 there were no major 
differences between the biocides.  
Figure. 4.32. MIC data for QACs and PHMB.  
By plating out the wells at the end of the Bioscreen it was possible to generate data on 
the Minimum Biocidal Concentration (MBC) as well as the MIC. MBC were again 
determined using the approach of Lambert and Pearson (2002) but in this case (log TVC 
test / LogTVCControl) was plotted against the Log of the biocide concentration to generate 
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the required inhibition profile (e.g. Figure 4.33). The resulting MBC (Figure 4.34) were 
consistently >80% greater than the associated MIC (Figure 4.32), indicating that these 
two strains of Acinetobacter are able to survive for significant lengths of time exposed to 
inhibitory concentrations of biocides. The greatest difference (≈100x greater) was seen 
with Clone 1 grown on glucose and exposed to Benzethonium chloride and the smallest 
difference was (≈6x greater) seen when 882 was grown on ethanol and exposed to 
Benzethonium chloride. In the case of the QATs ethanol grown cultures had lower MBC 
than glucose grown cultures (Figure 4.34).  
 
Figure. 4.33. MBC inhibition profile for PHMB. 
 
Figure. 4.34. MBC data for QACs and PHMB.  
 Determination of MBC of QACs and PHMB using MBEC systems 4.4.2
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The MBEC system was used to determine the response to pre-grown biofilms to the 
biocides under investigation. These biofilms were exposed to biocides for 15 minutes 
prior to neutralisations and the enumeration of the numbers of bacteria surviving on 
the pegs. As previously describes a MBC was determined by the Lambert and Pearson 
(2002) approach with (log TVCtest / LogTVCControl) being plotted against the Log of the biocide concentration to generate the required inhibition profile.  The resulting MBC’s 
were significantly greater than those calculated for planktonic cells grown in the 
Bioscreen (Figure 4.35). It should be noted that in these 24 hour MIC experiments no 
growth was detected above the MIC values (Figure 4.36) from time zero, demonstrating 
that the biocides were having an immediate effect on the replication of these bacteria.  
 
Figure. 4.35. Biofilm MBC data for QACs and PHMB.  
 
Figure 4.36. Bioscreen output for Clone 1 grown on ethanol. 
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 Determination of the impact of QACs and PHMB on biofilm formation 4.4.3
The MBEC system was used to determine the impact of QACs and PHMB on the ability of 
Clone 1 and 882 to form biofilms, which is an approximation of a MIC for a biofilm. This 
was carried out by placing the MBEC biofilm plates into 96 well plates that contained 
different levels of biocide along with the bacteria and growth media. Biofilm formation 
was assessed by the number of bacteria recoverable from rinsed pegs after 24 hour 
incubation. Two approaches were used to determine biomass concentration firstly a 
semi quantitative method based on optical density and secondly a quantitative method 
using ATP content (See section.2.5.6). 
Both approaches generated a similar biofilm formation vs concentration relationship 
indicating that ATP and OD measurements were both acceptable indications of biofilm 
formation (Figure 4.37-4.40). In all cases (both bacteria and both carbon sources) no 
biofilm formation occurred above a concentration of 5% for all biocides under 
investigation. This sharp cut off meant that the application of the Lambert and Pearson 
(2002) approach was not appropriate since all the M)C’s calculated were at or around 
5% (data not shown). Between 5% and 0.0078% there was a linear reduction in biofilm 
formation when plotted against the log of the biocide concentration (Figure 4.41 to 
4.44).  
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Figure. 4.37. Biofilm formation: Clone 1 on Glucose a). ATP, b). OD. Figure. 4.38. Biofilm formation: Clone 1 on Ethanol a). ATP, b). OD. 
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Figure. 4.39. Biofilm formation:882 on Glucose a). ATP, b). OD. 
 
 
Figure. 4.40. Biofilm formation: 882 on Ethanol a). ATP, b). OD. 
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Figure. 4.41. Concentrations vs biofilm formation: Clone 1 on Glucose a) 
ATP, b). OD. 
 
 
Figure. 4.42. Concentrations vs biofilm formation: Clone 1 on Ethanol a) 
ATP, b). OD. 
0%
10%
20%
30%
40%
50%
60%
70%
80%
90%
1.5 2.0 2.5 3.0 3.5 4.0 4.5 5.0
%
 
Re
du
ct
io
n 
in
 b
io
film
 
fo
rm
at
io
n 
via
 A
TP
 
a)                                                  log concentratiion mg/l 
Benzalkonium chloride
BARQUAT
Benzethonium chloride
BARDAP
PHMB
0%
10%
20%
30%
40%
50%
60%
1.5 2.0 2.5 3.0 3.5 4.0 4.5 5.0
%
 
Re
du
ct
io
n 
in
 b
io
film
 
fo
rm
at
io
n 
via
 O
D 
b)                                                   log concentratiion (mg/l)  
Benzalkonium chloride
BARQUAT
Benzethonium chloride
BARDAP
PHMB
0%
10%
20%
30%
40%
50%
60%
70%
80%
90%
1.5 2.0 2.5 3.0 3.5 4.0 4.5 5.0
%
 
Re
du
ct
io
n 
in
 b
io
film
 
fo
rm
at
io
n 
via
 A
TP
 
a)                                                     log concentratiion mg/l 
Benzalkonium chloride
BARQUAT
Benzethonium chloride
BARDAP
PHMB
0%
10%
20%
30%
40%
50%
60%
1.5 2.0 2.5 3.0 3.5 4.0 4.5 5.0
%
 
Re
du
ct
io
n 
in
 b
io
film
 
fo
rm
at
io
n 
via
 O
D 
b)                                                        log concentratiion mg/l 
Benzalkonium chloride
BARQUAT
Benzethonium chloride
BARDAP
PHMB
118 
 
 
Figure. 4.43. Concentrations vs biofilm formation: 882on Glucose a). 
ATP. b). OD. 
 
Figure. 4.44. Concentrations vs biofilm formation: 882 on Ethanol a) 
ATP. b). OD. 
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 Discussion 4.4.4
The MIC and MBC of a range of quaternary ammonium compounds (QACs) and PHMB 
has been determined for the two strong biofilm forming strains i.e. Clone 1 and 882 on 
different carbon sources i.e. ethanol, glucose using the Bioscreen technology. In the case 
of glucose both strains (Clone 1 and 882) were least sensitive to PHMB and most 
sensitive to Barquat, however in the case of ethanol there were no major differences 
observed between biocides in 882 and in case of Clone 1 Benzethonium chloride was 
the most effective as compared to other biocides.  
The MBC determined for both strains demonstrated that they have the ability to survive 
concentrations 80% greater than the MIC. The greatest difference (≈100x greater) was 
seen with Clone 1 grown on glucose and exposed to Benzethonium chloride and the 
smallest difference was (≈6x greater) seen when 882 was grown on ethanol and 
exposed to Benzethonium chloride. In the case of the QACs ethanol grown cultures had 
lower MBC than glucose grown cultures, which may be due to the solubilisation of QACs 
in alcohols may facilitate the entry of these biocides into the bacterial cells.  
MBC for biofilms were also determined using pre-grown biofilms on MBEC pegs. MBC 
for biofilms were an order of magnitude greater (104 mg/l) than those calculated for 
planktonic cells (102 to 103 mg/l) indicating that the formation of biofilms increased the 
ability of Acinetobacter spp to survive treatment with QAT’s and P(MB. Given that 
biofilm formation provided such a significant improvement in survival, the ability of 
Acinetobacter spp. to form biofilms in the presence of these biocides becomes important. 
In all cases (both bacteria and both carbon sources) no biofilm formation occurred 
above a concentration of 5% (5x104 mg/l) for all biocides under investigation and 
between 4% and 0.0078% there was a linear reduction in biofilm formation when 
plotted against the log of the biocide concentration (Figure 4.4139 to 4.44). This 
indicates that planktonic A. baumannii cells can form biofilms at concentrations above 
the MBC for planktonic cells and close to or equal to the MBC for pre-grown biofilms. 
These results correlate with the findings of Kuwamura-Sato et al (Kawamura-Sato et al. 
2008) who determined the MICs and MBCs values of different biocides i.e. 
chlorhexidinegluconate, benzethonium chloride bezalkonium chloride and alkyl 
diaminoethylglycine hydrochloride (ADH) against a range of clinical isolates of 
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Acinetobacter. MIC90s obtained by the broth micro-dilution method for benzethonium 
chloride and bezalkonium chloride were ζʹͷmg/L which is consistent with the results 
obtained with glucose grown isolates and are generally lower than the ethanol grown 
cultures.  However, maximum MIC for specific strains were 50 mg/l for bezalkonium 
chloride and 100 mg/l for benzethonium chloride values greater than any recorded in 
this study. They also determined the MBC values of the four disinfectant and found that 
the MBC for the majority of strains were <64 mg/l, although the presence of organic 
material (3% BSA) generated higher MBC values (512 mg/L) which were closer to the 
values generated here. Although the methods employed to determine MIC and MBC 
values are different to those employed here the major difference is that in this study 
there is a greater difference between the MBC and the MIC values. Other authors have 
assessed the susceptibility of Acinetobacter sp to disinfectants (Martro et al. 2003, 
Wisplinghoff et al. 2007), however, they did not consider the disinfectants considered 
here. In both cases they did not find any correlation between antibiotic resistance and 
biocide susceptibility. One study that did consider Benzalkonium and Benzethonium 
chloride (Kawamura-Sato et al. 2010) found some correlation between antibiotic 
resistance and a reduced susceptibility to these biocides amongst a small number of 
clinical isolates.   
The impact of these biocides on other bacteria has been more extensively investigated. 
Joynson et al (Joynson et al., 2002), reported that the MICs of Benzalkonium chloride 
against Pseudomonas aeruginosa NCIMB 10421 was 25.4mg/L.  Penna and his collegues 
(Penna et al. 2001), worked with 10% w/v  Benzalkonium chloride and 
monoquaternary mixture of alkyldimethylbenzylammonium chlorides and found that 
MICs of 156mg/L against Bacillus stearothermophilus ATCC 7953, 59mg/L against E.coli 
ATCC 25922, 78mg/L against Enterobacter cloacae IAL 1976 and 59mg/L against 
Serratia and Staphylococcus aureus ATCC 25923. Walsh et al (Walsh et al., 2003a), 
checked the MICs of Didecyldimethylammonium chloride (DDDMAC or DDAC) and 
reported a MIC of 5mg/L against Staphylococcus aureus ATCC 9518 and E.coli ATCC 
10536 but 500mg/L against P. aeruginosa ATCC 15442. Ioannou et al (McBain et al., 
2004) used Didecyldimethylammonium chloride (DDDMAC or DDAC) and found the 
MICs against Staphylococcus aureus ATCC 6538 was 0.4mg/L. They also determined the 
MICs of N-alkyldimethylbenzylammonium chloride against Staphylococcus aureus ATCC 
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6538 and found a MIC of 0.7mg/L. Lambert and Pearson (Lambert and Pearson, 2000a) 
worked on the MICs of N-alkyltrimethylammonium bromide (C8, C10, C12, C14, C16, C18) 
against Staphylococcus aureus ATCC 6538 and P. aeruginosa ATCC 2730 and reported 
that MICs of Staphylococcus aureus ATCC 6538 against C8 was 594mg/l, C10 was 
79.4mg/L, C12 was 7.9 mg/L, C14 was 1.22 mg/L, C16 was 0.51 mg/L and C18 was 1.02 
mg/L. However, in case of P. aeruginosa ATCC 2730 the MICs values were higher as 
compared to Staphylococcus aureus ATCC 6538 against all the of N-
alkyltrimethylammonium bromide i.e C8 (4844 mg/L), C10 (1462 mg/L), C12 346 (mg/L), 
C14 (83.7mg/L) and more than 1000 mg/L against both the C16 and C18. McBain et al 
(McBain et al., 2004), determined the MICs of Bardac against different bacteria and 
reported that MICs against Pseudomonas sp strain MBRG 4.7 was 15.6mg/L, 
Enterococcus saccharolytics strain MBRG 20.9 was 31.2mg/L, Aeromonas hydrophila 
MBRG 4.3 was 15.6, Citrobacter sp. strain MBRG 20.9 was 7.8mg/L and against 
Sphingobacterium multivorum MBRG 30.1 was 3.9mg/L. (Espinal et al., 2011).  
The prolonged survival of clinical isolates of Acinetobacter spp. at the MIC has been 
reported by other authors (Kawamura-Sato et al., 2008, Kawamura-Sato et al. 2010), 
this agrees with the observations in this study that A. boumannii strains can survive 
inhibitory concentrations of biocides for prolonged periods prior to the formation of 
biofilms. Thomas et al (Thomas et al. 2011) reported that effective disinfection in the 
presence of a biofilm often requires higher concentrations of antimicrobial agents when 
compared to planktonic bacteria. The antimicrobial concentrations required for biofilm 
inactivation can be 100 times that required for inactivation of removal planktonic cells 
(Rasmussen and Givskov, 2006).  A similar observation was made here where the 
increase in MBC was between 10 and 100x the MBC concentration for planktonic cells. 
These impacts may be species specific for example the efficacy of ortho-pthalaldehyde 
was reduced against Mycobacterial biofilms but not against P. aeruginosa ones. Survival 
of bacteria in biofilms has been identified as contributing to a number of outbreaks, e.g. 
P. aeruginosa resistance to iodophores, Serratia marcescens resistance to benzylkonium 
chloride and chlorhexidine.  Recently a major outbreak of Pseudomonas infections in a 
neonatal unit in Northern Ireland was associated with biofilms in water distribution 
system (RQIA, 2012).  
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 Key findings 4.4.5 MIC values for both strains were below 35 mg/l for all biocides tested;  There was a greater variability in MIC values apparent for the glucose grown 
bacteria rather than the ethanol grown bacteria;  MBC for planktonic cells were from 6 to 100 x greater than the MIC values;  MBC were lower for ethanol grown bacteria rather than glucose grown bacteria;  MBC values for biofilms were orders of magnitude greater than MBC values for 
planktonic cells with little variation between biocides or carbon source;  Planktonic cells were able to form biofilms at concentrations up to a concentration 
of 4% for all biocides, a concentration above the 24 hour MIC and MBC for 
planktonic cells.  
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 Evaluation of antimicrobial wound dressing 4.5
A range of common antimicrobial wound dressings (NSCD, ISCD, Honey and PHMB) 
were evaluated for their ability to prevent the growth of a range of commonly occurring 
wound pathogens i.e. A. baumannii, P. aeruginosa and S. aureus. Two approaches were 
used to evaluate these dressings the first employing planktonic cells and the second 
cells immobilised in a collagen matrix.  
 Planktonic cells 4.5.1
In the majority of cases there were significant differences (p<0.05) between strains of 
the same species when treated with the same dressing. The only exception being S. 
aureus treated with the Honey dressing where ANOVA suggested that there were no 
significant difference at 95% confidence limits between species (See Appendix). This 
meant that it was not possible to combine the data on a species by species basis. It also 
indicated that significant variations in the susceptibility of wound pathogens to 
antimicrobial dressings were present at the sub species level (Table 4.6) in a number of 
cases the difference between minimum and maximum impacts were many orders of 
magnitude.  
Dressin
g 
Mean Log Reductions (cfu) 
MaximumDifferenc
e 
A. boumannii P. aeruginosa S. aureus 
 
Min Max Min Max Min Max 
NSCD 7.2 9.9 6.8 8.4 6.6 7.4 2.7 
ISCD 6.0 8.5 5.3 8.3 2.5 7.2 4.7 
Honey 2.8 9.4 5.3 8.3 6.3 6.9 6.6 
PHMB 2.7 4.9 3.3 9.1 5.3 7.0 5.8 
Table 4.6 Variations in response to antimicrobial wound dressings-planktonic cells. 
The NSCD dressing demonstrated a high level of antimicrobial activity generating kills 
close to the maximum possible across all strains investigated (Figure 4.45 a). Total kills 
i.e. no recoverable bacteria are indicated by the diagonal hatching on the histogram 
bars. After NSCD the Honey dressing performed best with maximum kills for a number 
of A. baumannii and P. aeruginosa strains (Figure 4.45 c) and a consistent level of kill for 
S. aureus with no significant differences (ANOVA, P>0.05) between the impacts on all 
strains tested. However, the Honey dressing did have some significant dips in 
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performance particularly against A. baumannii 882 and 292 and the Type strain of P. 
aeruginosa.  In all these three cases the log reduction achieved was significantly lower 
(P<0.05) than that achieved with the majority of the other strains.  
The ISCD dressing had a relatively consistent performance across the A. baumannii and 
P. aeruginosa strains tested (Figure 4.45 b) but failed to generate a complete kill in all 
but two occasions. It was significantly poorer (P<0.05) in performance when compared 
to NSCD for 4 out of the 5 A. baumannii strains, however with the exception of the Type 
strain there was no significant difference (P>0.05) between ISCD and NSCD for the 
other P. aeruginosa strains. In the case of S. aureus ISCD was again significantly (p<0.05) 
poorer in performance than NSCD for the majority of strains. A similar picture emerges 
when ISCD is compared with the Honey dressing with the latter being generally more 
effective. The only exception being A. baumannii strain 882 where the Honey dressing 
has a significantly poorer performance (p<0.05).The PHMB dressing had the poorest 
overall performance of the four dressings failing to generate a complete kill for any of 
the bacterial strains tested. It was particularly poor against A. baumannii where is had 
significantly poorer performance (P<0.05) than any of the other dressings against any of 
the strains with the exception of 882 and the Honey dressing. PHMB performed better 
against the strains of P. aeruginosa and S. aureus tested, performing as well as the other 
dressings in the majority of cases although it did have particularly poor performance 
against the P. aeruginosa type strain.  
 Collagen immobilised cells 4.5.2
As was the case with the planktonic cells there were significant differences (ANOVA, 
p<0.05) between strains of the same species when treated with the same dressing, 
consequently it was not possible to collate data on a species level (See Appendix). It also 
indicated that collagen wound model reflected the significant sub-species levels 
variations in the susceptibility to antimicrobial dressings seen in the planktonic model 
(Table 4.7) in a number of cases the difference between minimum and maximum 
impacts were many orders of magnitude. Unlike the planktonic model the NSCD and 
ISCD produced broadly similar results (Figure 4.46 a & b) with the major differences 
being seen with the P. aeruginosa strains where NSCD generated greater log reductions 
than  ISCD in 4 out of the 6 strains tested (p<0.05, See Appendix). There were no 
differences between the two dressings when tested against S. aureus.  
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Table 4.7 Variations in response to antimicrobial wound dressings-immobilised cells.   
The NSCD performed significantly better than the Honey dressing for all strains with the 
exception of S. aureus 4330 and significantly better than the PHMB dressing for all 
strains with the exception of the P. aeruginosa Type strain and Type 5.  The ISCD 
performed significantly better than the Honey dressing for all strains with the exception 
of S. aureus 4330 and P. aeruginosa Type 2 and significantly better than PHMB with the 
exception of three P. aeruginosa strains (Type, Type 3 and 5) (See Appendix).  
Comparison between the Honey and the PHMB dressing was variable with Honey being 
generally better against S. aureus, whilst PHMB was generally better against P. 
aeruginosa, with a broadly similar picture against A. baumannii (See Appendix). 
 Comparison between the two methods 4.5.3
The use of collagen potentially provided a diffusion barrier to the antimicrobials 
present in the dressing. Consequently, you might expect that reduction measured 
through the collagen approach to be less than that seen for the planktonic approach 
where there is no barrier between the dressing and the bacteria. This is generally the 
case across all the dressing with more strains showing no difference between the two 
approaches or the collagen approach generating a lower reduction in viable counts than 
the planktonic approach (Table 4.8, See appendix). However, in the case of the ISCD, 
Honey and PHMB dressings there are exceptions to this expectation suggesting that the 
collagen did not generate a consistent barrier to the diffusion of the active ingredients.  
 
 
Dressing 
Mean Log Reductions (cfu) 
Maximum 
Difference 
Acinetobacter Pseudomonas S. aureus 
 
Min Max Min Max Min Max 
NSCD 6.6 8.9 6.3 8.3 4.8 8.6 3.8 
ISCD 6.2 8.9 4.8 8.3 5.1 8.6 3.5 
Honey 2.0 6.2 1.8 4.9 4.9 5.6 4.2 
PHMB 2.6 6.4 3.6 8.3 3.6 4.2 3.8 
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Table 4.8 Comparison of the two assessment methods 
 
 
 
 
 
 
 
 
NSCD ISCD Honey PHMB 
C
>
P 
C=P C<P C>P C=P C<P C>P C=P C<P C>P C=P C<P 
A. baumannii  All   
882, 
292 
All 
others 
882 292 
All 
others 
882, 
292 
 
All 
others 
P. aeruginosa  
Type, 
T4 
All 
others 
Type T4 
All 
others 
  All Type 
T3,4 
& 5 
T1,2 
S. aureus  
6538, 
9B/F6 
All 
others 
6538 
4300 
9B/F6 
7F/C7 
13142 
 
6538 
9B/F6 
All 
others 
  All 
C>P: Collagen reduction greater than planktonic reduction, C=P: No difference between methods,                 
C<P: Collagen reduction less than planktonic reduction. Differences at 95% CLs (See appendix). 
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Figure 4.45. Biocidal impact of antimicrobial wound dressings against planktonic cells (a) NSCD (b) ISCD(c) Honey (d) PHMB. 
a b 
c d 
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Figure 4.46. Biocidal impact of antimicrobial wound dressings against immobilised cells (a) NSCD (b) ISCD(c) Honey (d) PHMB. 
a b 
c d 
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 Discussion 4.5.4
A range of antimicrobial wound dressings (NSCD, ISCD, Honey and PHMB) were 
evaluated for their ability to prevent the growth of a range of commonly occurring 
wound pathogens i.e. A. baumannii, P. aeruginosa and S. aureus. Two approaches were 
used to evaluate these dressings i.e. planktonic cells and the second cells immobilised in 
a collagen matrix. In both approaches there were significant differences (p<0.05) 
between strains of the same species when treated with the same dressing indicating 
that significant variations in the susceptibility of wound pathogens to antimicrobial 
dressings were present at the sub species level (Table 4.6). The diffusion barrier 
provided by the collagen matrix generated lower reduction values than the planktonic 
approach with a few exceptions. Generally speaking the Honey dressing was most 
impacted by the use of a collagen matrix than the other dressings.  
The pathogens investigated included both Gram positive and Gram negative organisms 
known to colonise and infect a variety of dermal wounds (Bowler et al., 2012). In a 
recent study conducted by (Lipova et al., 2010), it was reported that, out of a total 777 
bacterial strains isolated from burn patients, 65% of these strains were identified as 
Gram-Positive and 35% as Gram-negative. The most commonly isolated Gram-Positive 
opportunistic pathogens were coagulase-negative Staphyloccous and Bacillus sp and 
most common among the Gram-negative opportunistic pathogens includes E. coli, A.  
baumannii and P. aeruginosa (Lipova et al., 2010).Since bacteria are capable of forming 
biofilm on living tissues e.g. a wound bed, which enhances their tolerance to 
antimicrobial agents (Zubair et al., 2011) and the host immune cells, it was important to 
evaluate the susceptibility of these pathogens to the variety of dressing in both of their 
free living and immobilised forms. The results of NSCD and ISCD dressings correlate 
with the finding of other studies that showed greater antimicrobial activity of NSCD 
than ISCD dressings (Tkachenko and Karas, 2012, Bradshaw, 2011, Thomas et al. 2011). 
Silver has been used medically for thousands of years (Thomas et al. 2011). Dressings 
containing silver has recently been strongly marketed and has increased in usage by 
~200% since 1996 and now used extensively in the care of chronic wounds (Bradshaw, 
2011). The antimicrobial properties of Silver are due to its ability to form ionic salts 
(Ag+) in the presence of acids. Positively charged silver ions are attracted by the 
negatively charged structures of cell membrane which 
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enter into the bacterial cell (Michaels et al., 2009). The interaction of (Ag+) with the 
bacterial thiol (-SH) group leads to inactivation, blocking the key pathways such as 
cellular respiration structural changes in the bacterial membrane and blocking of 
enzyme and transport systems (Asavavisithchai et al. 2010). They may also act by 
denaturing bacterial RNA or DNA which may lead to the inhibition of transcription and 
replication (Fong and Wood, 2006). Unlike antibiotics, which are generally 
biochemically specific, metals are toxic to multiple components of the bacterial cells. 
This multi-system affect means it is less likely that bacteria will develop the resistance 
to silver, as multiple random mutations required. However, it might be possible that 
exposure of low level of silver may aid the development of resistance (Leaper, 2006). 
The different forms of silver has been tested and it has been proved that the elemental 
silver (Ag) has little or no antibacterial activity; however in its ionic cation form (Ag+), it 
is highly active, in the presence of wound exudates, silver readily ionizes. Different 
variation in the form of silver between dressings may therefore affect the ability to 
release ions (Lansdown, 2004). Silver is effective against some antibiotic resistance 
bacteria, including MRSA and Vancomycin-resistant Enterococci (Jones et al., 2004). In 
addition, MRSA isolated from wound for known silver resistant genes were tested and 
were found to be susceptible to the silver dressing used (Loh et al. 2009). Silver based 
dressing are widley used in wound care (Klasen, 2000b, Klasen, 2000a, Demling and 
Desanti, 2001, Ip et al. 2006), the only side effects reported is skin discolouration and 
irritation (White and Cooper, 2005). Qquestions have been raised regarding the long 
term use of silver on wounds especially in infants (Denyer, 2009), but to date no 
pathological consequences of silver used dressing has been reported, except some 
reports about the systemic uptake and deposition of silvers in organs (Denyer, 2009, 
Wang et al. 2009).  
The results with Manuka honey dressing correlates with the findings of other studies 
that showed antimicrobial activity of honey (Bradshaw, 2011, Stephen-Haynes, 2004). 
These dressings have been successfully used for the treatment of recalcitrant wounds 
containing pathogens resistant to antibiotics; the dressings can be applied directly to 
the wound and can be used for 2-3 days without changing (Visavadia et al. 2008). 
However a large scale randomized trial showed no significant advantage for the use of 
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honey dressings over standard wound care in the treatment of chronic wounds (Du Toit 
and Page, 2009).  
The exact mode of action of honey dressings is not fully understood, however it is 
hyperosmolar and thus restricts the availability of environmental water to bacteria and 
other organisms (Molan, 2001), which results in cell disruption and death. Another 
property of honey is the release of hydrogen peroxide as the honey is diluted by 
exudates (Molan, 2004). The production of hydrogen peroxide being associated with 
glucose oxidase activity (French et al. 2005). Although honey has a general broad- 
spectrum antimicrobial action, different honey e.g. Manuka (New Zeland), Heather (UK) 
and Khadikraft (India) vary substantially in their activity (Mullai and Menon, 2007). 
Some honeys varieties particularly the Manuka and Leptospermum honeys have the 
ability to retain their antimicrobial property even without the release of hydrogen 
peroxide (Cooper et al., 2002b, Cooper et al. 2002a), which is thought to be associated 
with a phytochemical component (Molan, 2002). These phytochemical factors (non-
peroxidase factors) exert a high antimicrobial effect in some honeys (e.g. Manuka 
honey) that do not degrade even when treated with heat or light and remain effective 
following dilution (Olaitan et al. 2007). Consequently the antibacterial effect of honey 
has been attributed to a range of properties including pH, osmosis, hydrogen peroxide 
and phytochemical content (Stephen-Haynes, 2004).  
Recently polyhexamethylenebiguanide (PHMB) has been introduced as a component of 
wound dressings. PHMB is a fast acting biguanide compound composed of synthetic 
mixture of polymers, having structural similarities to the antimicrobial peptides AMPs 
produced by many cells within the wounds, such as keratinocytes and inflammatory 
neutrophils, where they are thought to help the cells against infection (Sørensen et al., 
2003, Ousey and McIntosh, 2009). AMP have a broad spectrum of activity against 
bacteria, viruses and fungi including cell death by disrupting cell membrane integrity 
(Moore and Gray, 2007) and are proven to be effective against P. aeruginosa and S. 
aureus which are common in many chronic wounds (Abdelrahman and Newton, 2011). 
PHMB products include TelfTM AMD drain, Kendall AMD antimicrobial foam (0.5 % 
PHMB), Biocellulose based PHMB-donating dressings e.g Suprasorb X+PHMB, which 
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contains 0.3% PHMB. In vitro and in vivo studies have proved that dressing or products 
containing PHMB reduces wound pain rapidly and effectively (Daeschlein et al., 2007, 
Galitz et al., 2009), reduces wound malodour (Daeschlein et al., 2007), reduces MMP-
induced periwound breakdown (Cazzaniga et al., 2007, Werner et al., 2004), reduces 
slough within wound (Mueller and Krebsbach, 2008), increases keratinocyte and 
fibroblast activity (Wiegand et al. 2007), increases formation of granulation tissue 
(Mueller and Krebsbach, 2008),  and helps remove non-viable tissue (Kaehn, 2009). 
Alblas et al (Alblas et al., 2011, Wild et al. 2012) reported the antimicrobial activity of 
PHMB against treatment or prophylaxis of local infections in burns and trauma wounds.  
In wound care, PHMB has demonstrated the ability to block P. aeruginosa induced 
infections (Cazzaniga et al., 2007), and can also kill a range of bacteria and fungi (Lee et 
al. 2004b, Werthen et al. 2004). A number of German studies have shown that PHMB 
demonstrated a positive effect on bacterial biofilms (Harbs and Siebert, 2007, Butcher, 
2012). A prospective, randomised study was conducted to directly compare the 
efficiency of two PHMB products on the eradication of MRSA infections proved that 6 
out of 15 patients were MRSA free after one week of therapy, and 10 out of 15 were 
MRSA free by the end of week two. In Suprasorb X+PHMB dressing group 13 out of 15 
were MRSA negative at the end of week one (p<0.05), and were all negative by the end 
of the week two (p<0.05) (Gray et al., 2010). 
 Key findings 4.5.5 Broadly speaking the NSDC dressings was the most effective wound dressing 
overall, with the PHMB dressing being the least effective;  The biocidal impact of the Honey dressing was the most effected by immobilising 
bacteria in a collagen matrix;  There were significant differences in susceptibility to all dressings between strains 
of the same species. 
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5 General Discussion 
Historically the clinical isolation of Acinetobacter sp was frequently ignored, since it was 
often considered a low grade pathogen (Bergogne-Berezin et al., 1996). However, in 
recent years, multi-drug resistant (MDR) strains of  A. baumannii have emerged as a 
major cause of nosocomial infections associated with significant morbidity and 
mortality (McConnell et al. 2012). Over the last 20 years a worldwide expansion in 
Acinetobacter infections has been observed associated with intensive care units (ICUs), 
long term care facilities and wounded personnel (Sebeny et al., 2008, Sengstock et al. 
2010). The developing resistance patterns seen in Acinetobacter sp suggest that the 
number of effective antibiotics may shortly be exhausted (Hanlon, 2005). The ability of 
Acinetobacter sp to resist desiccation and persist on hospital surfaces, materials and 
medical devices has played a critical role in the emergence of this bacterium as a human 
pathogen (Villegas and Hartstein, 2003).  A. baumannii is able to form strong adherent 
biofilms that help the bacteria to survive for several weeks on abiotic surfaces resulting 
in contamination of hospital and medical instruments, e.g. incubator tubes, water lines, 
cleaning instruments, pillows and linen (Harrison et al., 2008, Donlan, 2008, Villegas 
and Hartstein, 2003, McConnell et al. 2012). The ability of clinical strains of A. 
baumannii to form strong adherent biofilms has now been recognised as a key virulence 
factor for this pathogen (Wroblewska et al. 2008).  
 In this study the MICs and MBCs of alcohols and alcohol containing products against 
clinical strains of A. baumannii were determined. It was observed that the MBC of 
ethanol and IPA for all strains ranged from 50 to 55% v/v and the MIC of ethanol and 
IPA for all clinical strains ranged from 3.1 to 9.0% v/v. A carbohydrate free minimal 
media employing alcohols as sole carbon sources has been developed and our results 
revealed that all Acinetobacter strains under investigation have the ability to grow on 
minimal media supplemented with either ethanol or IPA as a sole carbon source. 
However, the Type strain was significantly more sensitive to alcohols and had a reduced 
ability to utilise ethanol or IPA as its sole carbon source. The MBC’s determined here are 
below the in use concentrations recommended for alcohols (60-70%) (Fraise et al. 
2012). The impact of ethanol in the presence of other carbon sources has been 
investigated by a number of authors (Pirog et al. 2002, Smith et al. 2004), a situation 
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that mirrors the experiments reported here employing TSB and MRD. The growth of 
Acinetobacter strains on minimal media with ethanol as a sole carbon source without 
supplementation is well established (Navon-Venezia et al.  1995, Walzer et al. 2006) a 
situation reflected in the growth of the clinical strains observed here. Enhanced 
pathogenicity due to the presence of alcohol has been reported for Acinetobacter sp 
(Smith et al. 2004) again in the presence of other carbon sources. The positive impact of 
ethanol was reduced as the concentration was raised to 5% v/v and became negative 
above 5% v/v (Smith et al.  2004), a trend that is reflected in the data collected here 
(Figures 4.1 and 4.2). Enhanced growth of Acinetobacter strains at alcohol 
concentrations at or around 1% v/v has been reported by a number of authors (Smith et 
al. 2004, Edwards et al.  2007a). Edwards et al (Edwards et al. 2007b), reported the 
enhancement of growth and virulence in the presence of ethanol and found the significant increase in growth when the minimal media is supplemented with ζͳ% v/v 
of four commercially available hand rubs i.e Purell, Spirogel, Softalind and Skinman. 
They reported that the unknown factor which enhanced pathogenicity and virulence to 
A. baumannii was secretion of proteins in response to alcohols. One of these proteins 
was identified as OmpA, which was recognized as having emulsifying activity, which 
could be useful in scavenging carbon for growth from complex energy sources such as 
hydrocarbons. The secretion of OmpA by A. baumannii following exposure to 0.5% v/v 
ethanol in minimal media has also been described by Walzer et al (Walzer et al. 2006), 
suggesting that it may be the important response to growth and survival under low 
nutrient conditions. These bioemulsifiers protein may also be helpful in bacterial 
adhesion, quorum sensing and the development of biofilms (Ron and Rosenberg, 2001). 
The MIC determined for ethanol and IPA for the clinical strains investigated are towards 
the upper end of published values for alcohol MICs on bacteria in general that range 
from 1 to 5% v/v (Oh and Marshall, 1993, Mazzola et al. 2009, Wadhwani et al. 2008). 
One published value for A. calcoaceticus of 4.4% v/v (Mazzola et al. 2009) is broadly 
similar to the values generated during this study with the exception of 882 which had 
an MIC of approximately double this value (Table 4.4). Interestingly these authors 
indicated that the presence of glycerine, a common component of alcohol hand gels 
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increased the M)C by ≈ͷͲ%, an observation that aligns with the reduced impact of 
Purell gel observed here (Fig. 4.2). 
Biofilms are defined as highly self-organized, three-dimensional structures where the 
microbial community is enclosed in a polymeric matrix of exopolymeric substances 
(EPS), constituting a survival mechanism for harsh environments (Espinal et al. 2011, 
Jahid and Ha, 2012). Biofilms are composed of microorganisms attached to either each 
other, to living or non-biotic surfaces and may be embedded within a complex matrix of 
polysaccharides, proteins, nucleic acids and glycoproteins (Donlan and Costerton, 
2002). For the effective eradication of microorganisms within a biofilm, higher 
concentrations of antimicrobial agent are often required when compared to their 
planktonic or free floating non- biofilm counterparts (Thomas et al. 2011). The 
antimicrobial concentrations required for biofilm removal can be 100-fold of that 
required for removal microorganisms in the planktonic state (Rasmussen and Givskov, 
2006). In the context of human health 80% of infections are suggested to be biofilm 
related (Davies, 2003, Blackwell, 2005),for example in chronic wounds, e.g. diabetic foot 
ulcers, pressure ulcers and venous leg ulcers biofilms are a central part of the evolution 
of the infection (James et al. 2007). The effective and efficient use of medical devices 
such as catheters, artificial valves etc. are often compromised by the formation of 
biofilms (Strelkova et al. 2012). A. baumannii is known to form strong adherent biofilms 
that allow the bacteria to survive for several weeks on abiotic surfaces in healthcare 
settings (Harrison et al. 2008, Donlan, 2008, Villegas and Hartstein, 2003, McConnell et 
al. 2012). However as observed here, biofilm formation amongst A. baumannii strains is 
not consistent (Fig. 4.9), Wroblewska et al (Wroblewska et al. 2008) investigated 34 
clinical strains from patients hospitalized in two tertiary care hospitals. The isolates 
demonstrated a wide range of biofilm forming ability, with 12% high, 41% medium and 
47% demonstrating a low level of biofilm production. A similar variation in adherence 
was observed when the adherence of clinical isolates to human bronchial tissue was 
investigated (Lee et al. 2006). In the current study a greater number of strains 
demonstrated a high level of adherence (Table 4.5) with the strength of adherence 
being dependent on the carbon source. Wroblewska et al (2008) did not consider the 
impact of carbon source on biofilm formation, but the data here clearly reveals that 
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alcohol based carbon sources increase adherence, with 71% of strains being highly 
adherent when fed on alcohol as the sole carbon source with only the Type strain and 
UK-HS remaining poorly adherent regardless of carbon source. Lee et al (2006) 
observed lower levels of adherence for Clone 1 than Clone 2 onto epithelial cells, when 
tested here for adherence to plastic surfaces no differences between Clones 1 and 2 was 
seen. Other authors (McQueary and Actis, 2011) have shown the Type strain to be 
comparable in its ability to form biofilms but in this case TSB was employed as a growth 
media, emphasising the importance of the carbon source on biofilm formation. The 
variations between strains and the impact of carbon source on biofilm formation was 
revealed in the hydrophobicity data, where there were clear differences observed  
between strains (Figures. 4.11) and the use of alcohol as a sole carbon sources 
generated greater hydrophobicity than glucose, SWF or TSB (Figure. 4.12).  This 
correlation between biofilm formation and hydrophobicity is to be expected since 
plastic surfaces are hydrophobic in nature.   
The MATH test has also been used to monitoring the cell surface hydrophobicity of 
nosocomial pathogen Pseudomonas aeruginosa as it grew in the presence of 
benzalkonium chloride (Machado et al. 2011). They reported that the strain OO14 
increased in hydrophobicity as the cells grew in resistance to the disinfectant. Bos et al 
(Bos et al. 1999) used the MATH test on dental colonisers such as Streptococcus and 
Actinomyces and found that the presence of divalent calcium cations increased the 
adhesion to hexadecane and chloroform. Costa, et al (Guimaraes et al. 2006) and Di 
Bonaventura, et al (Di Bonaventura et al. 2008), reported that hydrophobicity of the 
bacterial surface is an important factor for adherence and colonization of bacteria to 
both living (epithelial mucous tissues) and non-living surfaces (medical devices). 
Umamaheshwari and Jain, (Umamaheshwari and Jain, 2004), reported that the 
hydrophobic cell surface components may serve as a binding target for antibacterial 
lipobeads. Rosenberg (Rosenberg, 2006), reported that hydrophobic surface property of 
the bacteria play a vital role in growth on hydrophobic materials, initial biofilm 
formation, adhesion to host cells, aggregation and flocculation and it is the one of many 
parameters which determines the ability of a cell to adhere, invade and cause damage.  
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However, McQueary and Actic (2011) employed TSB as a growth media which as can be 
seen here does not favour biofilm formation in some A. baumannii strains. When the 
Type strain and more hydrophobic strains such as 882 and Clone 1 were grown on 
plastic surfaces and visualised via SEM, the less hydrophobic Type strain was unable to 
maintain a significant biofilm suggesting that when grown on a more minimal media the 
Type strain was unable to maintain a biofilm on a hydrophobic surface, indicating a 
direct correlation between hydrophobicity and biofilm formation. The Type strain was 
however able to form biofilms on hydrophilic surfaces (glass) under low sheer 
conditions, however, under these conditions the hydrophobic strains were also able to 
form biofilms through the generation of EPS.  
A number of gene products have been proven to play a role in attachment and biofilm 
formation on abiotic surfaces e.g. pilus production mediated by the CsuA/BABCDE 
usher-chaperone assembly system is required for the attachment and biofilm formation 
on the abiotic surfaces by the A. baumannii Type strain. This operon seems to be wide 
spread among clinical isolates and an indication that it is a common factor among 
different clinical isolates (Tomaras et al., 2003). However McQueary and Actic (2011) 
demonstrated that even in the presence of this gene significant strain to strain 
variations in biofilm formation were evident. The Type strain also has the ability to 
produce alternative pili that may help in the interaction of this pathogen with bronchial 
epithelial cells (De Breij et al., 2010). Loehfelm et al (Loehfelm et al. 2008) reported that 
biofilm-associated protein (Bap), conserved in the clinical isolates and appears to be 
associated with the cell-cell interactions that support the development and maturation 
of the biofilm. In addition to (Bap), the A. baumannii clinical isolates also produce poly-Ⱦ-1-6-N-acetylglucosamine (PNAG) for the development and maturation of the biofilm 
on glass surfaces by the cells cultured (Bentancor et al. 2012, Choi et al., 2009b). The 
strong biofilm forming strains was evaluated for the PNAG production both the strains 
(882 and Clone I) produced PNAG on Congo red plates, however no PNAG was 
detectable via 1H NMR suggesting that either Congo red plates is not a definitive screen 
for PNAG or the concentrations generated were too low to be detected following 
extraction.  
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A two component regulatory system has also been reported in the A. baumannii Type 
strain (ATCC 19606T) which comprises of: a sensor kinase encoded by bfmS, and a 
response regulator encoded by bfmR involved in bacteria-surface interaction (Tomaras 
et al., 2008). The insertional inactivation of bfmR results in the loss of expression of 
cusA/BABCDE operon resulted in the lack of pili production and biofilm formation on 
plastic surfaces when grown in rich medium (LB broth), however the inactivation of 
bfmS sensor kinase gene resulted in diminishment but not abolishment of biofilm 
formation (Tomaras et al. 2008). In the absence of BfmRS system the composition of 
culture media still influence the interaction of cells with abiotic surfaces, these finding 
indicates that the BfmRS system cross talks with other sensing components and 
suggests instead of one, there are multiple and different stimuli which could control the 
biofilm formation via BfmRS regulatory pathway (Tomaras et al. 2008). However, all 
Tomaras et al’s (2008) work was carried out using the Type strain with glucose as a 
carbon source, consequently the differences seen here with ethanol and other strains 
was not investigated.  
Another mechanism controlling bacterial adherence and biofilm formation is cell 
population density. Accordingly, environmental and clinical isolates produce quorum 
sensing signalling molecules (Gonzalez et al., 2001, Gonzalez et al., 2009), these studies 
proved that a large number of isolates produce quorum sensing and signalling 
molecules which seem to belong to three types of molecules. Although none of these 
sensors belongs to a particular species, however the Rf1-type sensor is more frequently 
found in isolates belonging to the A. calcoaceticus-baumannii complex. Niu et al (Niu et 
al. 2008) proved that the A. baumannii M2 clinical isolates produce an N-acyl-
homoserine lactone [N-3-hydroxydodecanoyl-homoserinem lactone], the product of the 
abaI auto inducer synthase gene, which is vital for the fully developed biofilm on abiotic 
surfaces, abaI auto inducer also helps this isolate to move in semisolid media.  
Generally, A. baumannii adheres to biotic and abiotic surfaces via the same steps 
described for general biofilm formation. The associated EPS being composed of 
carbohydrates, proteins, nucleic acids and other macromolecules (McConnell et al. 
2012). Pirog et al (Pirog et al. 2002), reported that Acinetobacter spp.12S has the ability 
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to grow and synthesize EPS on different carbohydrate substrates like mono and 
disaccharides, molasses and starch. He reported that the Acinetobacter spp. were grown 
on carbohydrate media containing no pantothenic acid (Vitamin B3), which is required 
for growth on C2-substrates. He used a mixture of carbohydrate sources (0.01, 0.1, 0.5 
and 1% v/v ethanol and 1% w/v glucose) and found that bacterial growth and EPS 
generation was higher when 0.01% v/v ethanol with 1% w/v glucose used. The EPS 
production was intensified as the content of the C2 substrate in the medium increased.  
The growth of the Acinetobacter strains at the expense of alcohol as the sole carbon 
source without any complex media supplements has already been identified as a 
characteristic of hydrophilic, strongly adherent strains such as 882 and Clone 1 (Section 
4.1.3). The formation of polysaccharide based EPS by these strains at the expense of 
alcohols as well as glucose is evident from the drip flow biofilms where the EPS is 
stained by the carbohydrate selective stain calcofluor white (Figures. 4.18-4.19), 
indicating that these strains are able to synthesise complex carbohydrates from C2 and 
C3 alcohols in minimal media. The formation of biofilms was observed as a blue colour 
around the red bacterial cells which starts forming after 24 hours, however biofilms 
were more obvious after 48 hours of continues growth in a drip flow reactor. Both the 
strains developed strong biofilm when the carbon sources were ethanol and IPA as 
compared to the glucose and can be seen easily by the fluorescent microscopy in 
addition A. baumannii strains 882 developed more compact biofilm as compared to 
Clone 1 on all the carbon sources (Figures. 4.18-19). 
The generation of EPS is associated with cell growth as can be seen from the batch 
growth of these strains (Figures 4.14 & 4.15), the resulting EPS is not utilised as a 
carbon source after formation and is produced during growth along with lactate, 
however the Type strain does not produce any biofilm or EPS when grown on similar 
carbon sources. The formation of acid from glucose is a common observation for A. 
calcoaceticus-baumannii complex as is the consumption of lactate as a sole carbon 
source (Nemec et al. 2011), in this case acid is also produced from C2 and C3 alcohols. 
Both the strong biofilm forming strain of A. baumannii i.e. Clone I and 882 are able to 
generate high MW EPS when grown on mineral media with ethanol as a sole carbon 
136 
 
 
source. Of the EPS extraction methods employed the TCA method was most successful from the perspective of the amount of material recovered and it’s MW. )n all cases 
analysis, in particular NMR, was hampered by the low solubility of the extracted 
material with the use of solid state NMR partially overcoming these problems. In both 
cases the EPS extracted contained both galactose and rhamnose sugars.   
Both the EDTA and TCA methods for EPS extraction were able to generate high MW 
material with Clone 1 producing the higher MW material in both cases. The TCA method 
isolated much higher MW material than the EDTA method suggesting that the EDTA 
method may be degrading the EPS resulting in smaller molecules, which may in turn 
result in the loss of material during dialysis which will contribute to the small amount of 
material available for NMR analysis. The TCA method has been successfully applied to 
EPS characterisation of Lactobacilli and Bifidobacteria (Salazar et al. 2009, Laws et al. 
2008)with the EPS recovered from the A. baumannii are within the range of MWs 
recorded for Bifidobacterium sp using the same approach (Leivers et al., 2011). The 
MALLS and FTIR data indicate the presence of high molecular weight compounds in the 
extracted EPS from the two strains under investigation. The 1H NMR and 13C NMR and 
HPAEC analysis indicates that this EPS is carbohydrate based and contains both 
galactose and rhamnose (Fig. 4. 29). These results correlate with the finding of (Yadav et 
al. 2012), who reported FTIR analysis of A. baumannii sugar and sugar derivative peaks 
falls in the region of 1000-1100cm-1. They also reported that the EPS produced by 
biofilm forming strains of A. junii (BB1) were primarily composed of neutral sugars 
(73.21%), amino acids (ʹ͵%Ȍ, Ƚ-amino acids (11-13%), uronic acid (10) and aromatic 
amino acids (1.23%) with three main sugars residues being present i.e. galactose, 
mannose and arabinose. The presence of galactose being consistent with the results 
reported here for Clone 1 and 882.  
The MIC and MBC concentrations of a range of quaternary ammonium compounds 
(QACs) and PHMB has been determined for the strong biofilm forming strains i.e. Clone 
1 and 882. In the case of glucose both strains (Clone 1 and 882) were least sensitive to 
PHMB and most sensitive to Barquat and Benzekonium chloride respectively, however 
in case of ethanol there were no appreciable difference observed between biocides in 
137 
 
 
the case of 882, in the case of Clone 1 Benzekonium chloride was the most effective as 
compared to other biocides. In the case of the MBC, both strains have the ability to 
survive for longer period of time and in case of QATs ethanol grown cultures proved to 
have lower MBC as compared to glucose.  
Pre-grown biofilms were used to determine MBC for biofilms and to compare responses 
of planktonic cells and biofilm cells. MBC values for biofilms were orders of magnitude 
greater than those calculated for planktonic cells. The MBEC system was also used to 
determine the impact of QACs and PHMB on the ability of Clone 1 and 882 to form 
biofilms. In all cases (both bacteria and both carbon sources) no biofilm formation 
occurred at a concentration of 5% for all biocides under investigation and between 4% 
and 0.0078% there was a linear reduction in biofilm formation when plotted against the 
log of the biocide concentration (Figure 4.18 to 4.21).  
Bacteria have a variety of mechanisms at their disposal to reduce the cytoplasmic 
concentration of biocides (Maillard, 2007). However, it has been difficult to producing 
stable bacterial resistance to high biocide concentrations (Suller and Russell, 1999, 
Fitzgerald et al., 1992). The use of step wise biocide concentration increases have 
resulted in bacteria with increased minimum inhibitory concentrations (MIC), but 
rarely at in-use concentrations (Thomas et al. 2005, Suller and Russell, 1999, Lear et al. 
2006, Walsh et al. 2003b). Alternative approaches which more closely mirror the way 
biocides are employed i.e. the exposure of high inoculums to high biocidal 
concentrations have produced some adaption but not as effectively as stepwise training 
(Walsh et al. 2003b, Thomas et al. 2000). Although it is not easy to develop resistant 
mutants to high biocide concentrations, exposure to low concentrations may induce 
low-level resistance in bacteria. The induction of bacterial resistance to almost all 
biocides has been documented, but particularly none oxidizing ones such as phenolics, 
bis-biguanides and quaternary ammonium compounds (Russell, 2004a, Moken et al. 
1997, McMurry et al. 1998). Although, the induction of oxy R and sox RS regulons 
following exposure to oxidising agents has been described (Chapman, 2003). These 
results correlate with the findings of Kuwamura-Sato et al (Kawamura-Sato et al. 2008) 
who determined the MICs and MBCs values of different biocides i.e. 
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chlorhexidinegluconate, benzethonium chloride bezalkonium chloride and alkyl 
diaminoethylglycine hydrochloride (ADH) against a range of clinical isolates of 
Acinetobacter. MIC90s obtained by the broth micro-dilution method for benzethonium 
chloride and bezalkonium chloride were ζʹͷmg/L which is consistent with the results 
obtained with glucose grown isolates and are generally lower than the ethanol grown 
cultures.  However, the maximum MIC for specific strains were 50 mg/l for bezalkonium 
chloride and 100 mg/l for benzethonium chloride values greater than any recorded in 
this study. They also determined the MBC values of the four disinfectant and found that 
the MBC for the majority of strains were <64 mg/l, although the presence of organic 
material (3% w/v BSA) generated higher MBC values (512 mg/L) which were closer to 
the values generated here. Although the methods employed to determine MIC and MBC 
values are different to those employed here the major difference is that in this study 
there is a greater difference between the MBC and the MIC values.  
Other authors have assessed the susceptibility of Acinetobacter sp to disinfectants 
(Martro et al. 2003, Wisplinghoff et al. 2007), however, they did not consider the 
disinfectants considered here. In both cases they did not find any correlation between 
antibiotic resistance and biocide susceptibility. One study that did consider 
Benzalkonium and Benzethonium chloride (Kawamura-Sato et al. 2010) found some 
correlation between antibiotic resistance and a reduced susceptibility to these biocides 
amongst a small number of clinical isolates.   
The prolonged survival of clinical isolates of Acinetobacter sp at the MIC has been 
reported by other authors (Kawamura-Sato et al. 2008, Kawamura-Sato et al. 2010), this 
agrees with the observations in the this study that A. baumannii strains can survive 
inhibitory concentrations of biocides for prolonged periods prior to the formation of 
biofilms.  
Thomas et al (Thomas et al. 2011) reported that effective disinfection in the presence of 
a biofilm often requires higher concentrations of antimicrobial agents when compared 
to planktonic bacteria. The antimicrobial concentrations required for biofilm 
inactivation can be 100 times that required for inactivation of removal planktonic cells 
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(Rasmussen and Givskov, 2006).  A similar observation was made here where the 
increase in MBC was between 10 and 100x the MBC concentration for planktonic cells.  
These impacts may be species specific for example the efficacy of ortho-pthalaldehyde 
was reduced against Mycobacterial biofilms but not against P. aeruginosa ones. Survival 
of bacteria in biofilms has been identified as contributing to a number of outbreaks, e.g. 
P. aeruginosa resistance to iodophores, Serratia marcescens resistance to benzylkonium 
chloride and chlorhexidine.  Recently a major outbreak of Pseudomonas infections in a 
neonatal unit in Northern Ireland was associated with biofilms in water distribution 
system (RQIA, 2012).  
Chronic wounds (e.g. diabetic lower limb and pressure ulcers) are generally heavily 
colonised with pathogenic bacteria. The healing of these wounds depends on adjusting 
the equilibrium between the hosts-immune system and the pathogens present in the 
wound environment (Stephen-Haynes, 2004). Within wound microorganisms exist in 
either a free floating/planktonic state or as part of a biofilm associated with the wound 
bed (Thomas et al. 2011). Many MDROs are also often associated with chronic and acute 
wounds. Topical antimicrobials are often the first approach applied to bio burden 
control, in wounds where there are clear signs of a progressive infection however; 
systematic antibiotics are generally applied (Bowler et al. 2012). Several factors 
determine the efficiency of systematic antibiotics such as: the extent of blood flow to the 
wound, the extent of antibiotic-resistance, the bacterial species present, the presence of 
biofilms (Zubair et al. 2011). Where MDROs have colonised the wound, the efficacy of 
systematic antibiotics treatment is uncertain. In this case the topical application of 
antiseptics and disinfectants may present a viable alternative due to their broader 
spectrum of activity and lack of bacterial resistance. By combining antiseptic and 
disinfectant agents with wound dressings it is possible to achieve a managed deliver of 
antimicrobial agents into the infected wound bed (Ovington, 2007). There is a large 
range of antimicrobial dressings available with varying claims of antimicrobial efficacy. 
Current approaches for the evaluation of antimicrobial wound dressings vary 
significantly in terms of media used, inoculum and sample size (Tkachenko and Karas, 
2012), which may make direct comparison between dressing difficult (Chopra, 2007). In 
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addition the presence of biofilms within wounds complicate the testing of these 
dressings, particularly when  of our current knowledge of bacterial biofilm is based on 
in vitro observations of bacterial adherence to solid surfaces. This is a marked contrast 
to the situation in a chronic wound where bacteria reside within a wound beds rather 
than attached to well defined solid surface (Werthan et al. 2010).  
The antimicrobial wound dressings (NSCD, ISCD, Honey and PHMB) were evaluated for 
their ability to prevent the growth of a range of commonly occurring wound pathogens 
i.e. A. baumannii, P. aeruginosa and S. aureus. Two approaches were used to evaluate 
these dressings i.e. planktonic cells and the second cells immobilised in a collagen 
matrix. In case of planktonic cells, majority of cases there were significant differences 
(p<0.05) between strains of the same species when treated with the same dressing. The 
NSCD dressing proved to have a high level of antimicrobial activity (Figure 4.45 a), after 
NSCD the Honey dressing performed best with maximum kills for a number of A. 
baumannii and P. aeruginosa strains (Figure 4.45 c) and a consistent level of kill for S. 
aureus with no significant differences (ANOVA, P>0.05) between the impacts on all 
strains tested. The ISCD dressing had a relatively consistent performance across the A. 
baumannii and P. aeruginosa strains tested (Figure 4.45 b) but failed to generate a 
complete kill in all but two occasions. It was significantly poorer (P<0.05) in 
performance when compared to NSCD for 4 out of the 5 A. baumannii strains, however 
with the exception of the Type strain there was no significant difference (P>0.05) 
between ISCD and NSCD for the other P. aeruginosa strains. In the case of S. aureus ISCD 
was again significantly (p<0.05) poorer in performance than NSCD for the majority of 
strains. The PHMB dressing had the poorest overall performance of the four dressings 
failing to generate a complete kill for any of the bacterial strains tested. It was 
particularly poor against A. baumannii where it had significantly poorer performance 
(P<0.05) than any of the other dressings against any of the strains with the exception of 
882 and the Honey dressing. PHMB performed better against the strains of P. 
aeruginosa and S. aureus tested, performing as well as the other dressings in the 
majority of cases although it did have particularly poor performance against the P. 
aeruginosa type strain.  
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In the case of collagen immobilised bacteria, as was the case with the planktonic cells, 
there were significant differences (ANOVA, p<0.05) between strains of the same species 
when treated with the same dressing, consequently it was not possible to collate data on 
a species level. It also indicated that collagen wound model reflected the significant sub-
species levels variations in the susceptibility to antimicrobial dressings seen in the 
planktonic model (Table 4.7) in a number of cases the difference between minimum and 
maximum impacts were many orders of magnitude. Unlike the planktonic model the 
NSCD and ISCD produced broadly similar results (Figure 4.46) with the major 
differences being seen with the P. aeruginosa strains where NSCD generated greater log 
reductions than  ISCD in 4 out of the 6 strains tested (p<0.05, See Appendix). However, 
there were no differences between the two dressings when tested against S. aureus. The 
NSCD performed significantly better than the Honey dressing for all strains with the 
exception of S. aureus 4330 and significantly better than the PHMB dressing for all 
strains with the exception of the P. aeruginosa Type strain and Type 5.  The ISCD 
performed significantly better than the Honey dressing for all strains with the exception 
of S. aureus 4330 and P. aeruginosa Type 2 and significantly better than PHMB with the 
exception of three P. aeruginosa strains (Type, Type 3 and 5) (See Appendix).  
Comparison between the Honey and the PHMB dressing was variable with Honey being 
generally better against S. aureus, whilst PHMB was generally better against P. 
aeruginosa, with a broadly similar picture against A. baumannii (See Appendix). The use 
of collagen potentially provided a diffusion barrier to the antimicrobials present in the 
dressing. Consequently, you might expect that reduction measured through the collagen 
approach to be less than that seen for the planktonic approach where there is no barrier 
between the dressing and the bacteria. This is generally the case across all the dressing 
with more strains showing no difference between the two approaches or the collagen 
approach generating a lower reduction in viable counts than the planktonic approach 
(Table 4.8). However, in the case of the ISCD, Honey and PHMB dressings there are 
exceptions to this expectation suggesting that the collagen did not generate a consistent 
barrier to the diffusion of the active ingredients.  
The multi-drug resistant organisms (MDROs) investigated in this study includes both 
Gram positive and Gram negative groups that are well known to colonise and 
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potentially infect the variety of dermal wounds (Bowler et al. 2012). In a recent study 
conducted by (Lipova et al. 2010) it was reported that, out of a total 777 bacterial 
strains isolated from burn patients, 65% of these strains were identified as Gram-
Positive and 35% as Gram-negative. The most commonly isolated Gram-Positive 
opportunistic pathogens were coagulase-negative Staphylococcus and Bacillus sp and 
most common among the Gram-negative opportunistic pathogens includes E. coli, A. 
baumannii and P. aeruginosa (Lipova et al. 2010).Since bacteria are capable of forming 
biofilm on living tissues e.g. a wound bed which enhances their tolerance to 
antimicrobial agents (Zubair et al. 2011) and the host immune cells, it was important to 
evaluate the susceptibility of these MDROs to the variety of dressing includes silver 
coated dressings etc., in both of their living forms i.e. most natural tolerant form and 
less natural free living form.  
6 Major Findings 
The major findings of this study are outlined below:  The ability of A. baumannii  to utilise alcohols as sole carbon sources varies 
between strains with a number of clinical isolates being better suited to the 
utilisation of these compounds than the Type strain;  The ability of A. baumannii  strains to form biofilms on plastic surfaces varied 
between strains and between carbon sources;  Strong biofilm forming strains were able to form biofilms on both hydrophobic 
(plastic) and hydrophilic (glass ) surfaces through the generation of 
carbohydrate based EPS;  Strong biofilm forming strains were able to generate high MW EPS containing  
galactose and rhamnose sugars;  When challenged with a range of biocides biofilm forming strains were able to 
form biofilms at concentrations above the MBC of planktonic cells;  The formation of biofilms provided enhanced protection when exposed to a 
range of biocides with biofilm MBC being orders of magnitude greater than the 
MBC for planktonic cells. 
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8 Appendix 
 Statistical analysis of ethanol growth data 8.1
 
Descriptives 
 N Mean Std. 
Deviation 
Std. Error 95% Confidence Interval for 
Mean 
Min Max 
Lower Bound Upper Bound 
UK-HS 
Ethanol 
 
Control 4 8.9570 .03302 .01651 8.9045 9.0096 8.92 9.00 
0.1% 4 8.5282 .00928 .00464 8.5134 8.5430 8.51 8.54 
1% 4 8.0106 .01393 .00697 7.9884 8.0327 8.00 8.03 
3% 4 8.0946 .08403 .04202 7.9609 8.2283 7.97 8.16 
5% 4 4.4950 .13492 .06746 4.2803 4.7097 4.39 4.69 
Total 20 7.6171 1.64002 .36672 6.8495 8.3846 4.39 9.00 
UK-HS IPA 
Control 4 8.9570 .03302 .01651 8.9045 9.0096 8.92 9.00 
0.1% 4 8.0620 .61545 .30772 7.0826 9.0413 7.42 8.74 
1% 4 8.1718 .69169 .34584 7.0712 9.2725 7.15 8.60 
3% 4 7.0987 .23922 .11961 6.7180 7.4793 6.74 7.25 
5% 4 4.9088 .02911 .01455 4.8625 4.9551 4.88 4.94 
Total 20 7.4397 1.48213 .33141 6.7460 8.1333 4.88 9.00 
UK-HS Salvo 
 
Control 4 8.9570 .03302 .01651 8.9045 9.0096 8.92 9.00 
0.1% 4 8.0106 .01393 .00697 7.9884 8.0327 8.00 8.03 
1% 4 6.5774 .19034 .09517 6.2745 6.8803 6.30 6.71 
3% 4 5.6211 .34763 .17381 5.0680 6.1743 5.15 5.97 
5% 4 3.4950 .13492 .06746 3.2803 3.7097 3.39 3.69 
Total 20 6.5322 1.96037 .43835 5.6147 7.4497 3.39 9.00 
UK-HS Purell 
Control 4 8.9570 .03302 .01651 8.9045 9.0096 8.92 9.00 
0.1% 4 8.5282 .00928 .00464 8.5134 8.5430 8.51 8.54 
1% 4 7.7042 .05612 .02806 7.6149 7.7935 7.64 7.77 
3% 4 6.8591 .25844 .12922 6.4479 7.2703 6.52 7.15 
5% 4 7.9088 .02911 .01455 7.8625 7.9551 7.88 7.94 
Total 20 7.9915 .74635 .16689 7.6422 8.3408 6.52 9.00 
Type Ethanol 
 
Control 4 8.9570 .03302 .01651 8.9045 9.0096 8.92 9.00 
0.1% 4 7.9189 .06776 .03388 7.8111 8.0267 7.82 7.98 
1% 4 6.6184 .16649 .08325 6.3535 6.8834 6.38 6.76 
3% 4 6.7290 .03333 .01666 6.6760 6.7821 6.68 6.75 
5% 4 3.8617 .08375 .04188 3.7284 3.9950 3.74 3.94 
Total 20 6.8170 1.75355 .39211 5.9963 7.6377 3.74 9.00 
Type IPA Control 4 8.9570 .03302 .01651 8.9045 9.0096 8.92 9.00 
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0.1% 4 7.6078 .09334 .04667 7.4593 7.7563 7.53 7.72 
1% 4 7.1611 .16175 .08088 6.9037 7.4185 7.01 7.30 
3% 4 5.6211 .34763 .17381 5.0680 6.1743 5.15 5.97 
5% 4 4.8121 .03099 .01549 4.7628 4.8614 4.77 4.84 
Total 20 6.8318 1.51417 .33858 6.1232 7.5405 4.77 9.00 
Type Salvo 
Control 4 8.9570 .03302 .01651 8.9045 9.0096 8.92 9.00 
0.1% 4 7.9189 .06776 .03388 7.8111 8.0267 7.82 7.98 
1% 4 7.0104 .14475 .07237 6.7801 7.2408 6.87 7.15 
3% 4 6.7290 .03333 .01666 6.6760 6.7821 6.68 6.75 
5% 4 5.5282 .00928 .00464 5.5134 5.5430 5.51 5.54 
Total 20 7.2287 1.18529 .26504 6.6740 7.7835 5.51 9.00 
TypePurell 
Control 4 8.9570 .03302 .01651 8.9045 9.0096 8.92 9.00 
0.1% 4 8.0805 .10501 .05250 7.9134 8.2476 7.93 8.15 
1% 4 7.6769 .04996 .02498 7.5974 7.7564 7.60 7.71 
3% 4 6.4888 .23350 .11675 6.1173 6.8604 6.15 6.64 
5% 4 5.0341 .08098 .04049 4.9053 5.1630 4.99 5.16 
Total 20 7.2475 1.40166 .31342 6.5915 7.9035 4.99 9.00 
ANOVA 
 Sum of Squares df Mean Square F Sig. 
UK-HS 
Ethanol 
Between Groups 51.024 4 12.756 2394.466 .000 
Within Groups .080 15 .005   
Total 51.104 19    
UK-HS IPA 
Between Groups 38.988 4 9.747 53.183 .000 
Within Groups 2.749 15 .183   
Total 41.737 19    
UK-HS Salvo 
Between Groups 72.488 4 18.122 513.187 .000 
Within Groups .530 15 .035   
Total 73.018 19    
UK-HS Purell 
Between Groups 10.368 4 2.592 180.087 .000 
Within Groups .216 15 .014   
Total 10.584 19    
Type 
Ethanol 
Between Groups 58.299 4 14.575 1754.941 .000 
Within Groups .125 15 .008   
Total 58.424 19    
Type IPA 
Between Groups 43.088 4 10.772 341.380 .000 
Within Groups .473 15 .032   
Total 43.562 19    
Type Salvo 
Between Groups 26.610 4 6.652 1195.221 .000 
Within Groups .083 15 .006   
Total 26.693 19    
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Type Purell 
Between Groups 37.101 4 9.275 612.717 .000 
Within Groups .227 15 .015   
Total 37.329 19    
Multiple Comparisons 
Games-Howell 
Dependent Variable 
(I) 
VAR00001 
(J) 
VAR00001 
Mean 
Difference (I-
J) 
Std. Error Sig. 
95% Confidence Interval 
Lower 
Bound 
Upper Bound 
UK-HS Ethanol 
Control 
0.1% .42882
*
 .01715 .000 .3462 .5114 
1% .94646
*
 .01792 .000 .8672 1.0258 
3% .86242
*
 .04514 .000 .6592 1.0657 
5% 4.46204
*
 .06945 .000 4.1206 4.8034 
0.1% 
Control -.42882
*
 .01715 .000 -.5114 -.3462 
1% .51764
*
 .00837 .000 .4846 .5506 
3% .43360
*
 .04227 .007 .2132 .6540 
5% 4.03322
*
 .06762 .000 3.6769 4.3895 
1% 
Control -.94646
*
 .01792 .000 -1.0258 -.8672 
0.1% -.51764
*
 .00837 .000 -.5506 -.4846 
3% -.08404 .04259 .433 -.3017 .1336 
5% 3.51557
*
 .06782 .000 3.1612 3.8700 
3% 
Control -.86242
*
 .04514 .000 -1.0657 -.6592 
0.1% -.43360
*
 .04227 .007 -.6540 -.2132 
1% .08404 .04259 .433 -.1336 .3017 
5% 3.59962
*
 .07948 .000 3.2814 3.9178 
5% 
Control -4.46204
*
 .06945 .000 -4.8034 -4.1206 
0.1% -4.03322
*
 .06762 .000 -4.3895 -3.6769 
1% -3.51557
*
 .06782 .000 -3.8700 -3.1612 
3% -3.59962
*
 .07948 .000 -3.9178 -3.2814 
UK-HS IPA 
Control 
0.1% .89507 .30817 .215 -.7329 2.5230 
1% .78519 .34624 .349 -1.0454 2.6158 
3% 1.85834
*
 .12074 .002 1.2345 2.4822 
5% 4.04819
*
 .02201 .000 3.9652 4.1312 
0.1% 
Control -.89507 .30817 .215 -2.5230 .7329 
1% -.10988 .46293 .999 -1.8542 1.6344 
3% .96327 .33015 .178 -.5270 2.4535 
5% 3.15313
*
 .30807 .008 1.5242 4.7820 
1% 
Control -.78519 .34624 .349 -2.6158 1.0454 
0.1% .10988 .46293 .999 -1.6344 1.8542 
3% 1.07315 .36594 .182 -.6221 2.7684 
5% 3.26301
*
 .34615 .010 1.4315 5.0945 
3% 
Control -1.85834
*
 .12074 .002 -2.4822 -1.2345 
0.1% -.96327 .33015 .178 -2.4535 .5270 
1% -1.07315 .36594 .182 -2.7684 .6221 
5% 2.18985
*
 .12049 .001 1.5638 2.8159 
5% 
Control -4.04819
*
 .02201 .000 -4.1312 -3.9652 
0.1% -3.15313
*
 .30807 .008 -4.7820 -1.5242 
1% -3.26301
*
 .34615 .010 -5.0945 -1.4315 
3% -2.18985
*
 .12049 .001 -2.8159 -1.5638 
UK- HSSalvo 
Control 
0.1% .94646
*
 .01792 .000 .8672 1.0258 
1% 2.37960
*
 .09659 .000 1.8876 2.8716 
3% 3.33590
*
 .17460 .001 2.4215 4.2503 
5% 5.46204
*
 .06945 .000 5.1206 5.8034 
0.1% 
Control -.94646
*
 .01792 .000 -1.0258 -.8672 
1% 1.43314
*
 .09543 .002 .9308 1.9355 
3% 2.38943
*
 .17395 .003 1.4688 3.3100 
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5% 4.51557
*
 .06782 .000 4.1612 4.8700 
1% 
Control -2.37960
*
 .09659 .000 -2.8716 -1.8876 
0.1% -1.43314
*
 .09543 .002 -1.9355 -.9308 
3% .95630
*
 .19816 .028 .1366 1.7760 
5% 3.08244
*
 .11666 .000 2.6285 3.5364 
3% 
Control -3.33590
*
 .17460 .001 -4.2503 -2.4215 
0.1% -2.38943
*
 .17395 .003 -3.3100 -1.4688 
1% -.95630
*
 .19816 .028 -1.7760 -.1366 
5% 2.12614
*
 .18645 .002 1.2843 2.9680 
5% 
Control -5.46204
*
 .06945 .000 -5.8034 -5.1206 
0.1% -4.51557
*
 .06782 .000 -4.8700 -4.1612 
1% -3.08244
*
 .11666 .000 -3.5364 -2.6285 
3% -2.12614
*
 .18645 .002 -2.9680 -1.2843 
UK-HSPurell 
Control 
0.1% .42882
*
 .01715 .000 .3462 .5114 
1% 1.25282
*
 .03256 .000 1.1206 1.3850 
3% 2.09791
*
 .13027 .002 1.4224 2.7734 
5% 1.04819
*
 .02201 .000 .9652 1.1312 
0.1% 
Control -.42882
*
 .01715 .000 -.5114 -.3462 
1% .82400
*
 .02844 .000 .6786 .9694 
3% 1.66909
*
 .12930 .004 .9845 2.3537 
5% .61937
*
 .01527 .000 .5474 .6913 
1% 
Control -1.25282
*
 .03256 .000 -1.3850 -1.1206 
0.1% -.82400
*
 .02844 .000 -.9694 -.6786 
3% .84510
*
 .13223 .024 .1855 1.5047 
5% -.20462
*
 .03161 .010 -.3372 -.0720 
3% 
Control -2.09791
*
 .13027 .002 -2.7734 -1.4224 
0.1% -1.66909
*
 .12930 .004 -2.3537 -.9845 
1% -.84510
*
 .13223 .024 -1.5047 -.1855 
5% -1.04972
*
 .13004 .014 -1.7274 -.3721 
5% 
Control -1.04819
*
 .02201 .000 -1.1312 -.9652 
0.1% -.61937
*
 .01527 .000 -.6913 -.5474 
1% .20462
*
 .03161 .010 .0720 .3372 
3% 1.04972
*
 .13004 .014 .3721 1.7274 
Type Ethanol 
Control 
0.1% 1.03811
*
 .03769 .000 .8774 1.1988 
1% 2.33859
*
 .08487 .000 1.9113 2.7659 
3% 2.22798
*
 .02346 .000 2.1400 2.3160 
5% 5.09532
*
 .04501 .000 4.8928 5.2978 
0.1% 
Control -1.03811
*
 .03769 .000 -1.1988 -.8774 
1% 1.30048
*
 .08987 .001 .8992 1.7018 
3% 1.18987
*
 .03775 .000 1.0292 1.3505 
5% 4.05721
*
 .05386 .000 3.8522 4.2622 
1% 
Control -2.33859
*
 .08487 .000 -2.7659 -1.9113 
0.1% -1.30048
*
 .08987 .001 -1.7018 -.8992 
3% -.11061 .08490 .709 -.5377 .3165 
5% 2.75673
*
 .09318 .000 2.3626 3.1508 
3% 
Control -2.22798
*
 .02346 .000 -2.3160 -2.1400 
0.1% -1.18987
*
 .03775 .000 -1.3505 -1.0292 
1% .11061 .08490 .709 -.3165 .5377 
5% 2.86734
*
 .04507 .000 2.6650 3.0697 
5% 
Control -5.09532
*
 .04501 .000 -5.2978 -4.8928 
0.1% -4.05721
*
 .05386 .000 -4.2622 -3.8522 
1% -2.75673
*
 .09318 .000 -3.1508 -2.3626 
3% -2.86734
*
 .04507 .000 -3.0697 -2.6650 
Type IPA Control 
0.1% 1.34923
*
 .04951 .000 1.1210 1.5775 
1% 1.79595
*
 .08254 .001 1.3815 2.2104 
3% 3.33590
*
 .17460 .001 2.4215 4.2503 
5% 4.14493
*
 .02264 .000 4.0599 4.2300 
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0.1% 
Control -1.34923
*
 .04951 .000 -1.5775 -1.1210 
1% .44672
*
 .09338 .027 .0657 .8278 
3% 1.98667
*
 .17997 .004 1.1137 2.8596 
5% 2.79570
*
 .04918 .000 2.5660 3.0254 
1% 
Control -1.79595
*
 .08254 .001 -2.2104 -1.3815 
0.1% -.44672
*
 .09338 .027 -.8278 -.0657 
3% 1.53995
*
 .19171 .005 .7124 2.3675 
5% 2.34898
*
 .08235 .000 1.9330 2.7649 
3% 
Control -3.33590
*
 .17460 .001 -4.2503 -2.4215 
0.1% -1.98667
*
 .17997 .004 -2.8596 -1.1137 
1% -1.53995
*
 .19171 .005 -2.3675 -.7124 
5% .80903 .17450 .069 -.1063 1.7243 
5% 
Control -4.14493
*
 .02264 .000 -4.2300 -4.0599 
0.1% -2.79570
*
 .04918 .000 -3.0254 -2.5660 
1% -2.34898
*
 .08235 .000 -2.7649 -1.9330 
3% -.80903 .17450 .069 -1.7243 .1063 
Type Salvo 
Control 
0.1% 1.03811
*
 .03769 .000 .8774 1.1988 
1% 1.94658
*
 .07423 .000 1.5784 2.3147 
3% 2.22798
*
 .02346 .000 2.1400 2.3160 
5% 3.42882
*
 .01715 .000 3.3462 3.5114 
0.1% 
Control -1.03811
*
 .03769 .000 -1.1988 -.8774 
1% .90847
*
 .07991 .001 .5641 1.2529 
3% 1.18987
*
 .03775 .000 1.0292 1.3505 
5% 2.39071
*
 .03419 .000 2.2140 2.5675 
1% 
Control -1.94658
*
 .07423 .000 -2.3147 -1.5784 
0.1% -.90847
*
 .07991 .001 -1.2529 -.5641 
3% .28140 .07427 .105 -.0865 .6493 
5% 1.48224
*
 .07252 .001 1.0998 1.8647 
3% 
Control -2.22798
*
 .02346 .000 -2.3160 -2.1400 
0.1% -1.18987
*
 .03775 .000 -1.3505 -1.0292 
1% -.28140 .07427 .105 -.6493 .0865 
5% 1.20084
*
 .01730 .000 1.1174 1.2843 
5% 
Control -3.42882
*
 .01715 .000 -3.5114 -3.3462 
0.1% -2.39071
*
 .03419 .000 -2.5675 -2.2140 
1% -1.48224
*
 .07252 .001 -1.8647 -1.0998 
3% -1.20084
*
 .01730 .000 -1.2843 -1.1174 
Type Purell 
Control 
0.1% .87655
*
 .05504 .001 .6167 1.1364 
1% 1.28012
*
 .02994 .000 1.1619 1.3984 
3% 2.46819
*
 .11791 .001 1.8598 3.0766 
5% 3.92291
*
 .04372 .000 3.7278 4.1180 
0.1% 
Control -.87655
*
 .05504 .001 -1.1364 -.6167 
1% .40357
*
 .05814 .008 .1540 .6531 
3% 1.59165
*
 .12801 .001 1.0342 2.1491 
5% 3.04636
*
 .06630 .000 2.7922 3.3005 
1% 
Control -1.28012
*
 .02994 .000 -1.3984 -1.1619 
0.1% -.40357
*
 .05814 .008 -.6531 -.1540 
3% 1.18808
*
 .11939 .006 .5916 1.7846 
5% 2.64279
*
 .04757 .000 2.4519 2.8337 
3% 
Control -2.46819
*
 .11791 .001 -3.0766 -1.8598 
0.1% -1.59165
*
 .12801 .001 -2.1491 -1.0342 
1% -1.18808
*
 .11939 .006 -1.7846 -.5916 
5% 1.45472
*
 .12357 .002 .8826 2.0268 
5% 
Control -3.92291
*
 .04372 .000 -4.1180 -3.7278 
0.1% -3.04636
*
 .06630 .000 -3.3005 -2.7922 
1% -2.64279
*
 .04757 .000 -2.8337 -2.4519 
3% -1.45472
*
 .12357 .002 -2.0268 -.8826 
*. The mean difference is significant at the 0.05 level. 
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 Statistical analysis of low alcohol growth data 8.2
 
Descriptives 
 N Mean Std. Dev Std. Error 95% Confidence Interval 
for Mean 
Minimum Maximum 
Lower 
Bound 
Upper Bound 
UK-HS 
Ethanol 
Cont 4 8.2000 .00000 .00000 8.2000 8.2000 8.20 8.20 
0.001% 4 5.2858 .30034 .15017 4.8078 5.7637 5.03 5.60 
0.01% 4 5.2996 .51239 .25620 4.4843 6.1150 4.82 5.74 
0.03% 4 4.6362 .60691 .30346 3.6705 5.6019 4.06 5.49 
0.05% 4 4.0190 .01200 .00600 3.9999 4.0381 4.01 4.03 
Total 20 5.4881 1.51177 .33804 4.7806 6.1956 4.01 8.20 
UK-HS IPA 
Cont 4 8.2000 .00000 .00000 8.2000 8.2000 8.20 8.20 
0.001% 4 5.3543 .08394 .04197 5.2208 5.4879 5.31 5.48 
0.01% 4 5.2192 .44944 .22472 4.5040 5.9344 4.76 5.78 
0.03% 4 5.0811 .06343 .03171 4.9802 5.1820 5.02 5.15 
0.05% 4 4.8767 .03332 .01666 4.8237 4.9297 4.85 4.91 
Total 20 5.7463 1.28238 .28675 5.1461 6.3464 4.76 8.20 
Type 
Ethanol 
Cont 4 8.4000 .00000 .00000 8.4000 8.4000 8.40 8.40 
0.001% 4 6.3971 .09997 .04998 6.2380 6.5562 6.31 6.49 
0.01% 4 6.2996 .51239 .25620 5.4843 7.1150 5.82 6.74 
0.03% 4 4.0444 .03340 .01670 3.9912 4.0975 4.00 4.08 
0.05% 4 3.2365 .15200 .07600 2.9946 3.4783 3.01 3.32 
Total 20 5.6755 1.90098 .42507 4.7858 6.5652 3.01 8.40 
Type IPA 
Cont 4 8.4000 .00000 .00000 8.4000 8.4000 8.40 8.40 
0.001% 4 5.3971 .09997 .04998 5.2380 5.5562 5.31 5.49 
0.01% 4 5.0822 .19044 .09522 4.7791 5.3852 4.97 5.37 
0.03% 4 4.1967 .07337 .03668 4.0800 4.3135 4.12 4.28 
0.05% 4 3.1648 .16866 .08433 2.8964 3.4332 3.01 3.32 
Total 20 5.2482 1.80582 .40379 4.4030 6.0933 3.01 8.40 
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ANOVA 
 Sum of Squares df Mean Square F Sig. 
UK-HS 
Ethanol 
Between Groups 41.260 4 10.315 71.508 .000 
Within Groups 2.164 15 .144   
Total 43.423 19    
UK-HS IPA 
Between Groups 30.603 4 7.651 178.612 .000 
Within Groups .643 15 .043   
Total 31.246 19    
Type 
Ethanol 
Between Groups 67.771 4 16.943 285.464 .000 
Within Groups .890 15 .059   
Total 68.661 19    
Type IPA 
Between Groups 61.718 4 15.430 963.225 .000 
Within Groups .240 15 .016   
Total 61.959 19    
 
 
Multiple Comparisons 
Games-Howell 
Dependent 
Variable 
(I) VAR00001 (J) 
VAR00001 
Mean 
Difference (I-
J) 
Std. Error Sig. 95% Confidence 
Interval 
Lower 
Bound 
Upper 
Bound 
UK-HS 
Ethanol 
 
Control 
0.001% 2.91425
*
 .15017 .001 2.1177 3.7108 
0.01% 2.90035
*
 .25620 .006 1.5414 4.2593 
0.03% 3.56381
*
 .30346 .005 1.9541 5.1735 
0.05% 4.18101
*
 .00600 .000 4.1492 4.2128 
0.001% 
Control -2.91425
*
 .15017 .001 -3.7108 -2.1177 
0.01% -.01390 .29696 1.000 -1.2209 1.1931 
0.03% .64956 .33858 .422 -.7886 2.0877 
0.05% 1.26676
*
 .15029 .014 .4714 2.0621 
0.01% 
Control -2.90035
*
 .25620 .006 -4.2593 -1.5414 
0.001% .01390 .29696 1.000 -1.1931 1.2209 
0.03% .66345 .39714 .512 -.8403 2.1672 
0.05% 1.28066 .25627 .058 -.0776 2.6389 
0.03% 
Control -3.56381
*
 .30346 .005 -5.1735 -1.9541 
0.001% -.64956 .33858 .422 -2.0877 .7886 
0.01% -.66345 .39714 .512 -2.1672 .8403 
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0.05% .61720 .30352 .418 -.9919 2.2263 
0.05% 
Control -4.18101
*
 .00600 .000 -4.2128 -4.1492 
0.001% -1.26676
*
 .15029 .014 -2.0621 -.4714 
0.01% -1.28066 .25627 .058 -2.6389 .0776 
0.03% -.61720 .30352 .418 -2.2263 .9919 
 
UK-HS IPA 
 
Control 
0.001% 2.84568
*
 .04197 .000 2.6231 3.0683 
0.01% 2.98079
*
 .22472 .004 1.7888 4.1728 
0.03% 3.11889
*
 .03171 .000 2.9507 3.2871 
0.05% 3.32330
*
 .01666 .000 3.2349 3.4117 
0.001% 
Control -2.84568
*
 .04197 .000 -3.0683 -2.6231 
0.01% .13512 .22860 .968 -1.0222 1.2925 
0.03% .27321
*
 .05260 .014 .0709 .4755 
0.05% .47762
*
 .04516 .002 .2748 .6804 
0.01% 
Control -2.98079
*
 .22472 .004 -4.1728 -1.7888 
0.001% -.13512 .22860 .968 -1.2925 1.0222 
0.03% .13810 .22695 .964 -1.0331 1.3093 
0.05% .34250 .22534 .613 -.8435 1.5285 
0.03% 
Control -3.11889
*
 .03171 .000 -3.2871 -2.9507 
0.001% -.27321
*
 .05260 .014 -.4755 -.0709 
0.01% -.13810 .22695 .964 -1.3093 1.0331 
0.05% .20441
*
 .03582 .016 .0546 .3542 
0.05% 
Control -3.32330
*
 .01666 .000 -3.4117 -3.2349 
0.001% -.47762
*
 .04516 .002 -.6804 -.2748 
0.01% -.34250 .22534 .613 -1.5285 .8435 
0.03% -.20441
*
 .03582 .016 -.3542 -.0546 
 
Type Ethanol 
 
Control 
0.001% 2.00288
*
 .04998 .000 1.7377 2.2680 
0.01% 2.10035
*
 .25620 .015 .7414 3.4593 
0.03% 4.35563
*
 .01670 .000 4.2670 4.4442 
0.05% 5.16353
*
 .07600 .000 4.7604 5.5667 
0.001% 
Control -2.00288
*
 .04998 .000 -2.2680 -1.7377 
0.01% .09747 .26103 .994 -1.2188 1.4138 
0.03% 2.35275
*
 .05270 .000 2.1069 2.5986 
0.05% 3.16064
*
 .09096 .000 2.8010 3.5203 
0.01% 
Control -2.10035
*
 .25620 .015 -3.4593 -.7414 
0.001% -.09747 .26103 .994 -1.4138 1.2188 
0.03% 2.25528
*
 .25674 .012 .9016 3.6089 
0.05% 3.06318
*
 .26723 .003 1.7880 4.3383 
0.03% 
Control -4.35563
*
 .01670 .000 -4.4442 -4.2670 
0.001% -2.35275
*
 .05270 .000 -2.5986 -2.1069 
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0.01% -2.25528
*
 .25674 .012 -3.6089 -.9016 
0.05% .80790
*
 .07781 .005 .4203 1.1955 
0.05% 
Control -5.16353
*
 .07600 .000 -5.5667 -4.7604 
0.001% -3.16064
*
 .09096 .000 -3.5203 -2.8010 
0.01% -3.06318
*
 .26723 .003 -4.3383 -1.7880 
0.03% -.80790
*
 .07781 .005 -1.1955 -.4203 
Type  
IPA 
Control 
0.001% 3.00288
*
 .04998 .000 2.7377 3.2680 
0.01% 3.31785
*
 .09522 .000 2.8127 3.8230 
0.03% 4.20325
*
 .03668 .000 4.0087 4.3978 
0.05% 5.23517
*
 .08433 .000 4.7878 5.6825 
0.001% 
Control -3.00288
*
 .04998 .000 -3.2680 -2.7377 
0.01% .31496 .10754 .157 -.1348 .7647 
0.03% 1.20037
*
 .06200 .000 .9607 1.4400 
0.05% 2.23229
*
 .09803 .000 1.8350 2.6296 
0.01% 
Control -3.31785
*
 .09522 .000 -3.8230 -2.8127 
0.001% -.31496 .10754 .157 -.7647 .1348 
0.03% .88540
*
 .10204 .005 .4238 1.3470 
0.05% 1.91733
*
 .12720 .000 1.4379 2.3968 
0.03% 
Control -4.20325
*
 .03668 .000 -4.3978 -4.0087 
0.001% -1.20037
*
 .06200 .000 -1.4400 -.9607 
0.01% -.88540
*
 .10204 .005 -1.3470 -.4238 
0.05% 1.03192
*
 .09197 .002 .6280 1.4358 
0.05% 
Control -5.23517
*
 .08433 .000 -5.6825 -4.7878 
0.001% -2.23229
*
 .09803 .000 -2.6296 -1.8350 
0.01% -1.91733
*
 .12720 .000 -2.3968 -1.4379 
0.03% -1.03192
*
 .09197 .002 -1.4358 -.6280 
*. The mean difference is significant at the 0.05 level. 
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 Comparison of wound models 8.3
 Planktonic wound model 8.3.1
 
Descriptive 
 N Mean Std. Dev Std. Error 95% Confidence Interval for Mean Min Max 
Lower Bound Upper Bound 
clone1 
NSCD 5 9.5420 .00000 .00000 9.5420 9.5420 9.54 9.54 
ISCD 5 7.2400 .12298 .05500 7.0873 7.3927 7.02 7.30 
Honey 5 8.8550 .00000 .00000 8.8550 8.8550 8.86 8.86 
PHMB 5 3.9270 .06918 .03094 3.8411 4.0129 3.83 4.02 
Total 20 7.3910 2.22475 .49747 6.3498 8.4322 3.83 9.54 
clone2 
NSCD 5 9.4790 .00000 .00000 9.4790 9.4790 9.48 9.48 
ISCD 5 6.5166 .48625 .21746 5.9128 7.1204 5.94 6.96 
Honey 5 9.4330 .00000 .00000 9.4330 9.4330 9.43 9.43 
PHMB 5 4.5754 .56477 .25257 3.8741 5.2767 3.91 5.30 
Total 20 7.5010 2.15319 .48147 6.4933 8.5087 3.91 9.48 
ukhs 
NSCD 5 9.2960 .00000 .00000 9.2960 9.2960 9.30 9.30 
ISCD 5 6.1802 .34764 .15547 5.7485 6.6119 5.90 6.78 
Honey 5 8.6490 .00000 .00000 8.6490 8.6490 8.65 8.65 
PHMB 5 4.1078 .36149 .16166 3.6589 4.5567 3.82 4.56 
Total 20 7.0582 2.12846 .47594 6.0621 8.0544 3.82 9.30 
Act_Ty
pe 
NSCD 5 9.9010 .00000 .00000 9.9010 9.9010 9.90 9.90 
ISCD 5 6.7566 .37294 .16678 6.2935 7.2197 6.26 7.09 
Honey 5 8.7240 .00000 .00000 8.7240 8.7240 8.72 8.72 
PHMB 5 4.4258 .12898 .05768 4.2657 4.5859 4.28 4.63 
Total 20 7.4519 2.13872 .47823 6.4509 8.4528 4.28 9.90 
A882 
NSCD 5 7.2280 .69143 .30922 6.3695 8.0865 6.48 8.29 
ISCD 5 5.9800 .17564 .07855 5.7619 6.1981 5.73 6.20 
Honey 5 2.8020 .14220 .06359 2.6254 2.9786 2.62 3.00 
PHMB 5 2.7300 .20396 .09121 2.4767 2.9833 2.51 3.01 
Total 20 4.6850 2.04992 .45837 3.7256 5.6444 2.51 8.29 
A292 
NSCD 5 8.5400 .00000 .00000 8.5400 8.5400 8.54 8.54 
ISCD 5 8.5400 .00000 .00000 8.5400 8.5400 8.54 8.54 
Honey 5 5.9220 .15928 .07123 5.7242 6.1198 5.76 6.18 
PHMB 5 4.9140 .26359 .11788 4.5867 5.2413 4.59 5.25 
Total 20 6.9790 1.64883 .36869 6.2073 7.7507 4.59 8.54 
Ps_Typ
e 
NSCD 5 8.3810 .00000 .00000 8.3810 8.3810 8.38 8.38 
ISCD 5 5.2588 .18911 .08457 5.0240 5.4936 5.01 5.50 
Honey 5 5.2822 .30779 .13765 4.9000 5.6644 4.96 5.80 
PHMB 5 3.3086 .44059 .19704 2.7615 3.8557 2.85 3.73 
Total 20 5.5577 1.88166 .42075 4.6770 6.4383 2.85 8.38 
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P1 
NSCD 5 7.9268 .09123 .04080 7.8135 8.0401 7.89 8.09 
ISCD 5 7.9268 .09123 .04080 7.8135 8.0401 7.89 8.09 
Honey 5 8.0900 .00000 .00000 8.0900 8.0900 8.09 8.09 
PHMB 5 9.0560 .57799 .25848 8.3383 9.7737 8.39 9.91 
Total 20 8.2499 .55363 .12380 7.9908 8.5090 7.89 9.91 
P2 
NSCD 5 7.8658 .13461 .06020 7.6987 8.0329 7.63 7.93 
ISCD 5 7.6508 .42901 .19186 7.1181 8.1835 6.95 7.93 
Honey 5 7.6698 .38626 .17274 7.1902 8.1494 7.00 7.93 
PHMB 5 6.3682 1.05817 .47323 5.0543 7.6821 5.62 8.00 
Total 20 7.3887 .82616 .18473 7.0020 7.7753 5.62 8.00 
P3 
NSCD 5 7.5326 .21332 .09540 7.2677 7.7975 7.15 7.63 
ISCD 5 6.7566 .74230 .33197 5.8349 7.6783 5.78 7.63 
Honey 5 7.6280 .00000 .00000 7.6280 7.6280 7.63 7.63 
PHMB 5 6.2278 1.02345 .45770 4.9570 7.4986 5.70 8.06 
Total 20 7.0363 .83406 .18650 6.6459 7.4266 5.70 8.06 
P4 
NSCD 5 6.7868 .86229 .38563 5.7161 7.8575 5.87 7.85 
ISCD 5 7.0330 .67744 .30296 6.1919 7.8741 6.38 7.85 
Honey 5 6.8266 .88591 .39619 5.7266 7.9266 5.83 7.85 
PHMB 5 7.1236 1.06871 .47794 5.7966 8.4506 5.98 8.26 
Total 20 6.9425 .82434 .18433 6.5567 7.3283 5.83 8.26 
P5 
NSCD 5 8.1816 .26922 .12040 7.8473 8.5159 7.70 8.30 
ISCD 5 8.3020 .00000 .00000 8.3020 8.3020 8.30 8.30 
Honey 5 8.3020 .00000 .00000 8.3020 8.3020 8.30 8.30 
PHMB 5 6.1198 .27887 .12471 5.7735 6.4661 5.79 6.47 
Total 20 7.7263 .96943 .21677 7.2726 8.1801 5.79 8.30 
St6538 
NSCD 5 7.0210 .00000 .00000 7.0210 7.0210 7.02 7.02 
ISCD 5 4.9442 .14727 .06586 4.7613 5.1271 4.74 5.11 
Honey 5 6.3454 .57441 .25689 5.6322 7.0586 5.89 7.32 
PHMB 5 5.7550 .18020 .08059 5.5312 5.9788 5.54 5.94 
Total 20 6.0164 .83393 .18647 5.6261 6.4067 4.74 7.32 
St4300 
NSCD 5 7.3960 .00000 .00000 7.3960 7.3960 7.40 7.40 
ISCD 5 7.2404 .15093 .06750 7.0530 7.4278 7.10 7.40 
Honey 5 6.4506 .20853 .09326 6.1917 6.7095 6.17 6.66 
PHMB 5 6.9596 .61217 .27377 6.1995 7.7197 6.12 7.40 
Total 20 7.0116 .47858 .10701 6.7877 7.2356 6.12 7.40 
St_7f_C
7 
NSCD 5 6.6444 .19924 .08910 6.3970 6.8918 6.44 6.84 
ISCD 5 2.5272 1.21978 .54550 1.0126 4.0418 .36 3.24 
Honey 5 6.8036 .07916 .03540 6.7053 6.9019 6.66 6.84 
PHMB 5 5.6288 .05329 .02383 5.5626 5.6950 5.56 5.68 
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Total 20 5.4010 1.85340 .41443 4.5336 6.2684 .36 6.84 
St1314
2 
NSCD 5 6.9438 .09123 .04080 6.8305 7.0571 6.90 7.11 
ISCD 5 6.9438 .09123 .04080 6.8305 7.0571 6.90 7.11 
Honey 5 6.9438 .09123 .04080 6.8305 7.0571 6.90 7.11 
PHMB 5 6.9438 .09123 .04080 6.8305 7.0571 6.90 7.11 
Total 20 6.9438 .08372 .01872 6.9046 6.9830 6.90 7.11 
St9B_F
6 
NSCD 5 6.8296 .60463 .27040 6.0788 7.5804 5.75 7.10 
ISCD 5 6.1060 .92685 .41450 4.9552 7.2568 5.25 7.10 
Honey 5 6.3418 .78577 .35141 5.3661 7.3175 5.36 7.10 
PHMB 5 5.3272 .60912 .27241 4.5709 6.0835 4.40 5.74 
Total 20 6.1511 .88080 .19695 5.7389 6.5634 4.40 7.10 
 
 
Multiple Comparisons 
Games-Howell 
Bacteria (I) VAR00001 (J) VAR00001 Mean 
Difference 
(I-J) 
Std. Error Sig. 95% Confidence Interval 
Lower Bound Upper Bound 
clone1 
NSCD 
ISCD 2.30200* .05500 .000 2.0781 2.5259 
Honey .68700 .00000 . .6870 .6870 
PHMB 5.61500* .03094 .000 5.4891 5.7409 
ISCD 
NSCD -2.30200* .05500 .000 -2.5259 -2.0781 
Honey -1.61500* .05500 .000 -1.8389 -1.3911 
PHMB 3.31300* .06310 .000 3.0978 3.5282 
Honey 
NSCD -.68700 .00000 . -.6870 -.6870 
ISCD 1.61500* .05500 .000 1.3911 1.8389 
PHMB 4.92800* .03094 .000 4.8021 5.0539 
PHMB 
NSCD -5.61500* .03094 .000 -5.7409 -5.4891 
ISCD -3.31300* .06310 .000 -3.5282 -3.0978 
Honey -4.92800* .03094 .000 -5.0539 -4.8021 
clone2 
NSCD 
ISCD 2.96240* .21746 .001 2.0772 3.8476 
Honey .04600 .00000 . .0460 .0460 
PHMB 4.90360* .25257 .000 3.8754 5.9318 
ISCD 
NSCD -2.96240* .21746 .001 -3.8476 -2.0772 
Honey -2.91640* .21746 .001 -3.8016 -2.0312 
PHMB 1.94120* .33329 .002 .8684 3.0140 
Honey 
NSCD -.04600 .00000 . -.0460 -.0460 
ISCD 2.91640* .21746 .001 2.0312 3.8016 
PHMB 4.85760* .25257 .000 3.8294 5.8858 
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PHMB 
NSCD -4.90360* .25257 .000 -5.9318 -3.8754 
ISCD -1.94120* .33329 .002 -3.0140 -.8684 
Honey -4.85760* .25257 .000 -5.8858 -3.8294 
ukhs 
NSCD 
ISCD 3.11580* .15547 .000 2.4829 3.7487 
Honey .64700 .00000 . .6470 .6470 
PHMB 5.18820* .16166 .000 4.5301 5.8463 
ISCD 
NSCD -3.11580* .15547 .000 -3.7487 -2.4829 
Honey -2.46880* .15547 .000 -3.1017 -1.8359 
PHMB 2.07240* .22429 .000 1.3539 2.7909 
Honey 
NSCD -.64700 .00000 . -.6470 -.6470 
ISCD 2.46880* .15547 .000 1.8359 3.1017 
PHMB 4.54120* .16166 .000 3.8831 5.1993 
PHMB 
NSCD -5.18820* .16166 .000 -5.8463 -4.5301 
ISCD -2.07240* .22429 .000 -2.7909 -1.3539 
Honey -4.54120* .16166 .000 -5.1993 -3.8831 
Act_Type 
NSCD 
ISCD 3.14440* .16678 .000 2.4654 3.8234 
Honey 1.17700 .00000 . 1.1770 1.1770 
PHMB 5.47520* .05768 .000 5.2404 5.7100 
ISCD 
NSCD -3.14440* .16678 .000 -3.8234 -2.4654 
Honey -1.96740* .16678 .001 -2.6464 -1.2884 
PHMB 2.33080* .17648 .000 1.6767 2.9849 
Honey 
NSCD -1.17700 .00000 . -1.1770 -1.1770 
ISCD 1.96740* .16678 .001 1.2884 2.6464 
PHMB 4.29820* .05768 .000 4.0634 4.5330 
PHMB 
NSCD -5.47520* .05768 .000 -5.7100 -5.2404 
ISCD -2.33080* .17648 .000 -2.9849 -1.6767 
Honey -4.29820* .05768 .000 -4.5330 -4.0634 
A882 
NSCD 
ISCD 1.24800* .31904 .047 .0204 2.4756 
Honey 4.42600* .31569 .000 3.1895 5.6625 
PHMB 4.49800* .32239 .000 3.2776 5.7184 
ISCD 
NSCD -1.24800* .31904 .047 -2.4756 -.0204 
Honey 3.17800* .10106 .000 2.8511 3.5049 
PHMB 3.25000* .12037 .000 2.8626 3.6374 
Honey 
NSCD -4.42600* .31569 .000 -5.6625 -3.1895 
ISCD -3.17800* .10106 .000 -3.5049 -2.8511 
PHMB .07200 .11119 .913 -.2941 .4381 
PHMB 
NSCD -4.49800* .32239 .000 -5.7184 -3.2776 
ISCD -3.25000* .12037 .000 -3.6374 -2.8626 
Honey -.07200 .11119 .913 -.4381 .2941 
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A292 
NSCD 
ISCD .00000 .00000 . .0000 .0000 
Honey 2.61800* .07123 .000 2.3280 2.9080 
PHMB 3.62600* .11788 .000 3.1461 4.1059 
ISCD 
NSCD .00000 .00000 . .0000 .0000 
Honey 2.61800* .07123 .000 2.3280 2.9080 
PHMB 3.62600* .11788 .000 3.1461 4.1059 
Honey 
NSCD -2.61800* .07123 .000 -2.9080 -2.3280 
ISCD -2.61800* .07123 .000 -2.9080 -2.3280 
PHMB 1.00800* .13773 .001 .5442 1.4718 
PHMB 
NSCD -3.62600* .11788 .000 -4.1059 -3.1461 
ISCD -3.62600* .11788 .000 -4.1059 -3.1461 
Honey -1.00800* .13773 .001 -1.4718 -.5442 
Ps_Type 
NSCD 
ISCD 3.12220* .08457 .000 2.7779 3.4665 
Honey 3.09880* .13765 .000 2.5385 3.6591 
PHMB 5.07240* .19704 .000 4.2703 5.8745 
ISCD 
NSCD -3.12220* .08457 .000 -3.4665 -2.7779 
Honey -.02340 .16155 .999 -.5659 .5191 
PHMB 1.95020* .21442 .001 1.1826 2.7178 
Honey 
NSCD -3.09880* .13765 .000 -3.6591 -2.5385 
ISCD .02340 .16155 .999 -.5191 .5659 
PHMB 1.97360* .24035 .000 1.1825 2.7647 
PHMB 
NSCD -5.07240* .19704 .000 -5.8745 -4.2703 
ISCD -1.95020* .21442 .001 -2.7178 -1.1826 
Honey -1.97360* .24035 .000 -2.7647 -1.1825 
P1 
NSCD 
ISCD .00000 .05770 1.000 -.1848 .1848 
Honey -.16320 .04080 .053 -.3293 .0029 
PHMB -1.12920* .26168 .038 -2.1697 -.0887 
ISCD 
NSCD .00000 .05770 1.000 -.1848 .1848 
Honey -.16320 .04080 .053 -.3293 .0029 
PHMB -1.12920* .26168 .038 -2.1697 -.0887 
Honey 
NSCD .16320 .04080 .053 -.0029 .3293 
ISCD .16320 .04080 .053 -.0029 .3293 
PHMB -.96600 .25848 .065 -2.0183 .0863 
PHMB 
NSCD 1.12920* .26168 .038 .0887 2.1697 
ISCD 1.12920* .26168 .038 .0887 2.1697 
Honey .96600 .25848 .065 -.0863 2.0183 
P2 NSCD 
ISCD .21500 .20108 .722 -.5404 .9704 
Honey .19600 .18293 .720 -.4812 .8732 
PHMB 1.49760 .47704 .106 -.4143 3.4095 
130 
 
 
ISCD 
NSCD -.21500 .20108 .722 -.9704 .5404 
Honey -.01900 .25817 1.000 -.8478 .8098 
PHMB 1.28260 .51064 .167 -.5634 3.1286 
Honey 
NSCD -.19600 .18293 .720 -.8732 .4812 
ISCD .01900 .25817 1.000 -.8098 .8478 
PHMB 1.30160 .50377 .158 -.5505 3.1537 
PHMB 
NSCD -1.49760 .47704 .106 -3.4095 .4143 
ISCD -1.28260 .51064 .167 -3.1286 .5634 
Honey -1.30160 .50377 .158 -3.1537 .5505 
P3 
NSCD 
ISCD .77600 .34540 .237 -.5356 2.0876 
Honey -.09540 .09540 .759 -.4838 .2930 
PHMB 1.30480 .46754 .142 -.5247 3.1343 
ISCD 
NSCD -.77600 .34540 .237 -2.0876 .5356 
Honey -.87140 .33197 .176 -2.2228 .4800 
PHMB .52880 .56541 .788 -1.3227 2.3803 
Honey 
NSCD .09540 .09540 .759 -.2930 .4838 
ISCD .87140 .33197 .176 -.4800 2.2228 
PHMB 1.40020 .45770 .118 -.4630 3.2634 
PHMB 
NSCD -1.30480 .46754 .142 -3.1343 .5247 
ISCD -.52880 .56541 .788 -2.3803 1.3227 
Honey -1.40020 .45770 .118 -3.2634 .4630 
P4 
NSCD 
ISCD -.24620 .49040 .956 -1.8371 1.3447 
Honey -.03980 .55288 1.000 -1.8106 1.7310 
PHMB -.33680 .61411 .944 -2.3238 1.6502 
ISCD 
NSCD .24620 .49040 .956 -1.3447 1.8371 
Honey .20640 .49875 .974 -1.4163 1.8291 
PHMB -.09060 .56587 .998 -1.9810 1.7998 
Honey 
NSCD .03980 .55288 1.000 -1.7310 1.8106 
ISCD -.20640 .49875 .974 -1.8291 1.4163 
PHMB -.29700 .62080 .962 -2.3009 1.7069 
PHMB 
NSCD .33680 .61411 .944 -1.6502 2.3238 
ISCD .09060 .56587 .998 -1.7998 1.9810 
Honey .29700 .62080 .962 -1.7069 2.3009 
P5 
NSCD 
ISCD -.12040 .12040 .759 -.6105 .3697 
Honey -.12040 .12040 .759 -.6105 .3697 
PHMB 2.06180* .17335 .000 1.5065 2.6171 
ISCD 
NSCD .12040 .12040 .759 -.3697 .6105 
Honey .00000 .00000 . .0000 .0000 
PHMB 2.18220* .12471 .000 1.6745 2.6899 
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Honey 
NSCD .12040 .12040 .759 -.3697 .6105 
ISCD .00000 .00000 . .0000 .0000 
PHMB 2.18220* .12471 .000 1.6745 2.6899 
PHMB 
NSCD -2.06180* .17335 .000 -2.6171 -1.5065 
ISCD -2.18220* .12471 .000 -2.6899 -1.6745 
Honey -2.18220* .12471 .000 -2.6899 -1.6745 
St6538 
NSCD 
ISCD 2.07680* .06586 .000 1.8087 2.3449 
Honey .67560 .25689 .176 -.3701 1.7213 
PHMB 1.26600* .08059 .000 .9379 1.5941 
ISCD 
NSCD -2.07680* .06586 .000 -2.3449 -1.8087 
Honey -1.40120* .26519 .015 -2.4207 -.3817 
PHMB -.81080* .10408 .000 -1.1472 -.4744 
Honey 
NSCD -.67560 .25689 .176 -1.7213 .3701 
ISCD 1.40120* .26519 .015 .3817 2.4207 
PHMB .59040 .26923 .248 -.4210 1.6018 
PHMB 
NSCD -1.26600* .08059 .000 -1.5941 -.9379 
ISCD .81080* .10408 .000 .4744 1.1472 
Honey -.59040 .26923 .248 -1.6018 .4210 
St4300 
NSCD 
ISCD .15560 .06750 .240 -.1192 .4304 
Honey .94540* .09326 .002 .5658 1.3250 
PHMB .43640 .27377 .472 -.6781 1.5509 
ISCD 
NSCD -.15560 .06750 .240 -.4304 .1192 
Honey .78980* .11512 .001 .4127 1.1669 
PHMB .28080 .28197 .760 -.8073 1.3689 
Honey 
NSCD -.94540* .09326 .002 -1.3250 -.5658 
ISCD -.78980* .11512 .001 -1.1669 -.4127 
PHMB -.50900 .28922 .388 -1.5833 .5653 
PHMB 
NSCD -.43640 .27377 .472 -1.5509 .6781 
ISCD -.28080 .28197 .760 -1.3689 .8073 
Honey .50900 .28922 .388 -.5653 1.5833 
St_7f_C7 
NSCD 
ISCD 4.11720* .55273 .005 1.9230 6.3114 
Honey -.15920 .09588 .425 -.5070 .1886 
PHMB 1.01560* .09224 .001 .6625 1.3687 
ISCD 
NSCD -4.11720* .55273 .005 -6.3114 -1.9230 
Honey -4.27640* .54665 .005 -6.4925 -2.0603 
PHMB -3.10160* .54602 .016 -5.3202 -.8830 
Honey 
NSCD .15920 .09588 .425 -.1886 .5070 
ISCD 4.27640* .54665 .005 2.0603 6.4925 
PHMB 1.17480* .04267 .000 1.0336 1.3160 
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PHMB 
NSCD -1.01560* .09224 .001 -1.3687 -.6625 
ISCD 3.10160* .54602 .016 .8830 5.3202 
Honey -1.17480* .04267 .000 -1.3160 -1.0336 
St13142 
NSCD 
ISCD .00000 .05770 1.000 -.1848 .1848 
Honey .00000 .05770 1.000 -.1848 .1848 
PHMB .00000 .05770 1.000 -.1848 .1848 
ISCD 
NSCD .00000 .05770 1.000 -.1848 .1848 
Honey .00000 .05770 1.000 -.1848 .1848 
PHMB .00000 .05770 1.000 -.1848 .1848 
Honey 
NSCD .00000 .05770 1.000 -.1848 .1848 
ISCD .00000 .05770 1.000 -.1848 .1848 
PHMB .00000 .05770 1.000 -.1848 .1848 
PHMB 
NSCD .00000 .05770 1.000 -.1848 .1848 
ISCD .00000 .05770 1.000 -.1848 .1848 
Honey .00000 .05770 1.000 -.1848 .1848 
St9B_F6 
NSCD 
ISCD .72360 .49490 .505 -.9221 2.3693 
Honey .48780 .44340 .700 -.9538 1.9294 
PHMB 1.50240* .38383 .019 .2732 2.7316 
ISCD 
NSCD -.72360 .49490 .505 -2.3693 .9221 
Honey -.23580 .54341 .971 -1.9868 1.5152 
PHMB .77880 .49600 .451 -.8686 2.4262 
Honey 
NSCD -.48780 .44340 .700 -1.9294 .9538 
ISCD .23580 .54341 .971 -1.5152 1.9868 
PHMB 1.01460 .44463 .186 -.4298 2.4590 
PHMB 
NSCD 
NSCD -1.50240* .38383 .019 -2.7316 -.2732 
ISCD -.77880 .49600 .451 -2.4262 .8686 
Honey -1.01460 .44463 .186 -2.4590 .4298 
*. The mean difference is significant at the 0.05 level. 
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 Collagen wound model comparison 8.3.2
 
Descriptives 
 N Mean Std. Dev Std. 
Err 
95% Confidence Interval for Mean Min Max 
Lower Bound Upper Bound 
clone1 
NSCD 5 8.6300 .00000 .00000 8.6300 8.6300 8.63 8.63 
ISCD 5 8.6300 .00000 .00000 8.6300 8.6300 8.63 8.63 
Honey 5 2.2156 .18713 .08369 1.9833 2.4479 1.94 2.43 
PHMB 5 2.8694 .36170 .16176 2.4203 3.3185 2.22 3.05 
Total 20 5.5863 3.13738 .70154 4.1179 7.0546 1.94 8.63 
clone2 
NSCD 5 8.4670 .00000 .00000 8.4670 8.4670 8.47 8.47 
ISCD 5 8.4670 .00000 .00000 8.4670 8.4670 8.47 8.47 
Honey 5 2.0320 .32237 .14417 1.6317 2.4323 1.49 2.32 
PHMB 5 2.6350 .29647 .13258 2.2669 3.0031 2.20 2.99 
Total 20 5.4003 3.16041 .70669 3.9211 6.8794 1.49 8.47 
ukhs 
NSCD 5 8.9030 .00000 .00000 8.9030 8.9030 8.90 8.90 
ISCD 5 8.9030 .00000 .00000 8.9030 8.9030 8.90 8.90 
Honey 5 2.4891 .18698 .08362 2.2569 2.7212 2.21 2.71 
PHMB 5 2.8346 .31209 .13957 2.4471 3.2221 2.60 3.36 
Total 20 5.7824 3.20846 .71743 4.2808 7.2840 2.21 8.90 
Act_Type 
NSCD 5 8.7025 .00000 .00000 8.7025 8.7025 8.70 8.70 
ISCD 5 8.7025 .00000 .00000 8.7025 8.7025 8.70 8.70 
Honey 5 4.5008 .08525 .03813 4.3950 4.6067 4.43 4.65 
PHMB 5 2.9699 .20385 .09116 2.7168 3.2230 2.75 3.25 
Total 20 6.2189 2.60988 .58359 4.9975 7.4404 2.75 8.70 
A882 
NSCD 5 6.5900 .13565 .06066 6.4216 6.7584 6.46 6.81 
ISCD 5 6.1900 .20248 .09055 5.9386 6.4414 5.89 6.43 
Honey 5 4.2420 .22443 .10037 3.9633 4.5207 3.87 4.47 
PHMB 5 3.3542 .15893 .07108 3.1569 3.5516 3.23 3.63 
Total 20 5.0941 1.38601 .30992 4.4454 5.7427 3.23 6.81 
A292 
NSCD 5 8.8172 .00000 .00000 8.8172 8.8172 8.82 8.82 
ISCD 5 8.8172 .00000 .00000 8.8172 8.8172 8.82 8.82 
Honey 5 6.1889 .24969 .11166 5.8789 6.4990 5.87 6.47 
PHMB 5 6.3517 .15893 .07108 6.1544 6.5491 6.23 6.63 
Total 20 7.5437 1.31487 .29401 6.9284 8.1591 5.87 8.82 
Ps_Type 
NSCD 5 8.3180 .00000 .00000 8.3180 8.3180 8.32 8.32 
ISCD 5 8.3180 .00000 .00000 8.3180 8.3180 8.32 8.32 
Honey 5 2.6574 .14049 .06283 2.4830 2.8318 2.48 2.85 
PHMB 5 8.3180 .00000 .00000 8.3180 8.3180 8.32 8.32 
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Total 20 6.9028 2.51561 .56251 5.7255 8.0802 2.48 8.32 
P1 
NSCD 5 6.4490 .12670 .05666 6.2917 6.6063 6.29 6.55 
ISCD 5 5.5046 .20808 .09306 5.2462 5.7630 5.26 5.79 
Honey 5 4.8686 .24635 .11017 4.5627 5.1745 4.62 5.23 
PHMB 5 3.6640 .13244 .05923 3.4996 3.8284 3.52 3.78 
Total 20 5.1216 1.05223 .23529 4.6291 5.6140 3.52 6.55 
P2 
NSCD 5 6.5230 .13843 .06191 6.3511 6.6949 6.32 6.68 
ISCD 5 4.8846 .32899 .14713 4.4761 5.2931 4.39 5.17 
Honey 5 4.6484 .20595 .09210 4.3927 4.9041 4.36 4.90 
PHMB 5 3.5564 .20387 .09117 3.3033 3.8095 3.34 3.84 
Total 20 4.9031 1.10882 .24794 4.3842 5.4220 3.34 6.68 
P3 
NSCD 5 6.4492 .16816 .07520 6.2404 6.6580 6.36 6.75 
ISCD 5 4.8048 .15562 .06959 4.6116 4.9980 4.68 5.02 
Honey 5 3.8344 .27864 .12461 3.4884 4.1804 3.52 4.13 
PHMB 5 4.7966 .28965 .12953 4.4370 5.1562 4.34 5.13 
Total 20 4.9712 .98758 .22083 4.5090 5.4335 3.52 6.75 
P4 
NSCD 5 6.7714 .16073 .07188 6.5718 6.9710 6.51 6.91 
ISCD 5 6.2560 .23027 .10298 5.9701 6.5419 5.85 6.40 
Honey 5 1.7500 .36216 .16196 1.3003 2.1997 1.51 2.37 
PHMB 5 5.8038 .03410 .01525 5.7615 5.8461 5.77 5.86 
Total 20 5.1453 2.05250 .45895 4.1847 6.1059 1.51 6.91 
P5 
NSCD 5 6.3242 .18671 .08350 6.0924 6.5560 6.19 6.63 
ISCD 5 6.4552 .31122 .13918 6.0688 6.8416 6.11 6.71 
Honey 5 2.4582 .32410 .14494 2.0558 2.8606 2.21 2.82 
PHMB 5 6.2410 .03417 .01528 6.1986 6.2834 6.21 6.30 
Total 20 5.3697 1.74082 .38926 4.5549 6.1844 2.21 6.71 
St6538 
NSCD 5 8.6300 .00000 .00000 8.6300 8.6300 8.63 8.63 
ISCD 5 8.6902 .13461 .06020 8.5231 8.8573 8.63 8.93 
Honey 5 5.2700 .24321 .10876 4.9680 5.5720 4.97 5.58 
PHMB 5 3.0858 .14657 .06555 2.9038 3.2678 2.88 3.26 
Total 20 6.4190 2.43636 .54479 5.2787 7.5593 2.88 8.93 
St4300 
NSCD 5 4.7926 .17496 .07824 4.5754 5.0098 4.60 4.99 
ISCD 5 5.0766 .14231 .06364 4.8999 5.2533 4.93 5.31 
Honey 5 4.8544 .18075 .08084 4.6300 5.0788 4.58 5.09 
PHMB 5 4.0042 .36675 .16402 3.5488 4.4596 3.58 4.46 
Total 20 4.6820 .46778 .10460 4.4630 4.9009 3.58 5.31 
St_7f_C7 
NSCD 5 6.1322 .17982 .08042 5.9089 6.3555 5.92 6.34 
ISCD 5 6.0104 .10662 .04768 5.8780 6.1428 5.90 6.14 
Honey 5 5.6480 .08818 .03944 5.5385 5.7575 5.57 5.74 
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PHMB 5 4.2356 .08095 .03620 4.1351 4.3361 4.13 4.35 
Total 20 5.5066 .78255 .17498 5.1403 5.8728 4.13 6.34 
St13142 
NSCD 5 5.5592 .17982 .08042 5.3359 5.7825 5.34 5.77 
ISCD 5 5.6002 .20708 .09261 5.3431 5.8573 5.40 5.93 
Honey 5 4.8542 .26564 .11880 4.5244 5.1840 4.53 5.17 
PHMB 5 3.5860 .04684 .02095 3.5278 3.6442 3.56 3.67 
Total 20 4.8999 .85408 .19098 4.5002 5.2996 3.56 5.93 
St9B_F6 
NSCD 5 5.8806 .20964 .09376 5.6203 6.1409 5.66 6.22 
ISCD 5 5.7426 .20808 .09306 5.4842 6.0010 5.50 6.03 
Honey 5 4.8294 .26555 .11876 4.4997 5.1591 4.50 5.15 
PHMB 5 3.6202 .08728 .03903 3.5118 3.7286 3.54 3.74 
Total 20 5.0182 .94463 .21123 4.5761 5.4603 3.54 6.22 
 
 
Multiple Comparisons 
Games-Howell 
Dependent 
Variable 
(I) 
VAR00001 
(J) VAR00001 Mean Difference 
(I-J) 
Std. Error Sig. 95% Confidence Interval 
Lower Bound Upper Bound 
clone1 
NSCD 
ISCD .00000 .00000 . .0000 .0000 
Honey 6.41440* .08369 .000 6.0737 6.7551 
PHMB 5.76060* .16176 .000 5.1021 6.4191 
ISCD 
NSCD .00000 .00000 . .0000 .0000 
Honey 6.41440* .08369 .000 6.0737 6.7551 
PHMB 5.76060* .16176 .000 5.1021 6.4191 
Honey 
NSCD -6.41440* .08369 .000 -6.7551 -6.0737 
ISCD -6.41440* .08369 .000 -6.7551 -6.0737 
PHMB -.65380* .18212 .043 -1.2843 -.0233 
PHMB 
NSCD -5.76060* .16176 .000 -6.4191 -5.1021 
ISCD -5.76060* .16176 .000 -6.4191 -5.1021 
Honey .65380* .18212 .043 .0233 1.2843 
clone2 
NSCD 
ISCD .00000 .00000 . .0000 .0000 
Honey 6.43500* .14417 .000 5.8481 7.0219 
PHMB 5.83200* .13258 .000 5.2923 6.3717 
ISCD 
NSCD .00000 .00000 . .0000 .0000 
Honey 6.43500* .14417 .000 5.8481 7.0219 
PHMB 5.83200* .13258 .000 5.2923 6.3717 
Honey 
NSCD -6.43500* .14417 .000 -7.0219 -5.8481 
ISCD -6.43500* .14417 .000 -7.0219 -5.8481 
PHMB -.60300 .19586 .060 -1.2312 .0252 
136 
 
 
PHMB 
NSCD -5.83200* .13258 .000 -6.3717 -5.2923 
ISCD -5.83200* .13258 .000 -6.3717 -5.2923 
Honey .60300 .19586 .060 -.0252 1.2312 
ukhs 
NSCD 
ISCD .00000 .00000 . .0000 .0000 
Honey 6.41394* .08362 .000 6.0735 6.7544 
PHMB 6.06844* .13957 .000 5.5003 6.6366 
ISCD 
NSCD .00000 .00000 . .0000 .0000 
Honey 6.41394* .08362 .000 6.0735 6.7544 
PHMB 6.06844* .13957 .000 5.5003 6.6366 
Honey 
NSCD -6.41394* .08362 .000 -6.7544 -6.0735 
ISCD -6.41394* .08362 .000 -6.7544 -6.0735 
PHMB -.34550 .16270 .240 -.8942 .2032 
PHMB 
NSCD -6.06844* .13957 .000 -6.6366 -5.5003 
ISCD -6.06844* .13957 .000 -6.6366 -5.5003 
Honey .34550 .16270 .240 -.2032 .8942 
Act_Type 
NSCD 
ISCD .00000 .00000 . .0000 .0000 
Honey 4.20166* .03813 .000 4.0465 4.3569 
PHMB 5.73264* .09116 .000 5.3615 6.1038 
ISCD 
NSCD .00000 .00000 . .0000 .0000 
Honey 4.20166* .03813 .000 4.0465 4.3569 
PHMB 5.73264* .09116 .000 5.3615 6.1038 
Honey 
NSCD -4.20166* .03813 .000 -4.3569 -4.0465 
ISCD -4.20166* .03813 .000 -4.3569 -4.0465 
PHMB 1.53098* .09881 .000 1.1756 1.8863 
PHMB 
NSCD -5.73264* .09116 .000 -6.1038 -5.3615 
ISCD -5.73264* .09116 .000 -6.1038 -5.3615 
Honey -1.53098* .09881 .000 -1.8863 -1.1756 
A882 
NSCD 
ISCD .40000* .10900 .032 .0390 .7610 
Honey 2.34800* .11728 .000 1.9531 2.7429 
PHMB 3.23575* .09344 .000 2.9348 3.5367 
ISCD 
NSCD -.40000* .10900 .032 -.7610 -.0390 
Honey 1.94800* .13518 .000 1.5141 2.3819 
PHMB 2.83575* .11512 .000 2.4623 3.2092 
Honey 
NSCD -2.34800* .11728 .000 -2.7429 -1.9531 
ISCD -1.94800* .13518 .000 -2.3819 -1.5141 
PHMB .88775* .12299 .001 .4837 1.2918 
PHMB 
NSCD -3.23575* .09344 .000 -3.5367 -2.9348 
ISCD -2.83575* .11512 .000 -3.2092 -2.4623 
Honey -.88775* .12299 .001 -1.2918 -.4837 
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A292 
NSCD 
ISCD .00000 .00000 . .0000 .0000 
Honey 2.62824* .11166 .000 2.1737 3.0828 
PHMB 2.46546* .07108 .000 2.1761 2.7548 
ISCD 
NSCD .00000 .00000 . .0000 .0000 
Honey 2.62824* .11166 .000 2.1737 3.0828 
PHMB 2.46546* .07108 .000 2.1761 2.7548 
Honey 
NSCD -2.62824* .11166 .000 -3.0828 -2.1737 
ISCD -2.62824* .11166 .000 -3.0828 -2.1737 
PHMB -.16278 .13237 .630 -.6047 .2791 
PHMB 
NSCD -2.46546* .07108 .000 -2.7548 -2.1761 
ISCD -2.46546* .07108 .000 -2.7548 -2.1761 
Honey .16278 .13237 .630 -.2791 .6047 
Ps_Type 
NSCD 
ISCD .00000 .00000 . .0000 .0000 
Honey 5.66060* .06283 .000 5.4048 5.9164 
PHMB .00000 .00000 . .0000 .0000 
ISCD 
NSCD .00000 .00000 . .0000 .0000 
Honey 5.66060* .06283 .000 5.4048 5.9164 
PHMB .00000 .00000 . .0000 .0000 
Honey 
NSCD -5.66060* .06283 .000 -5.9164 -5.4048 
ISCD -5.66060* .06283 .000 -5.9164 -5.4048 
PHMB -5.66060* .06283 .000 -5.9164 -5.4048 
PHMB 
NSCD .00000 .00000 . .0000 .0000 
ISCD .00000 .00000 . .0000 .0000 
Honey 5.66060* .06283 .000 5.4048 5.9164 
P1 
NSCD 
ISCD .94440* .10895 .000 .5780 1.3108 
Honey 1.58040* .12389 .000 1.1510 2.0098 
PHMB 2.78500* .08197 .000 2.5224 3.0476 
ISCD 
NSCD -.94440* .10895 .000 -1.3108 -.5780 
Honey .63600* .14421 .010 .1712 1.1008 
PHMB 1.84060* .11031 .000 1.4723 2.2089 
Honey 
NSCD -1.58040* .12389 .000 -2.0098 -1.1510 
ISCD -.63600* .14421 .010 -1.1008 -.1712 
PHMB 1.20460* .12508 .000 .7746 1.6346 
PHMB 
NSCD -2.78500* .08197 .000 -3.0476 -2.5224 
ISCD -1.84060* .11031 .000 -2.2089 -1.4723 
Honey -1.20460* .12508 .000 -1.6346 -.7746 
P2 NSCD 
ISCD 1.63840* .15962 .000 1.0650 2.2118 
Honey 1.87460* .11097 .000 1.5073 2.2419 
PHMB 2.96660* .11020 .000 2.6024 3.3308 
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ISCD 
NSCD -1.63840* .15962 .000 -2.2118 -1.0650 
Honey .23620 .17358 .559 -.3449 .8173 
PHMB 1.32820* .17309 .001 .7478 1.9086 
Honey 
NSCD -1.87460* .11097 .000 -2.2419 -1.5073 
ISCD -.23620 .17358 .559 -.8173 .3449 
PHMB 1.09200* .12960 .000 .6770 1.5070 
PHMB 
NSCD -2.96660* .11020 .000 -3.3308 -2.6024 
ISCD -1.32820* .17309 .001 -1.9086 -.7478 
Honey -1.09200* .12960 .000 -1.5070 -.6770 
P3 
NSCD 
ISCD 1.64440* .10246 .000 1.3158 1.9730 
Honey 2.61480* .14554 .000 2.1246 3.1050 
PHMB 1.65260* .14978 .000 1.1447 2.1605 
ISCD 
NSCD -1.64440* .10246 .000 -1.9730 -1.3158 
Honey .97040* .14273 .002 .4831 1.4577 
PHMB .00820 .14705 1.000 -.4974 .5138 
Honey 
NSCD -2.61480* .14554 .000 -3.1050 -2.1246 
ISCD -.97040* .14273 .002 -1.4577 -.4831 
PHMB -.96220* .17974 .003 -1.5380 -.3864 
PHMB 
NSCD -1.65260* .14978 .000 -2.1605 -1.1447 
ISCD -.00820 .14705 1.000 -.5138 .4974 
Honey .96220* .17974 .003 .3864 1.5380 
P4 
NSCD 
ISCD .51540* .12558 .018 .1020 .9288 
Honey 5.02140* .17720 .000 4.3907 5.6521 
PHMB .96760* .07348 .000 .6804 1.2548 
ISCD 
NSCD -.51540* .12558 .018 -.9288 -.1020 
Honey 4.50600* .19193 .000 3.8652 5.1468 
PHMB .45220* .10410 .038 .0372 .8672 
Honey 
NSCD -5.02140* .17720 .000 -5.6521 -4.3907 
ISCD -4.50600* .19193 .000 -5.1468 -3.8652 
PHMB -4.05380* .16268 .000 -4.7103 -3.3973 
PHMB 
NSCD -.96760* .07348 .000 -1.2548 -.6804 
ISCD -.45220* .10410 .038 -.8672 -.0372 
Honey 4.05380* .16268 .000 3.3973 4.7103 
P5 
NSCD 
ISCD -.13100 .16231 .849 -.6782 .4162 
Honey 3.86600* .16727 .000 3.2980 4.4340 
PHMB .08320 .08488 .768 -.2518 .4182 
ISCD 
NSCD .13100 .16231 .849 -.4162 .6782 
Honey 3.99700* .20095 .000 3.3533 4.6407 
PHMB .21420 .14002 .498 -.3492 .7776 
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Honey 
NSCD -3.86600* .16727 .000 -4.4340 -3.2980 
ISCD -3.99700* .20095 .000 -4.6407 -3.3533 
PHMB -3.78280* .14574 .000 -4.3697 -3.1959 
PHMB 
NSCD -.08320 .08488 .768 -.4182 .2518 
ISCD -.21420 .14002 .498 -.7776 .3492 
Honey 3.78280* .14574 .000 3.1959 4.3697 
St6538 
NSCD 
ISCD -.06020 .06020 .759 -.3053 .1849 
Honey 3.36000* .10876 .000 2.9172 3.8028 
PHMB 5.54420* .06555 .000 5.2774 5.8110 
ISCD 
NSCD .06020 .06020 .759 -.1849 .3053 
Honey 3.42020* .12431 .000 2.9951 3.8453 
PHMB 5.60440* .08900 .000 5.3189 5.8899 
Honey 
NSCD -3.36000* .10876 .000 -3.8028 -2.9172 
ISCD -3.42020* .12431 .000 -3.8453 -2.9951 
PHMB 2.18420* .12699 .000 1.7564 2.6120 
PHMB 
NSCD -5.54420* .06555 .000 -5.8110 -5.2774 
ISCD -5.60440* .08900 .000 -5.8899 -5.3189 
Honey -2.18420* .12699 .000 -2.6120 -1.7564 
St4300 
NSCD 
ISCD -.28400 .10086 .089 -.6101 .0421 
Honey -.06180 .11250 .944 -.4222 .2986 
PHMB .78840* .18172 .021 .1499 1.4269 
ISCD 
NSCD .28400 .10086 .089 -.0421 .6101 
Honey .22220 .10288 .218 -.1115 .5559 
PHMB 1.07240* .17593 .006 .4318 1.7130 
Honey 
NSCD .06180 .11250 .944 -.2986 .4222 
ISCD -.22220 .10288 .218 -.5559 .1115 
PHMB .85020* .18286 .015 .2115 1.4889 
PHMB 
NSCD -.78840* .18172 .021 -1.4269 -.1499 
ISCD -1.07240* .17593 .006 -1.7130 -.4318 
Honey -.85020* .18286 .015 -1.4889 -.2115 
St_7f_C7 
NSCD 
ISCD .12180 .09349 .591 -.1941 .4377 
Honey .48420* .08957 .007 .1711 .7973 
PHMB 1.89660* .08819 .000 1.5835 2.2097 
ISCD 
NSCD -.12180 .09349 .591 -.4377 .1941 
Honey .36240* .06188 .002 .1626 .5622 
PHMB 1.77480* .05987 .000 1.5799 1.9697 
Honey 
NSCD -.48420* .08957 .007 -.7973 -.1711 
ISCD -.36240* .06188 .002 -.5622 -.1626 
PHMB 1.41240* .05353 .000 1.2407 1.5841 
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PHMB 
NSCD -1.89660* .08819 .000 -2.2097 -1.5835 
ISCD -1.77480* .05987 .000 -1.9697 -1.5799 
Honey -1.41240* .05353 .000 -1.5841 -1.2407 
St13142 
NSCD 
ISCD -.04100 .12265 .986 -.4356 .3536 
Honey .70500* .14346 .007 .2307 1.1793 
PHMB 1.97320* .08310 .000 1.6542 2.2922 
ISCD 
NSCD .04100 .12265 .986 -.3536 .4356 
Honey .74600* .15063 .006 .2569 1.2351 
PHMB 2.01420* .09495 .000 1.6450 2.3834 
Honey 
NSCD -.70500* .14346 .007 -1.1793 -.2307 
ISCD -.74600* .15063 .006 -1.2351 -.2569 
PHMB 1.26820* .12063 .001 .7912 1.7452 
PHMB 
NSCD -1.97320* .08310 .000 -2.2922 -1.6542 
ISCD -2.01420* .09495 .000 -2.3834 -1.6450 
Honey -1.26820* .12063 .001 -1.7452 -.7912 
St9B_F6 
NSCD 
ISCD .13800 .13210 .730 -.2850 .5610 
Honey 1.05120* .15130 .001 .5606 1.5418 
PHMB 2.26040* .10156 .000 1.8949 2.6259 
ISCD 
NSCD -.13800 .13210 .730 -.5610 .2850 
Honey .91320* .15087 .002 .4236 1.4028 
PHMB 2.12240* .10091 .000 1.7597 2.4851 
Honey 
NSCD -1.05120* .15130 .001 -1.5418 -.5606 
ISCD -.91320* .15087 .002 -1.4028 -.4236 
PHMB 1.20920* .12501 .001 .7425 1.6759 
PHMB 
NSCD -2.26040* .10156 .000 -2.6259 -1.8949 
ISCD -2.12240* .10091 .000 -2.4851 -1.7597 
Honey -1.20920* .12501 .001 -1.6759 -.7425 
*. The mean difference is significant at the 0.05 level. 
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 Comparison between wound models (planktonic vs collagen) 8.3.3
Multiple Comparisons 
Games-Howell 
Acinetobactersp (I) VAR00001 (J) VAR00001 
Mean 
Difference (I-
J) 
Std. Error Sig. 
95% Confidence Interval 
Lower 
Bound 
Upper 
Bound 
Clone 1 
NSCD-P NSCD-C .91200 .00000 . .9120 .9120 
ISCD-P ISCD-C -1.39000* .05500 .000 -1.6757 -1.1043 
Honey-P Honey-C 6.63940* .08369 .000 6.2047 7.0741 
PHMB-P PHMB-C 1.05760* .16469 .020 .2336 1.8816 
Clone 2 
NSCD-P NSCD-C 1.01200 .00000 . 1.0120 1.0120 
ISCD-P ISCD-C -1.95040* .21746 .007 -3.0801 -.8207 
Honey-P Honey-C 7.40100* .14417 .000 6.6521 8.1499 
PHMB-P PHMB-C 1.94040* .28526 .006 .7091 3.1717 
UK-HS 
NSCD-P NSCD-C .39300 .00000 . .3930 .3930 
ISCD-P ISCD-C -2.72280* .15547 .001 -3.5304 -1.9152 
Honey-P Honey-C 6.15994* .08362 .000 5.7255 6.5943 
PHMB-P PHMB-C 1.27324* .21358 .005 .4233 2.1232 
Type 
NSCD-P NSCD-C 1.19850 .00000 . 1.1985 1.1985 
ISCD-P ISCD-C -1.94590* .16678 .003 -2.8123 -1.0795 
Honey-P Honey-C 4.22316* .03813 .000 4.0251 4.4212 
PHMB-P PHMB-C 1.45594* .10788 .000 1.0075 1.9044 
882 
NSCD-P NSCD-C .63800 .31511 .550 -.9357 2.2117 
ISCD-P ISCD-C -.21000 .11987 .662 -.6869 .2669 
Honey-P Honey-C -1.44000* .11882 .000 -1.9338 -.9462 
PHMB-P PHMB-C -.62425* .11564 .010 -1.0892 -.1593 
292 
NSCD-P NSCD-C -.27717 .00000 . -.2772 -.2772 
ISCD-P ISCD-C -.27717 .00000 . -.2772 -.2772 
Honey-P Honey-C -.26693 .13245 .531 -.8167 .2828 
PHMB-P PHMB-C -1.43771* .13765 .000 -2.0153 -.8601 
*. The mean difference is significant at the 0.05 level. 
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Multiple Comparisons 
Games-Howell 
Pseudomonas sp (I) VAR00001 (J) VAR00001 
Mean Difference 
(I-J) 
Std. Err Sig. 
95% Confidence Interval 
Lower 
Bound 
Upper 
Bound 
PS Type 
NSCD-P NSCD-C .06300 .00000 . .0630 .0630 
ISCD-P ISCD-C -3.05920* .08457 .000 -3.4985 -2.6199 
Honey-P Honey-C 2.62480* .15131 .000 1.9525 3.2971 
PHMB-P PHMB-C -5.00940* .19704 .000 -6.0330 -3.9858 
Ps Type 1 
NSCD-P NSCD-C 1.47780* .06982 .000 1.1939 1.7617 
ISCD-P ISCD-C 2.42220* .10161 .000 1.9671 2.8773 
Honey-P Honey-C 3.22140* .11017 .000 2.6491 3.7937 
PHMB-P PHMB-C 5.39200* .26518 .000 4.0846 6.6994 
Ps Type 2 
NSCD-P NSCD-C 1.34280* .08635 .000 1.0010 1.6846 
ISCD-P ISCD-C 2.76620* .24178 .000 1.7920 3.7404 
Honey-P Honey-C 3.02140* .19576 .000 2.1791 3.8637 
PHMB-P PHMB-C 2.81180* .48193 .029 .4018 5.2218 
Ps Type 3 
NSCD-P NSCD-C 1.08340* .12148 .000 .5956 1.5712 
ISCD-P ISCD-C 1.95180* .33918 .029 .2665 3.6371 
Honey-P Honey-C 3.79360* .12461 .000 3.1463 4.4409 
PHMB-P PHMB-C 1.43120 .47568 .231 -.8600 3.7224 
Ps Type 4 
NSCD-P NSCD-C .01540 .39227 1.000 -1.9507 1.9815 
ISCD-P ISCD-C .77700 .31998 .383 -.7240 2.2780 
Honey-P Honey-C 5.07660* .42802 .001 3.1331 7.0201 
PHMB-P PHMB-C 1.31980 .47818 .308 -1.1615 3.8011 
Ps Type 5 
NSCD-P NSCD-C 1.85740* .14652 .000 1.2581 2.4567 
ISCD-P ISCD-C 1.84680* .13918 .002 1.1238 2.5698 
Honey-P Honey-C 5.84380* .14494 .000 5.0909 6.5967 
PHMB-P PHMB-C -.12120 .12565 .959 -.7635 .5211 
*. The mean difference is significant at the 0.05 level. 
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Multiple Comparisons 
Games-Howell 
S. aureus (I) VAR00001 (J) VAR00001 
Mean Difference 
(I-J) 
Std. Error Sig. 
95% Confidence 
Interval 
Lower 
Bound 
Upper 
Bound 
6538 
NSCD-P NSCD-C -1.60900 .00000 . -1.6090 -1.6090 
ISCD-P ISCD-C -3.74600* .08923 .000 -4.0999 -3.3921 
Honey-P Honey-C 1.07540 .27896 .092 -.1827 2.3335 
PHMB-P PNMB-C 2.66920* .10388 .000 2.2535 3.0849 
43300 
NSCD-P NSCD-C 2.60340* .07824 .000 2.1969 3.0099 
ISCD-P ISCD-C 2.16380* .09277 .000 1.7964 2.5312 
Honey-P Honey-C 1.59620* .12342 .000 1.1052 2.0872 
PHMB-P PNMB-C 2.95540* .31914 .001 1.6146 4.2962 
87F/C7 
NSCD-P NSCD-C .51220* .12003 .034 .0359 .9885 
ISCD-P ISCD-C -3.48320* .54758 .024 -6.3042 -.6622 
Honey-P Honey-C 1.15560* .05299 .000 .9452 1.3660 
PHMB-P PNMB-C 1.39320* .04334 .000 1.2143 1.5721 
13142 
NSCD-P NSCD-C 1.38460* .09018 .000 .9926 1.7766 
ISCD-P ISCD-C 1.34360* .10120 .000 .8908 1.7964 
Honey-P Honey-C 2.08960* .12561 .000 1.5014 2.6778 
PHMB-P PNMB-C 3.35780* .04586 .000 3.1589 3.5567 
9B/F6 
NSCD-P NSCD-C .94900 .28619 .167 -.3892 2.2872 
ISCD-P ISCD-C .36340 .42482 .978 -1.7351 2.4619 
Honey-P Honey-C 1.51240 .37093 .084 -.2292 3.2540 
PHMB-P PNMB-C 1.70700* .27519 .025 .3082 3.1058 
*. The mean difference is significant at the 0.05 level. 
 
 
 
 
 
